{"cells":[{"cell_type":"markdown","metadata":{"id":"9ulcFsipRNZx"},"source":["__INSTALL SPACY__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":24589,"status":"ok","timestamp":1705231186725,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"4vLJE54Fslxw","outputId":"a8b07522-23ed-4aff-f46d-9e9cb1077601"},"outputs":[{"name":"stdout","output_type":"stream","text":["\n","\u001b[1m[\u001b[0m\u001b[34;49mnotice\u001b[0m\u001b[1;39;49m]\u001b[0m\u001b[39;49m A new release of pip is available: \u001b[0m\u001b[31;49m23.3.1\u001b[0m\u001b[39;49m -> \u001b[0m\u001b[32;49m23.3.2\u001b[0m\n","\u001b[1m[\u001b[0m\u001b[34;49mnotice\u001b[0m\u001b[1;39;49m]\u001b[0m\u001b[39;49m To update, run: \u001b[0m\u001b[32;49mpython3 -m pip install --upgrade pip\u001b[0m\n"]}],"source":["! pip install -U spacy -q"]},{"cell_type":"markdown","metadata":{"id":"aR8jEtpasm2z"},"source":["combine json files"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":16127,"status":"ok","timestamp":1705229138895,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"X1iiiWULssXG","outputId":"af2799a4-4cf7-4b4c-9598-3c5a724c0869"},"outputs":[{"name":"stdout","output_type":"stream","text":["2024-01-14 10:45:30.766794: E external/local_xla/xla/stream_executor/cuda/cuda_dnn.cc:9261] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n","2024-01-14 10:45:30.766878: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:607] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n","2024-01-14 10:45:30.769774: E external/local_xla/xla/stream_executor/cuda/cuda_blas.cc:1515] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n","2024-01-14 10:45:30.783021: I tensorflow/core/platform/cpu_feature_guard.cc:182] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n","To enable the following instructions: AVX2 FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n","2024-01-14 10:45:32.233767: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Could not find TensorRT\n","/usr/local/lib/python3.10/dist-packages/spacy/util.py:910: UserWarning: [W095] Model 'en_core_web_sm' (3.6.0) was trained with spaCy v3.6.0 and may not be 100% compatible with the current version (3.7.2). If you see errors or degraded performance, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n","  warnings.warn(warn_msg)\n","\u001b[1m\n","============================== Info about spaCy ==============================\u001b[0m\n","\n","spaCy version    3.7.2                         \n","Location         /usr/local/lib/python3.10/dist-packages/spacy\n","Platform         Linux-6.1.58+-x86_64-with-glibc2.35\n","Python version   3.10.12                       \n","Pipelines        en_core_web_sm (3.6.0)        \n","\n"]}],"source":["!python -m spacy info"]},{"cell_type":"markdown","metadata":{"id":"_BTjdeVKRNaB"},"source":["Import spacy english model."]},{"cell_type":"code","execution_count":null,"metadata":{"id":"jUqdhGWIsvls"},"outputs":[],"source":["import spacy\n","from spacy.tokens import DocBin\n","from tqdm import tqdm\n","\n","nlp = spacy.blank(\"en\") # load a new spacy model\n","db = DocBin() # create a DocBin object"]},{"cell_type":"markdown","metadata":{"id":"ZNQHC9_jRNaC"},"source":["__IMPORT TRAINING DATA.__"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"F-4WTpqMtgT2"},"outputs":[],"source":["import json\n","f = open('test-train-data/comb-annotations.json')\n","TRAIN_DATA = json.load(f)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":804,"status":"ok","timestamp":1705231215778,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"G9CC3dJ3tj2W","outputId":"ccb4525a-08ad-496b-bbb6-e20b3af6ca95"},"outputs":[{"name":"stdout","output_type":"stream","text":["{'classes': ['COMMON NAME', 'COMPOSITION NAME'], 'annotations': [['Image 1: Acid-labletsBP MEFTAL-500 Each Uncoated Tablet Contains: 500 mg Mefenamic Acid IP MET-EETTEO Excipients q.s. Dosage:As prescribed by the Physician Store protected from light & moisture at a temperature not exceeding 30C 205208 Keep out of reach of children. Registered Trademark BLUE MADE IN INDIA BY BLUE CROSS LABORATORIES PVTLTD L-17.VERNA INDUSTRIAL ESTATE VERNA.GOA403 722 CROSS Regd OPeninsula Chambers.G.K Mag Mumbai400 013. Rx Mefenamic AcidTablets:BP CCAo LOROURS MEFTAL-500 ', {'entities': [[24, 34, 'COMMON NAME'], [66, 90, 'COMPOSITION NAME']]}], ['Image 2: SCHEDULE H DRUG Warning To be Anti-inflammatory- Analgesic sold by retail on the prescription of a Registered MedicalPractitioner only Composition: Each uncoated tablet contains: \"Bronchospasm may be precipitated in Ibuproten IP 400 mg patients suffering from or with a previous ParacetamolIP 325 mg history ot bronchial asthma.Ibuprofen Excipients: q.s should not be given to patients In whom Dosage As directed by the Aspirin and other Non-steroidal Anti- Physician, inflammatory drugs induce the symptoms of AsthmaRhinitis or Urticaria.\"   Registered Trademark HCI    A Store protected from molsture. at a temperature below 30C. ARISTO (01)08906027790516 Manutactured in india by Keep out of reach of children, ARISTO Pharmaceuticals Pvt.Ltd Warning Taking more than daily Survey No.371,Kunbar Falia, dose may cause serious liver damage Village:Dabhel, Nani Daman-396 210, or allergic reactions (e.g.swelling of DAMAN (U.T.) the face, mouth and throat,difficulty Regd.Office:12,J.N. Heredia Marg, in breathing,Itching or rash) Mumbai-400 001 Flexon Flexon FlexonFlexonFlexonFlexonFlexonFlexon buprofen &Paracetamol Tablets IP Flexon M.LNo.DD/133 DP8 SCHEDULE H DRUG Warning:To be Anti-inflammatory Analgesic sold by retail on the prescription ot a Composition: Registered Medical Practitioner only. Each uncoated tabtet contains: \"Bronchospasm may be precipitated-in 400 mg Ibuproten IP patients suffering from or with a previous ParacetamolIP 325 mg history of bronchial asthma lbuproten Excipients q.s should not be given to patlents in whom Dosage:As directed by the Aspirin and other Non-steroidal Anti Physician, inflammatory drugs induce the symptoms   of Asthma, Rhinitis or Urticaria.  Registered Trademark     ', {'entities': [[225, 244, 'COMPOSITION NAME'], [288, 308, 'COMPOSITION NAME'], [1054, 1060, 'COMMON NAME']]}], ['Image 3: STHTGIRO FOR SALESIN NEPAL Zydus Cadid Ocid20 Ocid20 3 Each hard gelatin capsule contains OmeprazoleIP 20mg As enterid coated granules Excipients .S Sunset Yellow and Titanium Dioxide R Keep in a cool dry place,Protect from light & moisture Omeprazole Swallow whole-Do not chew or crush R CapsulesIP SCHEQUUHDRUG 2057687 Warnie of a Reg TqEToT eapsules FOR SALESN NEPAL ONLY TH fash 3TSRO Mfg.Lic.No.186 Manufactured by:Cadila Healthcare Limited Zydus Kundaim ial Estate,Plot No.203-213 Industr Kundaim, -403115,INDA Cadild Ocid2 o Ocid 3 Each hard gelatin capsule contains meprazole  erbcoate ', {'entities': [[99, 116, 'COMPOSITION NAME']]}], [\"Image 4: PANTOP PANTOP* wreg PANTOP* PANTOP* Pantoprazole SodiumDelayed-Release Tablets USP Pantoprazole Sodium Delayed-Relea wRey PANTOP* farnt t PANTOP Each delayed-release tablet contains Each delayed-release tablet contains Mfg.Lic.No.3721 Mfg Pantoprazole Sodium.tisp Pantoprazole Sodium USP equivalent.to Pantoprazote 40'mg equivalent to.Pantoprazole Colour:Sunset Yellow &Tartrazine Man CotourSunset Yellow&Tartrazine Manufactured in Nepalby (Dissolutioncomplies as per.USPTest III Dissolution complies as per USPTest III) Asia Asian Pharmaceuticals Pvt.Ltd. Omsa Omsatiya-1,Rupandehi  3 3 fafH  s fa H *Tra *Trade Mark Registered 911541   B.NO.PT 0515MFGMAY2023 EXP.APR.2026 M.R.PRS80.O0 PER1OTABS \", {'entities': [[9, 15, 'COMMON NAME'], [45, 87, 'COMMON NAME'], [311, 329, 'COMPOSITION NAME']]}], ['Image 5: NAROSEN-250 MA   M5 Each uncoated tablet contains. 2025 NaproxenP250 mg ffa Manufact dMarketedS EXP Mfg.L .13915 NaproxenJablets IP 7-RYO NAROSEN-250 ', {'entities': [[65, 80, 'COMPOSITION NAME']]}], [\"Image 6: RabeprazoleSodium lableis z0mg MAA2TS '1O'dX3 RABOGUT The tablet shouldbe taken whole and should not be broken, crushed or chewad Composition: before swallowing Each enteric coated tablet contains Rabeorazole Sodium.20-mg MigLic.Noa4 Dosage :As directed by the Phvsician Manufactarednnindia.hy HEMADRAS PHARMACEUTICALS Storage:Store balow 3C. Protect from light &moisture 137-B,Old Mahabaypram Road Karapakkam,Chenna-600 096. Keep out of reach otchildren. Rabeprazole Soditm Tablets 20mg 'ON'S \", {'entities': [[55, 62, 'COMMON NAME'], [206, 230, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 7: Pantoprazole40 mg as enterc coated pellets PUECER Domperidone 1P 30mg (as a sustained release pellets) fa fat-faar  Colour:Approved colour used in the capsuleshells Manufactured in Nepal by    Kasturi Pharmaceuticals Pvt.Ltd Bharatpur-16, Chitwan PUUEEED MS2 MAPRPS 5 Pantoprazole Gastro-resistant & Domperidone UCRRS Prolonged-release Capsules IP DECENT A division of Kasturi R530000 PULCER D Mfg.Lic.No.1761012065335 Composition: H Each hard gelatin capsule contains Pantoprazole Sodium IP eq to HHE\"g\" PEEEEED Pantoprazole 40 mg (as enteric coated pellets) fant  Domperidone IP 30 mg (as a sustained release pellets) fa ffa  Colour Approved colour used in the capsule shells Manufactured in Nepal by. KasturiPharmaceuticals Pyt.Ltd Bharatpur-16. ', {'entities': [[9, 26, 'COMPOSITION NAME'], [522, 540, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 8: EVEREST Each Capsulecontains harmaceotice! ffna Hc Pantoprazole Sodium P equivalent to Pante Domperidone 0.mg as prolonged release NarchBhaktapur Welpan 118 Pantoprazole Gastro Resistantang Domperidone Prolonged-Release Capsuies MfgLic.No 1760111024620 Welpan D EVEREST 9047 Each Capsule contain pnarmaceutical HIFTA zole Sodium Se aydrate Fanopr Man Tby as-ente ed pelle Ever Pharmaceuticals Pvt ECTRROE haktapu ', {'entities': [[262, 270, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 9: Rx Alidac Pantoprazole Tablets IP 40mg ORZA PantodacTablets Pantodac Each enteric coated tablet contains: Pantoprazole Sodium IR S2/603 equivalent to Pantoprazole 40mg Excipients q.s. Colours :Yellow Oxide of lron NF & Not chew or crush the tablet Titanium Dioxide DosageAs directed by the Physician   Store below 30c,Protect from-moisture FOR SALES IN NEPALONTT   30C ME1122 Under License from: PEERO KEEP OUT OF REACH OFCHILDREN Nycomed GmbH   Byk-Gulden-Str.2 NYCOMED 78467Konstanz, SCHEDULE HDRUG 20200 Germany Warning:To be sold by retalhon the prescrip tion of a Registered MedicalPractitioner only. Manufactured byCadila Healthcare Limited Kundaim Industrial Estate,lot No.203-213, fa daim.Goa-4035N ', {'entities': [[115, 127, 'COMPOSITION NAME']]}], ['Image 10: WORMEK atargg WORMEX WORMEX WORMEX WORMEXWORHEX WORMEX WORMEX ETABLETSIP ALBENDAZOLE TABLETSIP WORMEX - ALBENDAZOLETABLETSIP WORMEXaTHR ALBENDA EXa WORMEXaa WOR Each chewable tablet contains: ablet contains: Each cnewable tablet contains. Mig.Lic.No.:1618 Albendazole USP 400.mg Mfg.Lic.NO1618 400mg Mig.Lic.No1618 Each chew Atbendazole USP400 mg Marauiactured by: Colour:Erythrosine Manutactursdby: Albendazok ne ColourErythrosine Manutactured by ColourEry ARYA ARYA ARYA PHARMALAB PVT.LTD. PHARMAPY.LTD. PHARMALAB PYPIPO Chnaanpara.BraNepal BANO. MFG. Chnatapipara EXP WMT89006MAY22APR.25 WMT89006MAX22APR.25 M.RP.RS.10.O0PERTAB. M.R.PRS1O.OORERTAB. ', {'entities': [[31, 37, 'COMMON NAME'], [266, 288, 'COMPOSITION NAME']]}], ['Image 11: MfgLic.No1905 Manuiacturedby ARYA APPR9 PHARMALAB PVT.LTD EXP - Chhatapipara,Bara Nepal CIPRO-500APLT-  Ciprofloxacin TabletsUSP CIPRO500APL- Each filmcoated tableteontains CiprotloxacinsydroenorideUsp equivalenttoCiprofloxacn500 mg BNO Mfg.Lic.No.905 Manufactured bw ARYA PHARMALAB fa ', {'entities': [[114, 138, 'COMMON NAME']]}], ['Image 12: ALLOPATHIC.GROUPKHO WARNINGTobGod d retallon the prescriptcn oraRegrstered MedicarFractitioneronly, Flontin 500 Manufactured by: Deurali-Janta PharmaceuticalsPvt.Ltd. Dhapasi-1,Kathmandu,Nexal. Registered Trade Mark Flontin 500 Flontin 500 Flootin 500 Flontin 500 Ciprofloxacin Hydrochloride Tablets USP Flontin500 EacsFim ontin MAY25 Colour xideand Dosage:As by the Physician 501 005 Mfg.Lic. N ALL IC,GROUP:Kha WARNIN be sold by reta the pre don of a Registe Med raotitioner only ctured by Sali-Janta Vt.Ltd. maceutica redTrade Mark R Flontir ', {'entities': [[262, 273, 'COMMON NAME']]}], [\"Image 13: mredoyrPanaceaBiotec PharmaLtd PBPNT Bbay 1150 yes HOT holly-ownedSubsidlary ofPanacea Biotec Ltd. MalpurBadd Qistt Solan H.P.-173205India. E2S RSSS5EES Rx Nimesulide Flavoured A Tablets Dispersible Nimulid-MD Each uncoateddispersible tablet contalns: Nimesulide BR100 mg Dosage:As diretted by the Physician Storage:Storeat temperature below'25'C A protect from light and moisture. MAN2 KEEP THE MEOICNE OUT OF REACH OF CHILDREN SCHEDUCEHEPHESCRIPTION DRUGUCAUTIO PEEEET2 Manufacryredby Panacea BiotecPharma.Ltd MalpurBaddistt.Solan H.P.)-173205Jndia Rx NimesulideFlavoures A DispersibleTablets \", {'entities': [[262, 281, 'COMPOSITION NAME'], [564, 604, 'COMMON NAME']]}], ['Image 14: MAAARS MfgLic.No.2095 Each film coated tablet contains EXP IP 500 mg Tinidazole MaNutactured dy:    ARYA PHARMALAB PVT.LTD AAPa hatapipara,BaraNepal 3-400 TINIDAL-500- XNIDAL-500 Tinidazole Tabletsye TNIDAS-500 AHE Amoebicidalablets) 9-93 BONE 3-900 Lic.No.:2095 ach film coated tabiet contains inidazole 500.m ', {'entities': [[72, 89, 'COMPOSITION NAME'], [165, 177, 'COMMON NAME']]}], ['Image 15: Manutactured8y. Magnus Pharma Pyt.Ltd. Rampur Tokani Bara.Nepal Levofloxacin Tablets IP LEVOEEOX-500 M.R.P.R500PER10TABS MFG.MAY2023 EXP.APR.2025 B.No.8B23001 fat-400 Mfg.Lic.No8183 Each film coated tablet contains: Levofloxacin hemihydrate IP ff 500 mg eg.to Levofloxacin ColourTitanium Dioxide Manufactured Magnus PharmaPyt.Ltd. Rampur TokaniBar Nepal Levofloxacin Tabets IP LEVOOX-500 183 tq Lic ', {'entities': [[226, 253, 'COMPOSITION NAME'], [364, 383, 'COMMON NAME']]}], [\"Image 16: SwichCV-325 -325 swich CV-325 -325 Cefpodoxime Proxetil and Potassium Clavulanate Tablets S 325 Made inIndia by SwichcV-325 ALKEM-HEALTH SCIENCE A Unitof Alkem Laboratories Limited Each film-coated tablet contains SCHEDULE H1PRESCRIPTION Samardung Karek Block Cefpodoxime Proxetil IP equivalent to DRUG-CAUTION P.O.:Namthang,District-Namchi, Cefpodoxime.. .200 mg Sikkim737137. It is dangerous totake this Potassium Clavulanate Diluted P preparation except in accordance equivalent to Clavulanic Acid125 mg Marketed by with the medicatadvice. Excipients. .q.s. Not to be sold by retai without the ALKEM ColourTitaniumDioxide IP prescriphon ota Pegctered ALKEM.LABORATORIESLTD Medical Practitroner Dosage:As directed by the ALKEM HOUSE'Senapati Bapat Marg Physician. LowerPareMumbai-400013 Keep out of reach of children Registered Trade Mark Store below 25C To report a product query & adverse drug eyent,please reach us Protect from moisture. Mfg.Lic.No.:M/618/2012 at-contact@alkem.com SwichcV-325 -325 SwichcV.325 325 Cefpodoxime Proxetil and Potassium Clavulanate Tablets Swich cV 325 325 Made in lndia by ALKEMHEALTH SCIENCE Each-film-coated tablet contains it ofAlkem LaboratoriesLimite SCHEDULE lungKarek Block \", {'entities': [[45, 99, 'COMMON NAME'], [352, 373, 'COMPOSITION NAME'], [495, 516, 'COMPOSITION NAME']]}], [\"Image 17: Each film coated tablet contains Azithromycin Dihydrate I AZIPURE-S00 Equivalent to Azithromycin 500 mg Color Iron Oxide Red & Titanium Dioxide rafafraarrn P-r AZIPUELSOO H Mfg.Lic.No.:12013/069/070/VEGA-36 Manutacturedin Nepal by: Vega Pharmaceuticals Pvt.Ltd Lalitour-2.AunginatiNepal ega BE090DN'E 03FAZ50 AZITHROMYOIN TABLETS IP AZIPLRS-500 AZIPURE-500 U Each film coate Azithromycin Di Equivalent to A ColorIron Oxid \", {'entities': [[94, 113, 'COMPOSITION NAME'], [355, 366, 'COMMON NAME']]}], [\"Image 18: AMOXICILLIN AND POTASSIUM CLAVULANATE TABLETSIP ALKEM CLAVAM.375 375 Each film-cpated tobiet contains Keep out ot reach ot children Amoxicin.Trinydrate IP Store below 25c.Protect from moisture equivaient to Amoxicillin.... 250mg Mfg.Lic.No.:M7572016 Potassium Clavulanate Diluted IP Made in India by: equlvalent to Clavulanic Acid...125mg a Colaur' itanium Dioxide IP. Dosage The usual adult dose is ene tablet ALKEM eight hourly or as directed by the Physician. ALKEM HEALTH SCIENCE A Unit of Alkem Laboratonies Limited, Unit-2, OULEHPRESCRIPTION Samardung,Karek Block CAUTION P.ONamthangSouthSjkkim-737137 be sold by retall without th sion of red Medical Practtio Lower Parel,Mumbai-400-013. -Registered TradeMark CLAVAM375 375 CLAVAMSZS -375 \", {'entities': [[217, 238, 'COMMON NAME']]}], [\"Image 20: PHARMALABPVT.LTD. Chhatapipara,Sara, Nepal Amoxycillin Capsules BP SUPRAMOX 500 MPPPOPPPPS SUPRAMOK500 EXP 400 HHE a sach capsulecontains: moxycillin Trihydrate BP fg.Lic.No881 toAmoxycilin.500.mo Boprovedcoioursusedin opsule shelise Manufactureaby ARYA 40 PHARMALAEPVT.LTD. Chhatapipara,Sara,Nepal ON'E Amoxyciltin Capsules BP SUPRA SUPRAMOX 500 \", {'entities': [[53, 73, 'COMMON NAME']]}], ['Image 21: *O0 aeter*sis KEEP ALL MEDICINES OUT OF REACH OF CHILOREN Dosage:One tablet daily. or as directed by the Physician Mfg.Lic.No.:1807-B Crlee Ind-Swifr Clarie*op Each film coated extended-release tablet contains: Manufactured by Clarithromycin USP 500 mg Ind-Swift Limited Excipients q.s Colours : Quinoline Yellow and Titanium Dioxide Global Business Unit, Jawaharpur, Off NH21,DerabassiDistt.Mohali Storage:Store below 30c.Protect trom light & moisture. Punjab-140507.india *Trademark Registraton applied for. SWALLOW WHOLE TABLET ONCE A DAY WITH FOOD. Clarie*oD 00+aise1 Clarithromycin Extended-Release Tablets USP WARNiNGTo be sold by retail on the prescrptok Clarie*on f a Registered Medical Practitioner only. KEF ALL MEDICINES OUT OF REACH OF CHILDREN One tablet daily or as directed by the Physiclan 1807-B Ind-Swify ', {'entities': [[237, 262, 'COMPOSITION NAME']]}], ['Image 22: Each capsule contains; EXPMAX2025PE10.CAPS B.N0.101047 Indomethacin-sustained release pellets eguivalent to IndomethacinUSP 75mg Approved colours used in capsule shell Mfg.Lic.No.5325SR-101 Manufactured inNepal by fa S.RDRUG LABORATORIES PVT.LTD Satungal,Kathmandu SR Website:srdrug.net Indomethacin Sustained Release Capsules Indg SR $STTA3TR Each capsule>ontains:   Indomethacinustained   elease pellet auivalent to ', {'entities': [[118, 138, 'COMPOSITION NAME'], [297, 336, 'COMMON NAME']]}], ['Image 23: Colour Titanium Dioxide Mfg.Lic.No.12327 Manufactured by Deurali-Janta Pharmaceuticals Pvt.Ltd Dhapasi-1.Kathmandu,Nepal Registered Trade Mark. 02 fACE 16 ANTI-INFLAMMATORY ANALGESICTABLETS B.NOCECT/2602 CECLO100 01 crait-900 Aceclofenac Tablets Each film coated tablet contains: EXPOCT24 Aceclofenac BP 100 mg ECLO-100 Colour: Titanium Dioxide PErAT Mfg.Lic.No.:12327 CECLO-100 Manufactur Deural ', {'entities': [[236, 255, 'COMMON NAME'], [299, 320, 'COMPOSITION NAME']]}], ['Image 24: DICLUFENAC POTASSIUMI SUSTAINEDRELEASETABLETS .3. KALINAC-100 SR MFG-DEC f Each enteric coated sustained BNOKST9179 release tablet contains: - Diclofenac Potassium BP 100 mg Colours:Brilliant Blue & Mfg.Lic.No.1740 Sunset Yellow 2022 Manufactured in Nepal by Asian Pnarmaceuticals Pvt.Ltd Omsatiya-1.Rupandehi, Trade Mark Registered ASIAN HOV.2024 6 KALINACSR A. KALINAC100SR..KALC100SR DICLOFENAC POTASSIUM SUSRAINED RELEASESRBLETS .3 ALINACXIOO SR ', {'entities': [[10, 55, 'COMMON NAME'], [153, 183, 'COMPOSITION NAME']]}], ['Image 25: CHEWABLE ANTACID ANTIFLATULENT DIGENE SISTO For the relief of symptoms associated with acid indigestion and dyspepsia 15Tablets Each uncoated chewable tablet contains: Dried Aluminium Hydroxide Gel I.P. 300 mg Magnesium Aluminium Silicate Hydrate 50mg Magnesium Hydroxide I.P. 25 mg Simethicone I.P. 25mg Colours:Erythrosine &Ponceau 4R Keep all the medicines out of the reach of children Dosage:As advised by the physician Store below 30C.Protect from light. Mfg.Lic.No.281 2010015925 Manufactured by:Abbott India Limited, AN L-18/19,Verna Industrial Estate, Verna Salcette,Goa-403722,India -Regd.Trademark of Abbott GMBH & CO.KG MINT FLAVOUR Abbott B.NO.480006D7 MFD.12/2022 EXP.11/2025N M.R.P.R5.24-14 INCL.OF ALL TAXES ', {'entities': [[178, 314, 'COMPOSITION NAME']]}], ['Image 26: HEby. SRAPellets VegaPharmaceubgalsPvt.Ltd Dompericane Bom vega alitpur-22Bungm,Nepal. Equivalent to Domperidone Approyed colors used in capsuleshell 02FPAND/22 ISAFE-D Color Pantoorazole Gastro-Resistamand ANSA Domperidone Prolonged Releaseroapsules IP PANSAFED HIE PASSA Each hard gelatin capsule contains.   PantoprazoleSodium Sesquihydrate Mfg.Lic.No.1750504033606 Equivalent to Pentoprazole PANSAFE-D As enteric coated Tablet) Manufactured in Nepal by: ORPellets ANSSSED Jomperidont Vega Pharmaceutials Pvt.Ltd Equivalent te Domperidone vega Lalitpur-22,Bungmati Nepal Color: Approved.colors used in capsulelshe 02FPAND/22 Panteprezole Gastro-Resistantand DomperidoneProlonged.Releas Siesim ', {'entities': [[393, 405, 'COMPOSITION NAME']]}], [\"Image 27: Protect from light&moisture 137-8,Old MahabalipuramRoad Karapakkam.Chennai-600 096 T Esomeprazole Tablets 40mg EPAAAUT EXPPL JPRAGUT Me tablet should be taken whole and should not be broken.crushed or chewed pstore swallowing Composition: Each enteric Ccated tabletcontains reep out of reach otohidren, EPDROT Esomeprazole Magnesium USP MtgLic.No.:247 eq.to anhydrous Esomeprazole 40 mg Manufactured in India by Dosage :As directed by the Physician. THE MADRAS PHARMACEUTICALS Storage:Store below30C. 137-BOld MahabalipuraRoad, Protect from light & moisture 600096. rapakkam,Chennai 'ON'S Fsomensszs \", {'entities': [[95, 120, 'COMMON NAME'], [320, 346, 'COMPOSITION NAME']]}], ['Image 28: . RTOTETA 08- fast faror Mfg.Lic.No National Healthcare Manufactured National Healthcare Pvt. Ltd. Chhatapipra,Bara Nepal ESOMEPRAZOLE TABLETS Esofast-40 -40 SH-80 Each film coated tab contains: Esomeprazole Maor um Trihydrate IP Equivalent to Esom 4Omg S Cola m0 5.H TOTERI Har aa Mfg.Lic.N t-40 lational Healthcare Manufactur National Healtncare Pvt.Ltd ipra, Nepal ', {'entities': [[132, 152, 'COMMON NAME']]}], ['Image 29: Super CV375 3 per CV 375 National B.No.SCT23037 MFG.21APR.2023EXP.20APR.2025 .. M.R.P.Rs.300.00PER10TABS Healthcare Manufactured by National Healthcare Pvt.Ltd. HE Chhatapipra,Bara,Nepal. STTps Amoxicillin and Clavulanate Mfg.Lic.No.:6131 3 Potassium Tablets USP Each film coated tablet contains: Amoxicillin UsP as Trihydrate Super CV 375 250 mg equivalent to anhydrous Amoxicillin Diluted Potassium ClavulanateBP equivalent to Clavulanic Acid 125 mg Colour:Titanium Dioxide USP Super CV375 39   National .. Super CV375 Healthcare Manufactured by: HE National Healthcare Pvt.Ltd. Chhatapipra,Bara, Nepal. Mfg.Lic.No.:6131 Amoxicillin and Clavulanate Each film coated tablet contains Potassium Tablets USP Amoxicillin UsP as Trihydrate equivalent to anhydrous Amoxicillin 250 mg Super CV 375 Diluted Potassium Clavulanate BP 125 mg equivalent to Clavulanic Acid 3 Colour: Titanium Dioxide Super CV375 39 ', {'entities': [[716, 788, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 30: ACLOV C Each uncoated tablet contains: H 2 BNoAV2-0123 MFGSEP MRPRS200/10TS USP 400mg 400 Acyclovir 9h NIMBUS NIMBuS<(A division of LOMUS) 800 Manufactured by LOMus Pharmaceuticals Pvt.Ltd Mig.Lic No.4772/LP146 Gothatar Kathmandu,Nepal . AGLOV400 ACLOX400 ACLOV 400 ACLOV400 CLOV400 AU6.25 Acyclovir Tablets USP 22 ACLO Each uncoated tablet contains USP 400mg Acyclovir 40 ', {'entities': [[300, 321, 'COMMON NAME']]}], ['Image 31: vaacyciovirrabiets bot JLNEX IOOO HICTTCR-TO00 Eachim-coated tablet contains Mifg.Lic.No.:1761013100802 Valaevclovir Hydrochleride UsP HHE equizalent to Valacyclovir 1000 mg rarertfafhnent Colours:Brilliant Blue and fa-fa Titaram Dioxide IP ManufacturedinNeparby 2024 KevaPharmaceuticalsPvt.Ltd ananagar-16,Ctwan,Nepal acycloviTablets SP VALNEXOO0 H-9000 alm-coated tablecpntains Lic.No.176193100802 ovir Hydrochletce USP ', {'entities': [[163, 183, 'COMPOSITION NAME']]}], ['Image 33: Dosage ARisrO Pharmaceuticals Pvt.Ltd. As directed by the Physician Manufactured in India by Store protected from-moisture, at a ARIsro Pharmaceuticals Pvt.Ltd temperature not exceeding 30C Village:Makhnumajra,PO.Bhud,Baddi, 1OTTBS ARISTO Dist.Solan H.P-173205 Keep out of reach of children R Cefpodoxime Tablets IP 200 mg INNTTEEENEES BPP288 Monoral 200 200 mpositor SCHEDULE HT PRESCRIPTION DRUG CAUTION Each tilm-coated tablet contains t is dangerous to take-tnis preparation except CeipodoximeProxetilip in aocordancewith themedical.advice. equivalent to Cefpodoxime200 mg Not to be sold by retail without the prescription Excipients: ofa Registered Medical ractitioner. q.s. Colour Titanium Dioxide IP BON TMTrademark of MEG. Dosage: ARIsTO Pharmaceuticals Pvt.Ltd. As directed by the Physician Manufactured in India by Store protected from.moisture,at a ARIsTo Pharmaceuticals Pvt.Ltd. temperature not exceeding 30C. WS Village:MakhnumajraPO.BhudBaddi, ARISTO Keep out of reach of children Dist.Solan H.P-173205 Mon Cefpodoxime Tablets lP 200 mg ', {'entities': [[303, 332, 'COMMON NAME'], [1032, 1061, 'COMMON NAME']]}], ['Image 34: afr f Mfg.Lic.No.:10582 Manufactured in Nepal by CUREX Pharmaceuticals Pyt.Ltd. Banepa-10 Kavre District, Nepal. Cefpodoxime Proxetil and Potassium.Clavulanate Tablets CEFDOXCV-200 5-00 Each film coated tablet contains Cefpodoxime Proxetil USP eguivalent to Cefpodoxime 200-mg Potassium-Clavulanate diluted.iP equivalent to Clavulanic acid-125 T Mfg.Lic.No.:10582 CUREX Ltd. Pharmaceuticals Banepa-10 Disto ', {'entities': [[123, 177, 'COMMON NAME'], [268, 286, 'COMPOSITION NAME']]}], ['Image 35: Manufactured by 140 Qmed Formulation Pvt.Ltd QO0PIOCEF-200 Chhaling-S.Bhaktapur District.Nepal Cefixime Tablets USP PIOCEF-200 91415-200 HE 00730 Each film coated tablet contains Cefixime USP as Trlnydrate equivalent to Cefixime 200mg Colour:Erythrosine HTE:fa PIOCEF-200 Mfg.Lic.No.8584 Manufactured by : Qmed Formutation Pvt.Ltd Chhaling-5,Bhaktapur Dlstrict.Nepal 00 Cefixime ablets USP PI0G-F-200 Fachaon Colour:Erythrosme ', {'entities': [[105, 125, 'COMMON NAME'], [230, 244, 'COMPOSITION NAME']]}], ['Image 37: equivalent to Mfg-Lic.NoKTK28342/2004 Made in India by ML07T-0019/E MICRO LABS LIMITED Colour:Titanium Dioxide IP NO.121-124 Dosage:As directed by 4th PhaseK.I.A.D.B. the Physician. ade Mark Proprietor Cefpodoxime and CCC20 Potassium Clavulanate Tablets Microcef-CV200 HEDULEH1PRESCRIPTION CAUTION Each film.coated.tablet.contains Cefpodoxime ProxetilIP equivalent to Cefpodoxime 200.mg Potassium Clavulanate Diluted IP MigiNO.KTK/28/342/2004 equivalent to 00% Mage in India by MLO7T-0019/E Clavulanic Acid 125 mg MICRO LABS LIMITED Colour:Titanium Dioxide IP No.121-124 Dosage:As directed by 4th PhaseK.I.A.D.B. Bommasandra Industrial Area the Physician. ICRO LABS Anekal Taluk Bangalore-560 099. Keep in a dry place,below 25C Trade Mark Proprietor Cefpodoxime ano Potassium Clavulanate Tablets Microcef-CV200 Potassium Clavulanate Diloted ip fgc.No.:KTK/28/342/2004 equivalent to Clavulanic Acid 125 mg Made in India by: ML07T-0019/E MICRO LABS LIMITED Colour:Titanium Dioxide IP No.121-124, Dosage:As directed by 4th Phase,K.I.A.D.B. the Physician. Bommasandra Industrial Area, CFO LABS Anekal TalukBangalore-560 099 Keep in a dry place, below 25 ade Mark Proprietor Cefpodoxime and Potassium Clavuanate Tablets Microcef-CV200 ', {'entities': [[760, 805, 'COMMON NAME'], [892, 914, 'COMPOSITION NAME']]}], ['Image 38: SAREPRINPDS Co-trimoxazole Tablets IP Mfg.Lic.No.:1458 CAREPRIM-DS- HyE B.NO. Each uncoated tablet contains -fa1 IP 160 mg Trimethoprim Sulphamethoxazole IP 800 mg - ufg-f CAREPRIM-DS CAREPRIM-DS MFG National f Healtncare Manufacturedby: National Healthcare Pvt.Ltd Chhatapipra,BaraNepal. - - GAREPRIM-DS EXP MAREPRIM-DS Co-trimoxazole Tablets IP Mfg.LicNo.:1458 CAREPRIM-- Rach uncoatedtablet contains fa-fa1 IP 160 mg Trimethoprim Sulphamethoxazole IP 800 mg - CAREPRIM-DS RMDS ', {'entities': [[22, 44, 'COMMON NAME'], [430, 442, 'COMPOSITION NAME'], [443, 470, 'COMPOSITION NAME']]}], ['Image 39: Cefixime Tablets USP CEFMEX 400 800 ', {'entities': [[10, 26, 'COMMON NAME']]}], ['Image 40: LOMOPRIM-DS LOMOPRIM-DS LOMOPRIM-DS LOMOPRIM-DS Trimethoprim & SulphamethoxazoleTablets I.P -3 LOMOPRIM-DS f Each uncoatedtablet contains 160 mg Trimethoprim I.P. HE\" Sulphamethoxazole 1.P. 800 mg rt:fnt r Mfg.Lic.No.237/LR-16 fT Manufactured<by LOMUS PharmaceuticaisPvt.Ltd Gothatar,Kathoandu, Nepal ? LOMUS LOMOPRIM-DS LOMOPRIM-DS LOMOPRIM-DS LOMOPRIM.DS Trimethopam & Sulphamethoxazole Tablets l.P LOMOORIM-DS ', {'entities': [[58, 97, 'COMMON NAME']]}], ['Image 41: JTICEF200 fg.Lic.No.6173 f-f Manufactured by yfe44:308 ARYA PHARMALABIPVILID Chhatapipara,Bara,Nepal Cefixime Tablets USP UTICEF200 UTICEF-200 4H5300 mcoatedtabletcontains CefiximetUSPas:trinydrateeouivalent.to Anhydrous Cefixime200 mg Colour:Titanium Dioxide UTICER2 Mfg.Lic.No.6173 ', {'entities': [[111, 131, 'COMMON NAME'], [221, 245, 'COMPOSITION NAME']]}], [\"Image 42: vaiacveioviriaoietstst WSLNEX-IOOO HMCR-9000 Eacaim-coated tablet contains. Mifg.Lic.No.:1761013100802 Valaevclovir Hydrochleride USP equalent to Valacyclovir 1000 mg Colers:Brilliant Blue and rtfn Titanm Dioxide IP fa-far .131.70 Manufacturedin.Neoarby vaPharmaceucals'Pvt.Ltd nanagar-16,CwanNepal USP acyclovisTablets LNEX000 M-9000 m-coated tablecontains: Lic.No.:176103100802 ovir Hydroc USP \", {'entities': [[156, 176, 'COMPOSITION NAME']]}], ['Image 43: Fixim 200 Fixim200 TTCRHROO Fixim200 Cefixime Tablets USP 00 Mfg.Lic.No.:2616 Fixim200 R00 PER10 TABS B.No.FMTF Fixim 200 fR 00 Fixim 200 fnfay 00 Fixim 200 Fixim 200 Each film coated tablet contains: 3 Cefixime USP as Trihydrate equivalent to Anhydrous Cefixime 200 mg Colours:Titanium Dioxide UsP& National Manufactured by: Lake Indigo Carmine National Healthcare Pvt.Ltd. Healthcare Chhatapipra,Bara,Nepal fnfany Fixim 200 f R0 Fixim 200 ffa R00 Fixim 200 Cefixime Tablets USP Mfg.Lic.No.:2616 Fixim200 fR00 Ro ff ', {'entities': [[47, 63, 'COMMON NAME'], [254, 279, 'COMPOSITION NAME']]}], ['Image 44: Mtanium Dioxide IP IAN Mfg.Lic.No.1740519025013 ASIAN Trade Mark Registered ASIAN ASIAN IAN ASIAN ASI AS EXP.0CT.2024 MFG.NOV.2022 B.NO.CATF9019 Manufactured in Nepal by ASIAN Asian Pharmaceuticals Pyt.Ltd. ASIAN Omsatiya-1,Rupandehi CEFUSAFE-500 4-0CEFUSAFE-500-00 CEFUROXIME AXETIL TABLETS USP 994-400 PER10TABS M.R.P.Rs.700.00 AN ASIAN CEFUSAFE-500 Each film coated tablet contains Cefuroxime Axetil UsP equivalent to Cefuroxime 500mg ASIAN AS Colour:Titanium Dioxide IP ASIAN ASIAN Mfg.Lic.No.:1740519025013 Trace Mark Registered. ASIAN HHE SIAN fa ', {'entities': [[276, 301, 'COMMON NAME'], [431, 447, 'COMPOSITION NAME']]}], ['Image 45: Manufactured in Nepalby: pod -00  Nova Genctica Pvt. Ltd. Khani Khola-7.Naubise,Dhading Cefpodoxime Proxetil and Potassium lpodCV-200 Clavulanate Tablets Ipod CV-200 Composition: Each film coated tablet contains: 300 Caipodoxime Proxetil USP eqv.to Cefpodoxine 200 mg Potassium Clavulanate Diluted IP eqv.to Clavulanic Acid 125mg Colour Sunset Yeliow FCF ooc-io  hle lpod CV-200    Hrfafnt  003-Apod fa fa-fa 300 Mfg.Lic.No.10139 Manufactured in Nepal by Nova Genetica Pvt. Ltd. Khani Khola-7,Naubise,Dhading oo- y he Cefpodoxime Proxetil and Potassium Ipod CV-200 Clavulanate Tablets pod CV-200 3-00 Composition: 33200 Each film coated tablet contains Cefpodoxime Proxetil USP 200 mg eqv.to Cefpodoxime 125mg eqv.to Clavulanic Acid ColourSunset YellowFCF podCV-200 T   rafat  43-0 ffa-faa Mfg.Lic.No.10139 Manufactured in Nepal by : ', {'entities': [[259, 339, 'COMPOSITION NAME']]}], ['Image 46: Each film-coated tablet contains SCHEOULE HPRESCRIPTION Ciprofloxacin Hydrochloride IP DRUGCAUTION equivalent to Ciprofloxacin 500 mg Not to be sold by retall without the prescription of a Registered Colour:Titanium Dioxide IP Medical Practltioner. Dosage:As directed Mfg.Lic.No.M/600/2012ML24F-0074/C by the Physician. Store in a dry & dark place Made in India by: at a temperature not exceeding 30C MICRO LABS LIMITED Mamring,Namthang Road Caution:This drug may cause low blood sugar South Sikkim-737 132 and mental health related side effects MICRO LABS Regd.Trade Mark Microflox-500 Hargeia-y00 Microflox-500 AcnaF-400 R Ciprofloxacin Tablets IP Microflox-500 H4-900 Each film-coated tablet contains SCHEDULE HPRESCRIPTION Ciprofloxacin Hydrochloride IP DRUG-CAUTION Not to be sold by retail without equivalent to Ciprofloxacin 500 mg the prescription of a Registered Colour:Titanium Dioxide IP MedicalPractitioner Dosage:As directed Mfg.Lic.No.M/600/2012 by the Physician. ML24F-0074/C Made in India by dark ', {'entities': [[123, 143, 'COMPOSITION NAME'], [635, 659, 'COMMON NAME']]}], ['Image 47: Manufactured by: o f3.. National National Healthcare Pvt.Ltd Chhatapipra,Bara Nepal Healthcare Prodoxime CV ProdoximeCV Cefpodoxime Proxetil and Potassium Clavulanate Tablets Mfg.Lic.No.:11053 Prodoxime CV g ime HfH XP Each film coated tablet contains Cefpodoxime Proxetil USP .FEB.2024 equivalent to Cefpodoxime 200mg AR piluted Potassium Clavulanate BP 125 mg .500 equivalent to Clavulanic Acid USP 22076 Colour:Titanium Dioxide f Prodoxime CV Prodoxime CV .00 Manufactured by: 3of.. National National Healthcare Pvt.Ltd. T Healthcare Chhatapipra, Bara,Nepal Prodoxime Prodoxime CV Prodox Cefpodoxime Proxetil and PotassiumClavulanate Tablets Mfq.Lic.No.11053 ', {'entities': [[130, 184, 'COMMON NAME'], [311, 328, 'COMPOSITION NAME'], [391, 406, 'COMPOSITION NAME']]}], [\"Image 49: Cefadroxil MonohydrateBP Mfg.Lic.No.:5973 eq.to Anhydrous Cefadroxil 500 mg ULTRADROXIL-500 Approved colours used in capsule shells Manufactured by ARYA PHARMALABPVT.LTD Chhatapipara,Bara,Nepal EXP CefadroxilCapsules BR ULTRADROXIL-500 OLTRAEROXIL-5OO HTSy00 Each Capsule contains ffa Cefadroxil Monohydrate BP 'ON'E ULTRADROXIL-500 Approved coloursused in eapsule shells fafa Manufactured by: ARYA PHARMALAR Chhatapipara.Bara.Nepa \", {'entities': [[58, 85, 'COMPOSITION NAME'], [208, 226, 'COMMON NAME']]}], ['Image 50: Dosage:As directed by the Physician lovir Tablets USP Acyclovir Tablets USI sovir 400 Store below 30C.Protect from light. Lipsovir 400 Keep the medicine out of reach of children. HR 800 PiaR 00 Manufactured by: ncoated-tablet contains Mfg Lic.No.:G/1419 NEEAEEEA2 Each uncoated tablet contains LINCOLN 400 mg irUSP 400mg Acyclovir USP PHARMACEUTICALSLTD. Q.S. nts Trimul Estate,At.&Post-Khatraj Q.S. Excipients Tal.-Kalol,Dist-Gandhinagar, Gujarat, India B.No.HF0005MFG.10/2020EXP.09/2023 MR.P.RS.130.00PER 1OS INCL.OFALLTAXES ', {'entities': [[64, 81, 'COMMON NAME'], [331, 344, 'COMPOSITION NAME']]}], ['Image 51: ff- Each film coated tablet contains Valacyclovir Hydrochloride USP Mfg.Lic.No.:1760216092324 1000mg eqv.to Valacyclovir Colour:Titanium dioxide IP Manufactured by: Maruti Pharma Pvt.Ltd   Bahuwari-5,Bara (Nepal) Valacyclovir Tablets USP EX2S Valaderm-1000 -000 Composition: rrt:fan Each film coated ablet contains Valacyclovir Hydrochloride USP Mfg.L.No.:1760216092324 eqv.to Valacyclovir 1000 mg Colour:Titanium dioxide IP Manufactured by ', {'entities': [[223, 243, 'COMMON NAME'], [387, 407, 'COMPOSITION NAME']]}], ['Image 52: Dupbaston Dupbaston Batch 5680 10-mg-dydrogesterone MRPNRs0414/ 10 mg dydrogesterone tlm-coated tablets film-coatedtablets Abbott Abbott Dupbaston Dupbaston Manuf.date. Umg aydtogesterone 10.mg.dydrogesterone film-coatedtablets tilm-coated tablets Abbott Abbott - Dubisaston Dupbaston ane.drdrogesterone 10 mg dydrogesterone EXP bated-tablet film-coatedtablets Abbott a Abbott ', {'entities': [[74, 94, 'COMPOSITION NAME']]}], ['Image 53: 6 R CilostazolTablets l.P.50 mg Stiloz-50 10STRIPSOF 15 TABLETSEACH 6GlenmaRk ', {'entities': [[14, 31, 'COMMON NAME']]}], ['Image 55: Mfg.Lic.No.04221040 Made in India by MICRO LABS MICRO LAS LIMITEDUNIT-III R.S.No.63/3&4Thiruvandar Koil Puducherry-605102 MLO5T-0047  Regd.Trade Mark Norethisterone TabletsIP Norgesttisr Each uncoated toblet contains: Store in a dry &dark place, at a temperaturenot exceeding 30C thepresctiprg idaibher Mfg.Lic.No.021040 Made igndia by: MICROFLABS LIMITEDUNIT-IL ICRO LABS R.S.No.63 05402 05T-0047 Norethisterone TabletllP ', {'entities': [[160, 184, 'COMMON NAME']]}], [\"Image 56: ALLTATPTCR ERROUSSISEN DOOONTTOTTE Mfg.Lic.No.:10803 Manufactured by Deurali-Janta Pharmaceuticals Pvt.Ltd MRP' MFG Dhapasi-1,Kathmandu,Nepal Registered Trade Mark 01FCT12 Tranexamic Acid Tablets 500 mg FIBRINIC-500 -y00 Eachstilm coated tablet contains rranexamicsAcid.sRo500.mg FIBRINIC Colour TtaRiamsbioxide ERP Dosage:Assrected by thePhysician 500 Mfg.Lic. N10803 Manuto tured.by Deux Janta FIBRRIC EOC PhaK euticals Py Dhar Kathmandu R R ed Trade Mar 0 Trane Acid Tabl .mg \", {'entities': [[182, 205, 'COMMON NAME']]}], ['Image 57: soxsuprine Hydrochloride IP 10 mg fufn Excipients q.s. fa Manufactured by M.RP.RS.50.00 EXP.FEB.24 MFG. B.No.TIS-803 PER IOTABS .r ALIVE Pharmaceutical Pvt Ltd    Dumraha,Simariya VDC MfgLic.No.:4635 Sunsari,Nepal MAR.22 ISOX ISOX ISOX ISX ISOX Isoxsuprine Hydrochloride Tabletslp SOX SIESHTA Each uncoated tablet contains: rfefnnr  1sozsuprine Hydrochloride IP 10 mg  -f Excipients q.s. ', {'entities': [[255, 290, 'COMMON NAME']]}], ['Image 58: WHO-GMP COMPANY Isoxsuprine Hydrochloride Tablets IP ISOX 3ITSR ', {'entities': [[26, 62, 'COMMON NAME']]}], ['Image 59: R5.mg NorethisteroneTablets BP 5 mg Noret Tablets YFEMITRONE Tablets FEN contraindicated for Each uncoated tablet contains: ns oFregnancy. FEMITRONE is contra-ind.cated for Each uro Norethisterone 2061/LP-87 BP 5 mg the first four months of Pregnancy Noretie Mfg.Lic.No.:2061/LP-87 HIAA Manufactured by LOMUS Pharmaceuticals Pvt.Ltd R Gothatar Kathmancu, Nepal LOMUS LOMUS FEMTRONE FEMITRONE LOOUS SOWQT ', {'entities': [[16, 37, 'COMMON NAME']]}], ['Image 60: 10x10Tablets Tracem500 Tranexemic Acid Tablets CTAH 400 Florid ', {'entities': [[33, 48, 'COMPOSITION NAME']]}], ['Image 61: NOT EXCEEDING 30C. PROTECT FROM MOISTURE Keep out of reach ot children SCHEDULE H PRESCRIPTION DRUGCAUTON Not to be sold by retail withoul the prescription ot a Registered Medical Practitioner Mig.Lic.No.97ASC/P2009 M-Trade Mark under Registration torrent 20117295 PHARMA 807153-9092 Marketed by: TORRENT PHARMACEUTICALSLTD ndrad-382 721.Dist.MebsanaNDIA Manufactured by: Akums Drugs & PharmaceaticasL.td Plot No47&48Sector-6AE SDCUL.RanipurHendwar-249.403. Medroxyprogesterone DEVIRY-10 mg Acetate Tablets1.P. DEVIRY I Mg Luncoated tablet bontains 9 40mg hysician, TORE ATTEM EMATURE IOT EXCEEDIN ROTECTFRO MOISTURE eep out of reag Pmg n.No. Trade Mark under lorrant ', {'entities': []}], ['Image 62: Maautactured in India by ARIsTO Pharmaceuticals Pvt.Ltd. Plot No.208 New Industrial Area No.2 ARISTO Mandideep462046.DistRaisen (M.P. Dezacor6 SOTEPTY Composition: Each uncoated tabtet contains Defiazacortil! 16mg Excipients: q.s Dosage:As directed by the Physician Store in a cooland dry place. m Keep out of reach of children M.L.No.25/23/91 EDULEHPRES AF Manutacturedin.India by: ARIsTO Pharmaceuticals Pvt.Ltd. Plot No.:208Newndustrial Area No.2 ARISTO Mandideep-462046,DistRaisen (M.P.) Deflazacortablets 6 mg Pecoro SOTaR Deflazacort Excipients: q.. Dosage:As directed by the Physician. Store in a coohand dry place. m 9 Registered Trademan Manutacturi euticals Pvt.Ltd. ARISTO Plot No.2 146, Dist Raisen (M.P.) Mandideeps ', {'entities': []}], ['', {'entities': []}], ['Image 64: Lic.No38/UA/SC/P-2008 Manufactured in India by: MARTIN AND HARRIS GESTIN Marketed by WALTER BUSHNELL New Delhi-110048 Allvlestrenol Tablets ES GESTIN Compositlon: Each uncoated tablet contains Allylestrenol 5mg (Micronised) Dosage:As directed by the Physician. Storage:Store in acooldry.& dark place. SCRPTIENOROG-CAUTION to pe sodyuwigprr gpiesonption idiab MARTIN LABORATORI Village Libberh Mangalore Tehsil Roorkee Distt.Handwar Uttarakhand AHLP. Marketed by WALTER BUSHNELL New Delhi-110048 estrenonablets Compo Fach uncoated Allylestrenol (Micronised) Dosage:As directed by Storage :Store In ace & dark place. AUTION Tehsil Roor War,Uttarakhand. Marketed by WALTER BUS Ner elhj-11 ablets ', {'entities': [[203, 220, 'COMPOSITION NAME']]}], ['Image 65: Paracetamol IP500 mg H   erar fat   Manufactured in Nepal by Kasturi Pharmaceuticals Pvt.Ltd. OECENT Bharatpur-16,Chitwan A csion ofKast MAPPAS. BNPNNP2 ParacetamolTablets IP HHE \"JT\" Action500 R50000 Composition, Mfg.Lic.No.:1751224085135 Each uncoatedtablet contains.   Paracetamol IP500 mg    Manufactured in Nepaley Kasturi Pharmaceuticals Pvt.Ltd   Bharatpur-16Cnitwan ', {'entities': [[10, 30, 'COMPOSITION NAME'], [163, 181, 'COMMON NAME'], [282, 302, 'COMPOSITION NAME']]}], ['Image 66: ASTH XOO   Each uncoated tabiet contains: Over dose may be Injurious to liver Paracetamol I.P.500mg INCL.OFALDTAXE 2310806/2305/26 M.R.P.RS.6. B.No. Dosage:As directed by the physician Mfg.Lic.No.:KTK/25/445/2000   Manufactured by : Store in a dry placeprotected from light. medopharm   34B,Industrial Area, MaluR563160INDIA PARACETAMOL TABLTS IPSOO MG 10Tablets .25 MEDOMOSSOO Keep out of reach of children. 00    S ch.uncoatedexontains 2000 ', {'entities': [[88, 109, 'COMPOSITION NAME'], [335, 353, 'COMMON NAME']]}], ['Image 67: PARACETAMOL TABLETS IP SOO MG MEDOMOLSOO HSIHyOO 100 x 10 Tablets ', {'entities': [[10, 29, 'COMMON NAME']]}], [\"Image 70: 20x14's Strips DICLOFENAC POTASSIUM SUSTAINED RELEASE TABLETS h-900.3. KALINAC-100SR ASIAN \", {'entities': [[25, 71, 'COMMON NAME']]}], ['Image 71: *Trade Mark Registered ANASEN-500 DT ANASEN-500DT ANASEN-500DT MFG: Mfg.Lic.No.:11269 NAPROXENDISPERSIBLE TABLETS JAN. BNOASTF9050 ANASEN-500DT -400f3 Each uncoated dispersible tablet contains f. Naproxen BP 500.mg ANASEN-5000T ANASEN-500QT 40ofsf ANASEN-500DT f SOLAR DIVISION DEC-2024 Manutacturedin Nepal by Asian Pharmaceuticals Pvt.Ltd a Omsatiya-1Rupandehi. S fa-far *Trade Mark Registered ANASEN-500DT ANASEN-500DT -3ANASEN500DT ', {'entities': [[96, 123, 'COMMON NAME'], [206, 224, 'COMPOSITION NAME']]}], ['Image 72:    OTETHI Manufactured in Nepal by Nova Genctica Pvt.Ltd Mfg.Lic.No.8297 Khani Khola-7,Naubise,Dhading Spazox PATGTCRT Spazox Spazox Spazox parGITaRT Spazox Spazox Chlorzoxazone &ParacetamolTablets MAA MAPS Spazox X3 PTSIICRA Composition: Each uncoatedzablet contains   ChlorzoxazoneUSP 500 mg Paracetamol IR 500mg frraau Manufactured inNepal by: Nova Genetica Pvt.Ltd. 88-ZdS Mfg.Lic.No. Khani Khola-7,Naubise,Dhading. wnaSpax Spazox pazox Sp wrGlare Spazox pazox Chlorzexzzone &xsracetameTablets ', {'entities': [[174, 207, 'COMMON NAME'], [280, 324, 'COMPOSITION NAME']]}], ['Image 73: Progesterone Soft Gelatin Capsules Susten200 keep out ot the reach of children scheduleHdrug For Vaginal /Rectal/Oral Use warning:to be sold by retail on the prescriptianof a registered each soft gelatin-caesule contains medicalpractitioner only 200.mg progesterene-BP RegisterdTrade Mark Inatral,mcronise excipients q.s. M.LG/28/396 colour:titanium dioxide Manufactured in India by dosage:as directeaby the physician Sun Pharmaceutical direction for use:refer package insert 3222880 Ind.Ltd. stored at temperaiure not exceeding 30 Halol-Baroda Highway protected from lignt-and moisture Halol-389350-Gujarat dx3 Mn Susten200 Susten 200 Susten200 ', {'entities': [[10, 44, 'COMMON NAME'], [256, 278, 'COMPOSITION NAME']]}], ['Image 74: ALIVE 250-TRAX-250 PHARMACEUTICAL PVT.LTD Dumraha,Duhabi Municipality SunsariNepal TRAX-250-40TRAX-250 -4 EXP.SEP.24 MFG.OCT.22 B.No.CTX-90 Tranexamic Acid Capsules 446 TRAX-250 r a Each capsule contains PER 1OCAPS M.R.P.Rs.120.00 Tranexamic acid BP250 mg Approved colours used in capsule she Mfg.Lic.NQ11472 Manutactured by: TRAX-250 ALIVE PHARHRCEUTICALPVT.LTE T  DumrahDuhabi Municipality Sunsar,Nepal. TRAX-25-4RAX-250-40 ', {'entities': [[150, 174, 'COMMON NAME'], [241, 265, 'COMPOSITION NAME']]}], ['Image 75: BP 500mg Tranexamic Acid Excipients q.s. Colour:Brilliamt Blue Lake and Mfg.LIcO6226 Titanium Dioxide IP Manufactured by ALIVE PHARMACEUTICAL PVT.LTD Dumraha,Simanya VDC,Sunsari, Nepa PERIOTABS M.R.P.Rs.250.00 B.NOTX-905 EXP.PEB.25 MFGMAR.23 TRAX TRAX TRX FATFA ranexamicAcidTablets.BP TRAR TR Each film coated et contains: rfefnt f Tranexamic Acid fat-fanror m 500 mg Excipients q.s. MfgLoNo6226 ', {'entities': [[13, 34, 'COMPOSITION NAME'], [343, 358, 'COMPOSITION NAME']]}], ['Image 76: TROY Each film coatediablet contains: Tranexamic AcidBP 500 mg fast-fanorntr Excipients q.s. Mfg.Lic.No.6226 M.R.P.Rs,250.00 EXP.FEB.25 B.No.TTX-905 Colour:Brilliant Be Lake and PERIOTABS MFG.MAR.23 Titanium Dioxide4R f Manufaot OROLD Dumrano VDC.SunsanNapa TRAX TRAX TRAX TranexamicAcid Tablets B TRAE ', {'entities': [[48, 72, 'COMPOSITION NAME'], [283, 305, 'COMMON NAME']]}], ['Image 77: Letoripe REEAETAEED R 2.5mg letrozole Mfg.Lic.Nos.45&197 C Letoripe R 2.5mg letrozole DARNO.002-474-010 C M30 RENTEAAEED Letoripe ? 2.5mg letrozole Mfg.Lic.Nos.45 & 197 REATAAEEO Letoripe R 2.5mg letrozole DAR NO.002-474-010 REAEAAAEED Letoripe 2.5mg letrozole C ', {'entities': [[80, 95, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 78: CromipneneCitrateTabletsBP50 mg CLOPERT 50 C -fa f Each uncoated tablet contains Each 4986/LP-228 Clomiphene Citrate BP 50mg Mfg.Lic No.4986/LP-228 xedby Clomy US Manufacturedby LOMUS Pharmaceuticals Pvt. Ltd Gothatar,Kathmandu, Nepal LOMUS LOMUS CLOR CLOPERT50 CLOPERT 50 CLOPERT 50 CLOPERT50 ', {'entities': [[10, 41, 'COMPOSITION NAME'], [108, 134, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 80: Aceclofenac Sustained Release Tablet ACENIL-SR -3 ASTRAL 20x10 Tablets A Division of Magnus ', {'entities': [[10, 46, 'COMMON NAME']]}], ['Image 82: ViD Etoricoxib Tablets IP 12m6 VECOXIB-120 fFR-90 15 Tabs.x 10 strips ', {'entities': [[14, 32, 'COMMON NAME']]}], ['Image 83: 15x 10Tablets Etoricoxib Tablets IP Coxit-90 chaRie-go NIRVANA ', {'entities': [[24, 42, 'COMMON NAME']]}], ['Image 84: XUs A division of Time Phanmaceuticals P Ltd. Mfg.Lic.No1760615055313 ANTIFLA.200SR ANTIFLA.200SR ANTIFLA-200 SR ANTIFLA-200 SR ANTIFLA-200 SR Aceclofenac Sustained Release Tablets ANTIFLA-200 SR - 4AA-SSS Each film coated sustained relese tablet contains Aceclofenac IP 200mg ColourSunset Yellow / 00 .0 R55800 Manufactured in Nepal by 10 T TIME Pharmaceuticals (P.) Ltd. DN3-29 Gaindakot-10.Nawalparasi ON P Marketed by  -fg MMI NEXuS (A division of Time Pharmaceuticals P.Ltd. Mfg.Lic.No.1760615055313 2005R AFLA.2003R ANTIFLA.200SR ANTIFLA.200 SR ANTIFLA-200SR ', {'entities': [[153, 190, 'COMMON NAME'], [266, 286, 'COMPOSITION NAME']]}], ['Image 85: Aceclofenac Sustained Release Tablets ANTIFLA-200 SR -03 TP NEXUS ', {'entities': [[10, 47, 'COMMON NAME']]}], ['Image 86: Jr Each uncoatedtablet contains. N4 Naproxen1P250 mg 202 2 ar  200  fa-fao Manufactured and Marketed By Samar Pharma.Co.Pvt.Ltd Chhatapipra-2Bara (Nepal) MREC Naproxeexsbiets IP Mfg.LiCNo.13915 RARAT-RYO NAROSEN-250 cnuncoate contains Jar ', {'entities': [[46, 62, 'COMPOSITION NAME']]}], ['Image 87: Naproxen Tablets IP NAROSEN-250 RRAT-R4O AMAR 10x 10 Tablets ', {'entities': [[10, 26, 'COMMON NAME']]}], ['Image 88: ab-2 Heaithcare Manufactured by National Healthcare Pvt.Ltd Chhatapipra, Bara.Nepal. Tizanidine Hydrochloride Tablets IP feerard-R Tizatab-2 fesreura-R Each uncoated tablet contains. Tizanidine Hydrochloride IP 2 mg equivalent toTizanidine Tiaatab-2 H fafaa f-farors Healthcare Manufacturedib National Healthcare Pvt.Ltd. Chhatapipra,Bara Nepal Tizanidinethydrochloride TabletsIP 2atab-2 fe- t contains: Each uncoate ', {'entities': [[95, 127, 'COMMON NAME'], [193, 225, 'COMPOSITION NAME']]}], ['Image 89: ACENAC-100 TRC-300 ACENAC-100 u-300 ENAC-100   National Manufactured by: National Healthcare Pvt. Ltd. Reattncare Chhatapipra Bara,Nepal B.No.ACT23111 M.R.P.Rs.60.00/10TABS EXP.27JUN2025 MFG.28JUN2023 Aceclofenac Tablets Mfg.Lic.No.:5434 -300 ACENAC-100 -800 ACENAC-100 -800 ACENAC-100 4-800 Each-film coated tablet.contains 100 mg Aceclofenac BP ACENAC-100 Colour:Titanium.Dioxide UsP T-fa 9-800 ACENAC-100 -800 ACENAC-100 National Manufactured by: Nationai Heaithcare Pyt.Ltd Sealncar Chhatapipra,Sara,Nepai. ', {'entities': [[211, 230, 'COMMON NAME'], [335, 356, 'COMPOSITION NAME']]}], ['Image 90: Siclofenac PotassiumTablets USP Dicloback100 Roa-00 Anti-Inflammnatory Fac rm coatedtablet contains ienac Potassium 8P100 mg ColourTitanium Dioxide&Jndigo Carmine HET: HAE Lic.No.5755 Manufactured lgNegal by: MorangNepal (WHO-GM cormedCompany) loback 100 Fc-00 betsUsp. cloba 500 Srurh-?o nt-inflamm m coated tablet Potassiun ', {'entities': []}], ['Image 91: 20x 10 Tablets DiclofenacPotassium Tablets UsP Dicloback 100 Anti-inflammatory 5900 ', {'entities': [[25, 52, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 92: Aceclofenac Tablets ACENIL-100   PER10TABS M.R.P.Rs.SO.00 EXP.DEC.2024 MFG.JAN.2023 B.N0.AA23001 R-800 Each film coated tablet contains: Aceclofenac BP 100 mg Hanutacturedb Colour:Titanium DioxideiR Magnus Pharma Pvt.Ltd Mfg.Lic.No.7669 Rampur TokaniVDC-2BaraNepa Division of Magnus ACENIL GENIL -100 -900 Aceclorenac Tablet ', {'entities': [[10, 29, 'COMMON NAME'], [147, 168, 'COMPOSITION NAME']]}], ['Image 93: Each uncoated tabiet contains: Chlorzoxazone LUSP 250 mg BF 500 mg Paracetamol B.No.ZX2604 MRP.1TRS.R.90 MFG. Manutactured by: Mfg.Lic.No.:4414 Deurali-Janta Rharnaceuticals Pvt.Ltd Qhapasrt.Katnmande<Nep RegistereoTrapeMerk 0242X015 Chlorzoxazoneand Paracetamol Tablets EXP.DEC24 Zoxaen Zoxafen R Each uncoate let contains Chlorzoxazone 250 mg Paracetamol 500 mg ', {'entities': [[244, 280, 'COMMON NAME']]}], ['Image 94: R ZOXAFEN RT Chlorzoxazone & ParacetamoPTablets ', {'entities': [[23, 57, 'COMMON NAME']]}], ['Image 95: NUCOXI4.90 Fach film coatedabet contains: 90mg AAAEEEAES Etoricoxib IP Colours:Brilliant blue lake, Quinoline yellow lake ron oxide black & Titanium dioxide tore below 30CProtect f.om light osage:As directed by the physician eep out of reach of children fg.Lic.No.:186 202007 uactured toricoxb Tabies IP gmg NUCOXIA 90 ch film coated let contains: ricoxibIP 90 mg ', {'entities': [[67, 80, 'COMPOSITION NAME']]}], ['Image 96: Nucoxia90 Etoricoxib Tablets IP 90 mg Zydus Cadila 10X10 Tablets ', {'entities': [[20, 38, 'COMMON NAME']]}], ['Image 97: R Clarithromycin Extended-Release Tablets USP Clarie* oD t*3ist Ind-Swift 1x7 Tablets ', {'entities': [[12, 51, 'COMMON NAME']]}], ['Image 98: iViD Etoricoxib Tablets IP 6w 06 VECOXIB-90 fTCFTIR-RO 15 Tabs.x10 strips ', {'entities': [[15, 33, 'COMMON NAME']]}], [\"Image 99: Aden Storage:Store protected from light SCHEOULE'RRRESCRIPTION DRUO CAUTION Noto be sold by retal without the prescription of a Registered Mfg.Lic.No.:G/599 Manufactured in India by RPG LIF SCIENCES LIMITED 3102/A,G.I.D.C.Estate Ankleshwar-393002, Dist.Bharuch,Gujarat India Registered Trademark 15 Tablets Naproxen Tablets IP 250mg Naprosyn Composition: Eacn uncoated tablet contains 250 mg Naproxen IP Excipients q.s Dosage As prescribed oyth Physician. 30004 Storage:Storeprotected from light SCHEDULEHSASCRIPTION DRUG CAUTION ebe soldby retal whout the onof a Rogiste Mfg.LIc.No Manufacturedin by. RPGJFE 3102/AG.I.D Ankleshwar Dist.Bharuc India \", {'entities': [[317, 333, 'COMMON NAME'], [402, 413, 'COMPOSITION NAME']]}], [\"Image 100: Q-400 Mfg.Lic.No:2510 Each uncoatedtablet contains 400 mg MetronidazoleIP -34 1UN2G RT-00 EXP Manufactured by: ARYA Waming Metronidazole has been shown to be carcinogenic in mice &ras.unnecessary use of PHARMALAB PVT.LTD the drug should therefobe avoided Chhatapipara,Bara, Nepal NMEC Metronidazolesabetsyp ARMETRO-400 ARMETRO-400 DCHRACT-800 Mifg.Lic.No.:2510 Each uncoated tablet contains: BN Metronidazole 400 mg Hy6T' sufactured by \", {'entities': [[134, 147, 'COMPOSITION NAME']]}], [\"Image 101: Metronidazole Tablets IP 20 x 10's Blister Strips ARMETRO-400 Lt 3R4CT-800 ARYA \", {'entities': [[11, 32, 'COMMON NAME']]}], ['Image 103: osage:As advised by the Physician Store at a temperature not exceeding 30 Medicine:Keep out of reach of children SCHEDULEHPRESCRIPTIONDRUG-CAUTIOK Not to be soid by retail without the prescriotion ot o Registered Medicol Proctitioner Mfg.Lic. No.281 2001001330 Manufoctured by:Abbott India Limited, L-18/19.Verna Industriol Estate Verna Salcette.Goa-403 722 RFL -Regd.Trodemark of Abbott GMBH &CO.KG Sodium Picosulfate Tablets 10mg Cremalax 10 mg 6Toblets Eoch uncoated toblet contains Sodium Picosulfate B.P.10 mg Excipients q.s. Dosage:As advised by the Physician Store at a temperature not exceeding 30 Medicine:Keep out of reach of children SCHEDULEHPRESCRIPTIONORUG-CAUTION Not to be soid by retail without the prescription of a Psostered Medica Proctitionerd Mfg.Lic.No.:281 6500 ', {'entities': [[411, 437, 'COMMON NAME'], [497, 525, 'COMPOSITION NAME']]}], ['Image 105: SRRF HYOSPAN FORTE HYOSCINE BUTYLBROMIDE TABLETS IP 20 mg Made in Nepal by : OMNICA LABORATORIES PVT.LTD OMNICA I Bhaktapur, Kathmandi ', {'entities': [[30, 59, 'COMMON NAME']]}], [\"Image 106: ARLOCK FORTE ARDCKFORE HHE'TT Composition: 9-9 Each uncoated tablet contains Metronidazole IP 400mg Mfg.Lic.No.:995 EXP Diloxanide Furoate IP 500 mg Manutactured by: Warning Metronidazole has been shown to be AR carcinogenic ih mice &ratsunnecessary use of PHARMALABPVT.LTD. the drugshould therefore be avoided. Chhatapipara,Bara,Nepal Metronidazoie&DiloxanideFuroateTablets DIARLOCK FORTE DIARSOCKSFDRE ONE HHE'TT nposition:- 9-9 ach uncoategiablet contains IP 400mgMfg.Lic.No.995 uroateP500 mg \", {'entities': [[88, 110, 'COMPOSITION NAME'], [131, 159, 'COMPOSITION NAME'], [347, 385, 'COMMON NAME']]}], ['Image 107: Metronidazole & Diloxanide Furoate Tablets DIARLOCK FORTE ARYA ', {'entities': [[11, 53, 'COMMON NAME']]}], ['Image 108: Amoxicillin and Potassium Clavulanate Tablets1p INDCLAV625 Each film-coated tablet contains: Keep out of reach of children Amoxicillin Trihydrate IP Mfg.Lic.No.:MB/05/133 500 mg equivalent to Amoxicillin Made in India by Potassium Clavulanate Diluted IP 125 mg equivalent to Clavulanic Acid Colour Tanum Dioxide IP Indchenie Bosage The usuaradult dose is one tablet eight hourly or as directed by the Physician. Health Specialities Pvt.Ltd. Village-Thana,Tehsil Baddi Store at a temperature not exceeding 30C. Protect from light and moisture. Dist.-Solan.HimachalPradesh-173205 H.O:510,ShahNahar Ind.Estate SCHEDULE H PRE PTION DRUG-CAUTIO Dr.E.Moses RoadWorli, Mumbai-400 018 Not To be sold by rea vthout the prescriptior Registered Trade Mark. of a Registered Me Tacttionerd ', {'entities': [[11, 58, 'COMMON NAME'], [203, 214, 'COMPOSITION NAME'], [286, 301, 'COMPOSITION NAME']]}], ['Image 109: Composition: Per serving per hard gelatin capsule contains (Approx. %DV Streptococus faecalis 30 million cfu Clostridium butyricum 4 million cfu Bacillus mesentericus 2 million cfu Lactobacillus sporogenes 100 million cfu Excipients q.s. DV =Daily value** not establish Nutritional Value per capsule: Energy 0.4 Kcal 0.1g Carbohydrate 0.00 g Protein Fat 0.00 g Ingredients:Gelatin-Capsule Shel Streptococus faecalis, GPEETRETTE Clostridium butyricumBacillus mesentericusLactobacillus sporogenes CONTAINS SYNTHETIC FOOD COLOUR ADDED A CLASS II PRESERVATIVES F222222 2222222 22-22222S Storage Store in a cool dry and dark place.Protected from light and moisture. at a temperature not exceeding 25C Keep out ot reach of children. Dosage  Adult one capsule per day atter meals or as directed by Dietician EXP Health Supplement.NOT FOR MEDICINAL USE.(N.F.M.U) fssai Lic. No. : 12617006000254 Marketed By: GAMA MRE 6-060N10 GAMA Trade Concern Nepal Pvt.Ltd. eeeeooA Gama Trade Concern Nepal Pvt Ltd Kathmandu Nepal Probiotic Capsules GP LACFORTE Capsules Composition: %DV Per serving per hard gelatin capsule contains (Approx. 30 million ctu Streptococus faecalis 4 million ctu Clostrdium butyricum 2 million cio Bacius mesentericus 100.million ctu Lactobacillus sporogenes q.s. Excipients DV=Daily value** not establish Nutritional Value per capsule : 0.4 Kcal Energy wwong.L Carbohydrate 0.00 g Protein Fat rdetGea-Capsue SiSrspiocotue iaecas ', {'entities': [[1020, 1038, 'COMMON NAME']]}], ['Image 112: 4x5 x 10Tablets Hyoscine Butylbromide Tablets BP HYBRODS National Healthcare ', {'entities': [[27, 56, 'COMMON NAME']]}], ['Image 113: Aristozyme Capsules Osue GESTIENZYME CARSULES R URRCIAISH AEP nosition: capsule conta Contains antimicrod tive e IP1:1200 lethyl Paraben IP pyI ParabenP DiastaseD Excipients: q.s. llus oryzae, Pellets Colour:Er  Registered Trademark 1069 ic coated pe Anproved colours capsule ell nufactured in India by: not less tha mof STO Pharmaceuticals RvELto Cookedsta Survey No.:371.Kunbar FallaVillage Dabhel P130 NanDama:396210.DAMAN (U.T Regd.Oncas12J.N.Heradia Marg:mumbar 4o0001 Diastasa &Pepsn Capsules Aristczyme Capsules DIGESTIVEENZYME CAPSULES R URCTESH reservative Lach 30mg ungalc RegisteredTrademark Pcolours:used forcapsule shelt: Manufactured in India by pnove ARISTo Pharmaceuticals Pvt. Ltd. Sutvey No.371KunbakFana,VillageDabhe ARISTONani Daman-396 210,DAMAN(U.T.) 400001 gests not less than3go coagulated egg albane Diastase &Pepsin Capsules Aristozyme Capsules ESTIVEENZYME CAPSULES ', {'entities': [[11, 30, 'COMMON NAME']]}], ['Image 114: 10x 15Capsules Diastase & Pepsin Capsules Aristozyme C A P S U L E S ? QRCAISH DIGESTIVE ENZYME CAPSULES ARISTO ', {'entities': [[26, 52, 'COMMON NAME']]}], ['Image 115: ofaNeurologist/Specialis Eachfilm-coated tablet contains Citicoine Sodium 1.P Mfg.Lic.No. M/563/2010 equiyalent to Citicoline 500 mg torren Coour: Titanium Dioxide l.F Dose :As directed by the Neurologist /Specialist PHARIT 3211-802 STORE AT A TEMPERATURE NOT Manufactured oy TORRENT PHARMACEUTICALSLT LIGHT AND MOISTURE 32No.Middle KEEP UT OF REACHOF CHILDREN East District Gangtok,Sikkim-737 135 *CiticolineTablets LP500 mg CAUTION STROLIN Not to be sgld by retail without thg ictior ecjalis Eachfilm-coated tablet contains Citicoline Sodium I. Lic.No.M/563/2010 Mfg. 500mc uivalent to Citicol torrer st /Speclalis Neurolog PHART 732 directed by the OSe TOREA EMPERATURENOT Manufacturedt DING 30C,PROTECTEDFROM TORRENT PHARMACEU ', {'entities': [[126, 143, 'COMPOSITION NAME'], [409, 427, 'COMMON NAME']]}], ['Image 116: R Citicoline Tablets I.P. 500 mg STROLIN 500 mg 10STRIPSOF 10 TABLETS EACH ', {'entities': [[13, 31, 'COMMON NAME']]}], ['Image 117: ALKEM Citicoline Tablets IP Ceham-500 4-500 10Strips of 10 Tablets Each ', {'entities': [[17, 35, 'COMMON NAME']]}], [\"Image 119: Amoxycillin Trihydrate IP equivalenttoAmoxycillir 500 mg Potassium Clavulanate(diluted)IP equivalent to clavulanic Acid 125 mg Amoxycillin& Potassium Clavulanate TabletsIp AM-CLAV625 ach.uncoatedtabietcontains Amoxycillinurihyarate 00mg equivalentto.arnoxycillin valentto.clavulanic Acid Anoxycillin'e \", {'entities': [[138, 182, 'COMMON NAME']]}], ['Image 120: Pancreatin And Sodium Taurogqlycocholate Tablets ENZAR FORTE yR  x94 20STRIPSOF 15 TABLETSEACH ', {'entities': [[11, 59, 'COMMON NAME']]}], ['Image 121: Amoxycillin & Potassium Clavulanate Tablets IP AM-CLAV625 -4 10 Tablets ', {'entities': [[11, 54, 'COMMON NAME']]}], ['Image 122: FLUCLOXACILLIN CAPSULES BP Flupen-500 F19-y00 10x 10Capsules National Healthcare ', {'entities': [[11, 34, 'COMMON NAME']]}], ['Image 123: E-Cox XGEXX 5- HraRf  f E-Cox E-Cox E-Cox $R Each filrn coated tablet contains: Etoricoxib 90 mg Manufactured by: Colpur:SunsatYellow NEPAL PHARMACEUTICALS LABORATORYPVT.LYD. MfgLic./13438 Jestpur,Blrganj,Nopak. E-Cox E-COX $F E-Cox Etoricoxie Tablets fa E-COX- ', {'entities': [[91, 107, 'COMPOSITION NAME']]}], [\"Image 124: 20 x 10's Blister Strips) Etoricoxib Tablets IP E-Cox -chich NPP TM \", {'entities': [[37, 55, 'COMMON NAME']]}], [\"Image 125: Dr.Reddy's Caution. KetorolacTromethamine 1Not indicated for long term use. 2.Not recommended in pregnant mothers. Tablets IP10g Each film-coated tablet contains: TABS Ketorolac tromethamine IP .10mg KETOROL olours:Brilliant blue FCF lake Yellow oxide of lron Titanium dioxide IP NLAEEENEESS Manufactured in India by Dr.Reddy's Laboratories Ltd B2222553S8 SNo.245&45,Bachupally Village, Dosage as directe Sachupally Mandal,Medchal Malkajgiri District, Store protected froghsand moisture,at a Telangana State,INDIA temperature not excecding25*C ML63/RR/AP/96/F/R Keep out of reach of char Trademark under registrat150088467 R Caution: Dr.Reddy's Not indicated for long term use KetorolacTromethamine 2.Not recommended in pregnant nothers. ach Him-coated tabletcontanns: 10mg \", {'entities': [[31, 52, 'COMPOSITION NAME'], [179, 201, 'COMPOSITION NAME'], [688, 709, 'COMPOSITION NAME']]}], [\"Image 126: R Dr.Reddy's KetorolacTromethamineTablets IP10mg TM Ketorol 10mg 10tablets 10blisters per blister \", {'entities': [[24, 52, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 127: 002068E186P.200mg METRONDAZO Hafaft MET METR0-200 ff-   # 200 Each tabielo Each tablet cortains Manufactured by: Metrenda Metronidazole3.200mg LOMUS WticalsPxn.Ltd PharmaceuticalsPyt.Lid Hnrandu.Nep Gothatar, Kathmandu/Nepa MfgLic No. Mfg.Lic No.656/P-28 LOMUS LOMUS METRO-20 METRO-200 ', {'entities': [[133, 153, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 128: 50 Blisters of 10 Tablets Metronidazole Tablets B.P.200-mg Metro-200 AT-RO0 LOMUS ', {'entities': [[37, 58, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 129: 22h  ranta rast H h   Mfg.Lic.No1740707093713 WOCT DR 00 Manufactured by: 00 ARYA Each enteric coated tablet contains Pantoprazole Sodium IP as Sesquihydrate PHARMALABPVT.LTD NN $ eq.to Pantoprazole 40mg Chhatanicara,Bara.Nepa Panta Fast Panca Fast Rlloer wre Panta Fas! Rioc-bIe S Pantoprazole Tabiets IP H 22 PantaFast Q. RR Mfg.Lic.No.1740707093713 oCI DRC E Manufacturedby: ARYA ach enteric coated tablet contains azole Sodium IP as Sesquihydrate PHARMALAB PVT.LTD to Pantoprazole 40mg Chhatapipara Bara,Nepa PantaFast Panta Fast Panta Fast RllocI  00 11000 Pantoprazole Tablets IP H2h   Panta Fast NND 8 Mfg.Lic.No740707093713 Ae Manufacturedby iele ARYA S Each enteric coated tablet contains a Pantoprazole Sodium IP as Sesquihydrate PHARMALAB PVT.LTD. 40mg R R eg.to Pantoprazole Chhatapipara,Bara,Nepa E Panta Fast Panta Fast PantaFast RIoC D a Pantoprazole Tablets IP ', {'entities': [[483, 500, 'COMPOSITION NAME'], [573, 593, 'COMMON NAME'], [864, 887, 'COMMON NAME']]}], ['Image 130: 10Blisters of 15 Tablets each PX Pantoprazole Tablets IP R Pantocid ', {'entities': [[44, 64, 'COMMON NAME']]}], ['Image 131: aesfaer Pantoprazole Sodium If 40mg equivalent to Pantoprazole Manutacturedby: Colour:Quinoline Yeilow M NEPALPHARMACEUTICALS 2005 fa LABORATORY PRIVATE LIMITED Jeetpur Birganj, Nepal Registered Trade Mark Mfg.Lic.No.3889 PANOCIDDR s f PANOCIDDR fs 3PANOCIDDR Pantoprazole Gastro-Resistant Tablets 1P PANOOIDDR HA f ff-fa PANOCID DR s fs  PANOCIDDR Each enteric coated tablet contains 8 Pantoprazole SodiumiP eguivalent to Pantoprazole  40 mg Manutactured by: olour Qnnon NEPAL-PHARMACEUTICALS ', {'entities': [[271, 308, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 132: Esozol 40 Esozol 40 Manufactured inNepalby: Quest Phannaceuticals (P.) Ltd. Chhata Pipara,Bara Birganj. Esomeprazole Magnesium TablesP Esozol 40 Esozo140 S80 Each enteric-coated tablet contains: EsomeprazoleMagnesiumTrihydrate equivalentto Esomeprazole 40.mg Colours:Brilliant Blue Tartrazine Lake C &Titanium Dioxide Mfg.Lic 7304 40 Esoz0140 faaf ES 3 oZCIAC ', {'entities': [[115, 145, 'COMMON NAME'], [251, 269, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 133: 3 x10 Tablets Esomeprazole Magnesium Tablets IP Esozol40 80 ', {'entities': [[25, 55, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 134: Dusp Duspu retard retard 200.mg 200 mg 721930 mebeverine hydrochloride capsules capsules Duspatalin mebeverine hydrochloride Abbott retard MRP-NRS 200 mg 09 mebeverine hydrochloride capsules Abbott 08 Duspatalin Duspatalin 20 retard retard 200.mg 200 mg capsules mebeverine hydrochloride capsules mebeverine hydrochloride Duspatalin Abbott Abbott retard 00.mg shloride ', {'entities': [[168, 201, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 135: Dusp Duspi retard retard 200-mg 200 mg 721930 capsules mebeverine hydrochloride Duspatalin capsules mebeverine hydrochloride Abbott retard 200 mg 09-2 mebeverine hydrochloride capsules R Duspatalin Duspatalin 02 retard retard 200-mg 200 mg capsules capsules mebeverine-hydrochloride Duspatalin mebeverine hydrochloride Abbott Abbott retard oomg chloride ', {'entities': [[305, 329, 'COMPOSITION NAME']]}], ['Image 136: Duspatalin ? retard 200 mg 245 Mebeverine Hydrochloride 30 Capsules ', {'entities': [[42, 66, 'COMPOSITION NAME']]}], ['Image 137: NROL40 ROL40 Pantoprazole sodium sesquihydratep Mfg.N.4770910081530 equ.to Pantoprazole40 mg Manufactured in Nepal by: PANROL40 PANROLAD Color:Yellow Oxide of Iron Mednk.Pharmaceuticals Pvt Ltd Khairanani-2,Chainpur, Chitwan H M.R.P.Rs. Exp.Date:Jan.2024 BatchNo.:TPA-22001 01FPAN40/20 PANROL40 Pantoprazole Tablets IP ANROL40 4H6 PANROL40 120/15 Tabs. PANROL40 - RR80 3 PANROL40 Each enteric coated tablet contains Pantoprazole sodium sesquihydrateIP Mfg.Lic.No21770910081530 equ.to Pantoprazole 40 mg Manufactured in Nepal by PANROI ColorYellowOxide of Iron MedrikPharmaceuticals Pyt.Ltd Khairahani-2,Chainpur, Chitwan. HTET 01FPAN40/20 ', {'entities': [[86, 103, 'COMPOSITION NAME'], [306, 326, 'COMMON NAME']]}], ['Image 138: Pantoprazole Tablets IP PANROL40 RR80 15 Tabs X 10 Strips ', {'entities': [[11, 31, 'COMMON NAME']]}], ['Image 139: Tablets IP Mfg.Lic.No.:11287 CiticolineTablets IP Mfq.Lic.No.11287 ON-500 C-400 BRANTON-500 C-400 tablet contains: Each film coatedtablet contains: nIP eq. to Citicoline 500 mg a- Citicoline Sodium IP eq.to Citicoline 500 mg fa-a Dioxide H6- Colour :Titanium Dioxide H46- Manufactured by: Manufactured by Magnus Pharma Pyt.Ltd. Magnus Pharma Pyt.Ltd magnus Rampur Tokani, Bara, Nepal PSYNO 4gnus Rampur TokaniBara,Ne A Division of Magnu A Divi -400 BRANTON-500 BRANTON-500 RCR-400 BRANTON-500 B.No.EW22003MFG.DEC.2022EXP.NOV.2024 M.R.P.Rs.700.00PER10TABS ', {'entities': [[40, 57, 'COMMON NAME'], [218, 235, 'COMPOSITION NAME']]}], ['Image 140: PANSAFE-40 fafa a- .P./15TABSRs.120.00 G.DEC.22E No.001070 Pantoprazole Socibm Sesquihydrate Mfg.Lic.No.:11480/070/VEGA-1 Equivalent to Pantoprazole 40 mg Manufactured inNepal by Lalitpur-22BurgmaiNepal RegisteredraseMark ANTOPRAZOS ABLETSO NOV.24 PANSAFE-40 faf-fa ', {'entities': [[147, 165, 'COMPOSITION NAME']]}], ['Image 141: iViD Pantoprazole Sodium Delayed Release Tablets USP PANSAFE-40 w-80 15 Tabs.x 10 Strips ', {'entities': [[16, 59, 'COMMON NAME']]}], ['Image 142: ffa ESOFLUX-40 SHIMCR-80 ESOFLUX-40 Mig.Lic.No.:8084 TM Manufacturedby: NEPAL PHARMACEUTICALS LABORATORYPVT.LTD., Jeetpur, Birgani,Nepal LL TM Registered Trade Mark ESOFLUX-40 ESOFLOX-40 Esomeprazole Magnesium Tablets-IP ESOFLUX-40 SATETCRSO 36cux-40 ESOFLUX-40 Each.enteric coated.tablet.contains Esomeprazole Magnesium IP .eq.to Esomeprazole, 40mg LE ColourRed Oxide oflron ESOFLUX-40 SHIR-80 ESOFLUX-40 f ESOFLUX-40 SHIRART-X0 ESOFLUX-40 ', {'entities': [[198, 231, 'COMMON NAME'], [342, 360, 'COMPOSITION NAME']]}], ['Image 143: Esomeprazole Magnesium Tablets IP ESOFLUX-40 $-80 npl ', {'entities': [[11, 41, 'COMMON NAME']]}], ['Image 144: Eacn-enteric coated tabiercontains cacn.enteric-coatedrabiercontatns PantoprazoleSodium.Sesguihyarate Pantoprazole Sodium-Sesquihydrate equivalent toPantoprazole 40 mg equivalent.toPantoprazole40mg Mfg.Lic.No.:DD/220 sena/das Manufactured by: MEDLE PHARMACEUTICALS LTD medjey Ploo18&19.Survey No.378/7&8379/23 Zar Causeway Rd. Kachigam. Daman DiA S PANTAZ RANTAZ PantoorazoleSodium Tablets Pantoprazole-Sodium Tablets Each enteric coatedtablet contains: Eacherteric coated tablet contains Pantoprazole Sodrum Sesquihydrate Pantoprazole Sodium Sesquihydrete equivalantto Pantoprazole 40mg Mfg.Lic.No.D/220 anutaciured by: ', {'entities': [[374, 400, 'COMMON NAME'], [401, 428, 'COMMON NAME'], [581, 598, 'COMPOSITION NAME']]}], ['Image 145: 10x10 Tablets RX PANTAZ Pantoprazole Sodium Tablets yCTET medey ', {'entities': [[35, 62, 'COMMON NAME']]}], ['Image 146: Dhapasi, Kathmandu,Nepal ORM Registered Trade Mark 02RBT21 Rabeprazole Sodium Tablets IP 20 mg (Gastro Resistant Tablet) RABENORM Ridonlaf MRP. .NO.. PROTON PUMP INHIBITOR Each enteric coated tablet contains. Rabeprazole Sodium IP 20 mg Colour: Iron Oxide Red AABEN - 30 Mig.Lic.No.11462 Manufactured by. RN Deurali-Janta AANEEO Pharmaceuticals Pvt.Ltd. Dhapasi, Kathmandu,Nepal Registered Trade Mark. 02fRBT21 Rabeprazole Sodium Tablets IP 20 mg Gastro Resistant Tablet, RABENORM PROTON.PUMPINHIBITOR ', {'entities': [[70, 96, 'COMMON NAME'], [220, 247, 'COMPOSITION NAME']]}], ['Image 147: Rabeprazole Sodium Tablets IP 20 mg Gastro Resistant Tablet ? RABENORM Ridoilaf PROTONPUMPINHIBITOR ra ablets x 15Blisters ', {'entities': [[11, 37, 'COMMON NAME']]}], ['Image 148: PANPRAZ qrayrg Each enteric coated tablet contains Pantoprazole Sodium Sesquihydrate IP Eqv.to Pantoprazole 40mg Colour:Yellow Oxide of Iron DO NOT CRUSH OR CHEW THE TABLET HHE:\" Hf  y  faf   Mfg.Lic.No.:5775 Manufactured in Nepal by AMTECH MEDPVT.LTD Katahari-4,MorangNepal (WHO-GMP Certified Company) PANPRAZ PANPRAZ PANPRAZ PANPRAZ Pantoprazole Gastro Resistant Tablets IP PANPRAZ Each enteric coated tablet contains Pantoprazole Sodium Sesquihydrate IP 40 mg Eqy.to Pantoprazole Colour Yellow Oxide of-lron ', {'entities': [[106, 123, 'COMPOSITION NAME'], [346, 383, 'COMMON NAME']]}], ['Image 149: reachotchidren Trademark of Ozone Pharmaceuticals Ltd Pantoprazole Gastro-Resistant Tablers IP PERFEKT SCHEDULE H.PRESCRIPTH COMPOSITION: RUG-CAUTIONNO MSSS0 Each enteric coated tablet contains sold by retail withou. MNNO2 Pantoprazole Sodium Sesquihydrate IP BNNN2T TTASS. xescriptionota Reg. equivalent to Pantoprazole40mg Excipients 9.s Colours: Yellow Oxide of tron &Titaniom Mfg.LicNo.2Q5/DR/Mfg./2001 Dloxide1.P. Dosage: As directed by the Physician. Manufactured in India by: Tablet to be swallowed whole. OZONE PHARMACEUTICALS LTD DO NOT CHEWORCRWSH THE TABLET E.P.J.P.,Amingaon, Storage:Store in cool& dry place, Guwahati-781031(Assam) protect from light. P1730517 Medicine:Keep out ofreach of children Trademark of Ozone Pharmaceuticals Ltd PERI P Pantoprazole Gastro-Resistant Jablets IP PERFEKT ', {'entities': [[65, 102, 'COMMON NAME'], [319, 335, 'COMPOSITION NAME']]}], ['Image 150: CiticolineTabletsIP BRANTON-500 JCT-400 PSYNO 10X 10 Tablets A Division of Magnus ', {'entities': [[11, 30, 'COMMON NAME']]}], ['Image 151: R Pantoprazole Gastro-Resistant Tablets IP TM* Perfekt OZONE 10X10 TABLETS PHARMACEUTICALS LTD ', {'entities': [[13, 50, 'COMMON NAME']]}], ['Image 152: rarBaraBirgan Pre and Problotic Capsules Bactolac: Bactolac argclu lh2blre Each hard gelatin capsule co Mfg.Lic.No.11948 OT 495 Approved colours used in capsuleshells ', {'entities': [[25, 51, 'COMMON NAME']]}], ['Image 153: 10x6Capsules HHE Pre and Probiotic Capsules Bactolac ', {'entities': [[28, 54, 'COMMON NAME']]}], ['Image 154: Meanhcare Manutactured by: NationalHealth are Pvt.Ltd 30f.. Chhatapipra, .Nepal. Bacillus clausii Capsules Mfg.Lic.No.:174031310290 RORIET BACIFLORA aR ffna Each hard gefatin capsule contains H2BillionCFO Jus clausn Approved colours used in capsule National Hfaf Healthicare Manufactured by: O NatiohaFHealthcar Chhatappra,Bara, Nepa Bacillus elausii Capsul Mfg. NO.1740313102 BACIFLORA afu ', {'entities': [[92, 117, 'COMMON NAME']]}], ['Image 155: Bacillus clausii Capsules National Healthcare BACIFLORA aR4RT 10x 10Capsules ', {'entities': [[11, 36, 'COMMON NAME']]}], ['Image 156: c-Hblpe D Rabium-20 Each enteric coated tablet contains Rabeprazole Sodium IP 20 mg M6 H ColourYellow Oxide of Iron & SIA Titanium Dioxide IP SCCGGUEE Excipients: Q.S Dose:As directed by the Physician. Store below 25C.protect from light and moisture. Swallow whole tablet.Do not crush or chew Keep all medicines out of reach of children. Rx Aq PS  O ON NOO Rabeprazole Sodium - - SYIND TabletsAP20.mg oc-hrpe Rabiurzo Each enteric coated tablet contains Rabeprazole Sodium IP ....20mo ColourYellowxide of Iron & Titangin Dioxide IP ', {'entities': [[67, 94, 'COMPOSITION NAME']]}], ['Image 157: 15 x 15 Tablets Rx Rabeprazole Sodium Tablets IP 20 mg Rabium-20 INTAS ', {'entities': [[30, 56, 'COMMON NAME']]}], ['Image 159: Sompraz20 SCHEDULE HPRESCRIPTION DRUG Each enteric-coated tablet contains: CAUTION:Not to be sold by retail Esomeprazole Magnesium Trihydrate IP without the prescription of.a Registered 20 mg equivalent to Esomeprazole Medical Practitioner Excipients q.s. Colours:Ferric Oxide (RedUSP-NF  Registered Trade Mark Titanium Dioxide JP M.LM/645/2014 Dosage:As directed by the Physician Manufacturedin India by Tablets should be swollowod wnole sun pharma laboratories Itd and not to be chewed or crushed Plot No.107-108Namli Block Store at temperaturenct exceeding 30C P.O.RanipoolEast-Sikkim-737 135 protected from light and moisture Sompraz20 Sompraz20 Sompraz20 Esomeprazole Tablets iP Sompraz20 SCHEDULE R PRESCRIPTION DRUG Each enteric-coate blet contains: CAUTION:Not be sold by retail someprazole Mag ium Trihydrate IP without the presaotlon of a Registere quivalent to Esor 20 mg MedicalPras Cipients q.s ', {'entities': [[671, 691, 'COMMON NAME']]}], ['Image 160: Biotin With Calcium Pantothenate N-Acetyl Cysteine Minerals & Grape Seed Extract Tablets KTIN 10 Tablet 3 x10 Tablets DIETARY SUPPLEMENT NOT FOR MEDICINAL USE ', {'entities': [[11, 99, 'COMMON NAME']]}], ['Image 162: 50 Blisters of 10 Tablets T RIVI Thiamine Mononitrate, Pyridoxine HCI & Cyanocobalamin Tablets LOMUS ', {'entities': [[44, 105, 'COMMON NAME']]}], ['Image 164: 1x 10Capsules Methylcobalamin, Alpha Lipoic Acid Vitamin B1, B6 & Folic Acid Capsules R MeecobA R Fitwel Pharmaceuticals Pvt.Ltd. ', {'entities': [[25, 96, 'COMMON NAME']]}], ['Image 166: CO0-:OEGAMIN-1500 VE8AMISSTS0OVEGAMIN-1SUESAS9AMIN-150O -9400  1122h   h ah Each uncoated tablet contains MecobalaminJP 1500 mcg ATES HTE Mfg.Lic.No13544-072/073-VEGA-66 Manufacured lnNepalor VegaPharmaceuticalsPytata. VViD vega Lalitpur-22BungmatiNepal 04FV1500/22 Methylcobalamin Tablets.Usp VEGAMIN-1500 47-9400 H91212 MEGAUIN-IS-IN Each uncoated tablet contains Mecobalam1500 mcg 2 Hphlle HiE ', {'entities': [[277, 304, 'COMMON NAME']]}], ['Image 167: vega Methylcobalamin TabletsUSP VEGAMIN-1500 -9400 15 Tabs.x10 strips ', {'entities': [[16, 42, 'COMMON NAME']]}], ['Image 168: 7608 Mfg.Lic.No. ff fa MRPRER10 TABLETS BNo141093MFDMAR23EXPFEB25 MEN1500 NEWRON1500 NEWPON1500 Menufactured in Nepal by Quest Pharmaceutieak (PyLtd. Chhata PiparaBara.Birganj NEWRON1500 NEWRON1500 NEWRON1500 Methylcobalamin Tablets NEWRON1500 Rs200.00 Each uncoated tablet contains Methylcobalamin 1500 mcg. NEWRO500EWON1500WEWRON15CO HHE Mfg.Lic.No.7608 ffa-fa NEWRON 1500 NEWRON 1500 NEWRCN1500 Manufactured in Nepal by Quest Pharmaceuticals(R-Ctd Chhate Pipara Bara. Blgan ', {'entities': [[220, 243, 'COMMON NAME'], [294, 319, 'COMPOSITION NAME']]}], ['Image 169: HHE 10X 10Tablets Methylcobalamin Tablets NEWRON 1500 RRT 9400 ', {'entities': [[29, 52, 'COMMON NAME']]}], [\"Image 170: 20 X 10's (Strips) BISACODYL GASTRO-RESISTANT TABLETSIP LAXIT Improved Formula ASIAN \", {'entities': [[30, 66, 'COMMON NAME']]}], ['Image 171: lone Tone Thiamine Hydrochloride Tablets BP100 mg mfacturedby ORION onnn ORION PharmaL Dnaka,Banglades Tone Tone Thiamine Hydrochloride Taplets BP 100mg 0 00 Manufactured by. ORION ORION Pharma Dhaka,Bangladesh Thiamine HydrochlorigeTable BP 100mg EN ufactured oone Tone Hm Thiamine Hydrochloride BP100mg oron Dhaka,Ban one Thiamine Hydrochloride Tablets BP100mg ', {'entities': [[21, 51, 'COMMON NAME']]}], ['Image 172: 10x 10 Tablets Tone Thiamine Hydrochloride Tablets BP 100 mg Manufactured by: ORION ORION Ltd PharmaLtd. www.orionpharmabd.com Dhaka, Bangladesh InSearchofExcellence ', {'entities': [[31, 61, 'COMMON NAME']]}], [\"Image 173: 10x 10's Tablets no MethylcobalaminDispersible Tablets Neurocobal-1500 DT RRla-g400fs \", {'entities': [[31, 65, 'COMMON NAME']]}], ['Image 174: National Vitamin B1,B6,B12 & Calcium Healthcare Pantothenate Tablets NURVI Taff 20x10Tablets ', {'entities': []}], ['', {'entities': []}], [\"Image 176: 20 x10's (Strips THIAMINE TABLETSIP NEOVIT renfoTe SIAN \", {'entities': [[28, 46, 'COMMON NAME']]}], ['Image 178: 10x 10 tablets Vitamin B12,Alpha Lipoic Acid with Vitamin B Complex Tablets Maxobal Dietary Supplement not for medicinal use ', {'entities': [[26, 86, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 179: KLM MYO-INOSITOL.LYCOPENE.BIOTIN IRON.VITAMINS.MINERALS & AMINO ACID TABLETS Extend Hair 1X10TABLETS ', {'entities': [[15, 87, 'COMMON NAME']]}], ['Image 180: Piot No381Honzon mdustia Park Cholecalciferol (Vitamin D3P500 ai Bamangarn Ta.KarjanVadodara-391243. ColoursRed Oxide of iron&Titanium RegisteredOlfice:1004Hubtown Viva, Wegle Express HighwayJogeshwar E Dioxide IP Mombai-400060INDIA Appropriate overages of Vitamins added egistered trademark PM0100066 to compensate loss on storage MYO-INOSITOL.LYCOPENE.BIOTIN, IRON.VITAMINS,MINERALS&AMINO ACIDTABLETS Extend Composition: Each film coated tablet contains Hair Biotin USP 10 mg L-Arginine IP 50 mg L-Cysteine 50 mg Dosage: As directed by Physician L-Lysine Hydrochloride USP 20 mg Storage:Store at a temperature not 40 mg DL-Methionine BP exceeding 30C.Protect from sunlight. 10 mg Myo-Inositol BP Mfg.Lic.No.:G/28/1712 Ferrous Fumarate IP Eg.to Elemental Iron 10 mg Zinc Sulphate Monohydrate IP 25 mg Copper Sulphate Pentahydrate BP 2 mg Sodium Selenite Pentahydrate BP Eq.to Elemental Selenium 65 mcg KLM Calcium Pantothenate IP 200 mg Niacinamide IP 50 mg Mamufactured by: 6mg KLMABORATORIES PVT.LTD.Lycopene Preparation-10%USP NC.381Horizon IndustrialPark. Cholecalcifera (VitaminD3P5001U ear-BamangamTa.Kagan ColoursRed-Oxide of Jron &Titanium egjsteredCtfice:1004Hubtown Viva, E0009 DioxidelP MM22 em Express HighwayJogeshwari (E) ma-400 060,INDIA Appropriate overages of Vitamins added gistered trademark to compensate loss on storage. 00066 MYO-INOSITOL,LYCOPENE.BIOTIN, BON8 RON,VITAMINS,MINERALS&.AMINO CID-TABLETS Composition. Extend Each m coated tablet contains Hair Biotin USR 10 mg L-Arginineip 50 mg L-Cysteine 50 mg age:As directed by Physician. L-Lysine Hydrochloride USP 20 mg age: Store at a temperature not DL-Methionine BP 40 mg ing 30C.Protect from sunlight. Myo-lnasitol-BP 10mg G/28/1712 ', {'entities': [[343, 413, 'COMMON NAME']]}], ['Image 181: Dose:As directed by the Physician 2064423687224 stafa-co srafa-co DOVERIN-80 DOVERIN-80 DROTAVERINEHYDROCHLORIDE CAUTION:Not to be sold by retair without the prescription of a TABLETS IP 80 mg Registered MedicalPractitioner MMAO2 Store in a.dark dry place DOVERIN-80 Mfg.LicNo.G/162 Each-uncoated tablet contains Manutactured by Drotaverine Hydrochloride IP.80-mg INTAS Excipients:Q.S INTAS PHARMACEUTICALS LTD 7/3GlDC Estate Vatva Ahmedabad 382 445 INDIA Dose:As directed by the Physician 2064423687224 safa-co staRa-co DOVERIN-80 DOVERIN-80 DROTAVERINEHYDROCHLORIDE CAUTIONNQt to be sold by retail without the prescription of a TARIFTSIP80 mo Registered MedicalPractitioner ', {'entities': [[340, 374, 'COMPOSITION NAME'], [554, 578, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 182: 12321 POEGOPAN-2O Mig.Lc.No. Mapwacured.py Deurali-Janta Pharmaceuticals.Pvt.Ltd Dhapasi-1,Kathmendu,Nepal Registered Trade Ma D1HYO14 Anti-spasmodicTablets DEGOPAN-20-UECUYAN20 MRP B.NO. DECOPAN-20 MFG, Hyoscine Butylbromide Tabjets 20 mg AUG22EXP.JU Stuo-20 achfilm coated.tablet.containsy yoscine ButybromideBP-20-mg Colour Titanium Dioxide DECOPAKOO Mfg.Lic.No.1232 Manufacturedb Registered Trad 01HYO14 Anti-spasmodic:tablets DECOPAN2O ', {'entities': [[146, 167, 'COMMON NAME'], [215, 236, 'COMPOSITION NAME']]}], ['Image 183: Anti-spasmodic Tablets DECOPAN-20 Sqiuld-20 ', {'entities': [[11, 33, 'COMMON NAME']]}], [\"Image 185: 10 x 20's (Strips) DICYCLOMINE HYDROCHLORIDE TABLETS IP SPAZMOL ASIAN \", {'entities': [[30, 63, 'COMMON NAME']]}], ['Image 188: f -ONEHT BONEEE -BONE 3 rafaft Mfg.Lic.No.8872 BON-E Manufactored.By: A Division elMa Magnus Pharma Pvt.Ltd. magnus Rampur TokaniBaraNepal Thiamine Hydrochoride Tablets B-ONE B-ONE Each uncoatedtabiercontains: Thiamine Hydrochlonde 100mg IP BIONE Mfg.Lic. No. SYNO BON-E Manufac Mapnus MagnusRhama Pvt.Ltd. Bara,Nepal Rampur magnus -ONE ', {'entities': [[150, 171, 'COMPOSITION NAME']]}], ['Image 189: Thiamine Hydrochloride Tablets IP B-ONE - PSYNO 20x 10 Tablets A Division of Magnus ', {'entities': [[11, 41, 'COMMON NAME']]}], ['Image 190: Betahistine.Hydrochloride P16 mg CHEDOLEHPRESCRPTIOND CAUTON R216VERBET16 Dosage:As directed by the Physician Do not store above 30C Store protected from light. MfgLicNo.DL-134-M R Registered Trade Mark of 81245 Albert David Limited Manutacturedby ALBERT DAVID LIMITED ALBERT ae16 5/11.D.Gupta Lane DAVID Kolkata70Q 050,INDIA AUA Kothari Group BETAHISTINEAAROCH SRBET TABLETSIP IE ', {'entities': [[11, 43, 'COMPOSITION NAME']]}], ['Image 191: 10x 10 Tablets Rx BETAHISTINEHYDROCHLORIDETABLETSIP 16 VER BET C16 ALBERT DAVID ', {'entities': [[29, 62, 'COMMON NAME']]}], ['Image 193: 10x10 Tablets 180 mg Su ex180 Fexofenadine Hydrochloride Tablets USP ', {'entities': [[41, 75, 'COMMON NAME']]}], ['Image 194: A ARCE ARCETRIN BRAIR 3RART ARCETRIN CETRIN Mfg.Lic. Mfg.Lic.No.:2513 Cetirizine Hydrochloride Tablets IP loride Tablets IP RAR ARCETRIN RINona Manufact Each film coated tablet contains: ablet contains: Manufactured by AR loride lP 10mg Cetirizine Hydrochloride IP 10mg ARYA PHARMA PHARMALAB PVT.LTD Chhatapip Chhatapipara,Bara,Nepal B.N0.ART89011 MFG.JUN.22EXP.MAY25 M.R.P.RS.3500PER10TABS. ', {'entities': [[81, 113, 'COMMON NAME'], [248, 280, 'COMPOSITION NAME']]}], ['Image 195: Cetirizine Hydrochloride Tablets IP ARCETRIN TABLETS ARYA ', {'entities': [[11, 43, 'COMMON NAME']]}], ['Image 196: LevocetirizineTabletslp Levocetir LEVRIX-5 R-X LEVRI Each film ccated tablet contains Each flm coated tab Levocetirizine-Hydrochloride IP Levocetirizine Hydrac 715 Colours.Brart Blue & Quinoline Y Mfg.Lic.No.:10715 Colours.Brilliant Bue Manutactured-bd ARYAPAM.LO. PVT.LTD Bara,Nepa B.NLVT9000SMFG.NOV.22EXP.OCT.24 M.R.DRs,60.0SPER10 TAES ', {'entities': [[11, 34, 'COMMON NAME'], [117, 145, 'COMPOSITION NAME']]}], ['Image 197: LevocetirizineTablets IP 10x5x10 Tablets LEVRIX-5 ARYA ', {'entities': [[11, 32, 'COMMON NAME']]}], ['Image 198: Cinnarizine Tabletsip stugeron Sach uncoarediable MigLic.No.:A0/06 ME2 Manufacruredby contains Encore Healthcare Ryt Lk 25mg Cinnarizine PQNo.D-5.MIDC Rahan-431148 SCHEDULE H DRU8>Waning:To be Marketed by sold by retail on tosrescription of a Johnson &Johnson Pt Ltd A.SXarg.Mulund Wast 000200080 Oosage:Ascrectetoy tophysiola Store in a dry,weleyontllated place Janssen F1016C at temperature n0xceeding 30C Registered Trademark of Store protected frnrx light. Keep out Johnson &JohnsonU.S.A freach ot chllds EPP2E2 Stugerono 25TABLETS R Cinnarizine Tablets IP Stugerono REGRTG Mfg.Lic.No.:AD/061 Each uncoated tablet Manufactured by contains Encore Healthcare Pvt.Ltd. 25 mg Plot No.D-5,MIDC CinnarizineIP Palthan-431148 ', {'entities': [[11, 32, 'COMMON NAME'], [704, 717, 'COMPOSITION NAME']]}], ['Image 199: R Cinnarizine Tablets IP Stugeron (01) 18901012400675 (17) 250731 EJ21001 (21)552839233016689 Janssen ', {'entities': [[13, 32, 'COMMON NAME']]}], ['Image 200: ccobaianniabicts MCORA-1500 SAMCOBA-1500 HT-9y00 Each uncoated tablet contains N Mecobalamin-JP 1500 mcg Hrar N SCOS15 O f  far    MMAUUUC Manufactured and Marketed By Samar Pharma Co.Pvt.Ltd nr Chhatapipra-2,Bara Nepa BANO MP SAMAR Mecobalamin Tablets Mfg.Lic.No.13484 MCOBA SAMCOBA-150C Hc-qyo0 ach uncoate ', {'entities': [[92, 115, 'COMPOSITION NAME'], [244, 263, 'COMMON NAME']]}], ['Image 201: Fexofenadine Hydrochloride Tablets USP 120 Fenfex 10x 10 Tablets ', {'entities': [[11, 45, 'COMMON NAME']]}], ['Image 202: a-Biock.RoratnangSikkim737.133INDIA Cipla KIDSTM M OLLEEEEES Rx Montelukast Sodium.Chewable Tablets USP4 mg Montair Dosage:As directed by the Physician Store below25C CHEWABLE Protect from light & moisture TABLETS mg For paediatric use only Each uncoated chewable tablet contains. Keep out of reach of children Montelukast Sodium IP SCHEDULEHPRESCRIPTION 2123555 equivalent toMontelukast...4 mg DRUG-CAUTION METTT2 Cipla EXEPPP2G Not to besoid byretail.witnot theprescription.ctaRagista Mfd.by CIPLA LTD(Uniti) MedicaiPractitoner Taza Block,Rorathang/Sikkim 737 133 NDIA Cipla kIDsM Rx Montelukast Sodium Chewable Tablets USP 4 mg ', {'entities': [[75, 110, 'COMMON NAME'], [597, 632, 'COMMON NAME']]}], ['Image 203: Cipla KIDS Rx Montelukast Sodium Chewable Tablets USP4 mg Montair CHEWABLE 4mg TABLETS For paediatric use Strawberry Flavour 10x 15 Tablets ', {'entities': [[25, 60, 'COMMON NAME']]}], ['Image 204: F1254A etonctaRegseredMedicad Janssen 30 Tablets Flunanzine Dihydrochlonide Tablets sibelium10 mg ach uncoated tablet contains, Manuiactured by: onarzine Dnydrochlcride Bp Encore HealthcarePyt.Ltd POLNOD5<MLD.C YagesorededcytePm IndustnalArea,Paithan For Oral Use Aurangabad-431 148 Store at or belo30C.protece Marketed by: from light Jonnsor & Johnson Yeep out creaorand sight er cwdren PrvateLimited B.S.Marg.Mulund (West) 400.080 Tradenarkor &Johnson U.SA. Flunssine DidrochAde Tab ', {'entities': [[60, 94, 'COMMON NAME']]}], ['Image 205: 5 x30TABLETS Rx FlunarizineDihydrochloride Tablets sibelium10 mg EACH UNCOATED TABLET CONTAINS FLUNARIZINE DIHYDROCHLORIDE BP EQUIVALENT TO FLUNARIZINE 10 mg For Oral Use Manufactured by: Encore Healthcare Pvt.Ltd. Dosage :As directed by the physician Plot No.D-5,M.l.D.C.Industrial Area,Paithan Store at or below 30C, Aurangabad-431 148 protected from light. Marketed by: Keep out of reach and sight of children Johnson & Johnson Private Limited, L.B.S.Marg,Mulund West),Mumbai 400080 SCHEDULE HPRESCRIPTION Registered Trademark of DRUG-CAUTION Johnson & Johnson,U.S.A Not to be sold by retail without the prescription of a Registered Medical Practitioner Janssen ', {'entities': [[27, 61, 'COMMON NAME'], [151, 168, 'COMPOSITION NAME']]}], ['Image 209: Mecobalamin Tablets SAMCOBA-1500 H-9y00 10x10 Tablets ', {'entities': [[11, 30, 'COMMON NAME']]}], ['Image 210: Gangtok,Sikkim-737 135 Trypsin-Chymotrypsin Tablets CHYMORAL FORTE A4355 SCHEDULEHPRESCRIPTION CYYMORALFORTE DRUGACAUTION Not to b8 sold by retail without Each enteric-coated tablet contains the presctipton of a Registered 1,00,o00 Armour Units ot Enzymatic Activity Medical Practtioner Supplied by a Purified Concentrate which has SpeciicTrypsin and Chymotrypsin -Registered Trademark Activity in a Ratio of Approximately Six to One forrent ColoursPonceau 4R and Sunset Yellow FC PHARmA Dosage:As directed by the Physician 8089307-802 Manufactured:by: STORE IN A DRYPLACE BELOW25C TORRENT Keep out ot reachot children PHARMACEUTICALS LTD Swallow whole tablet, do not crush or chew. 32 No.MiddleCamp, NH-10,East-District, Mfg.Lic.No.M564/2010 Gangtok,Sikkim-737 135 R Trypsin-Chymotrypsin Tablets CHYMORA CHYMORALFORTS PESORIPTION ', {'entities': [[34, 62, 'COMMON NAME']]}], ['Image 211: FlunarizineHCITablets FLUGRAN-IO 4-90 LAPEN ', {'entities': [[11, 32, 'COMMON NAME']]}], ['Image 212: Store in a dry & dark place, at a temperature not exceeding 30C SCHEDULEHPRESCRIPTION DRUG-CAUTION Not to be sold by retall without the preschptior of a Registered Medical Practtioner Mfg.Lic.NoM/600/2012 Made in India by MICRO LABS MICRO LASS LIMITED Mamring.NamthangRoad, Namchi-737132,Sikkim Regd.Trade Mark R Ebastine Tablets IP20 mg Ebast-20 Each filmcoated tablat.contains Ebastine-P20mg Colours yolew Qxide ofrer and titapt Dioxidep Dosage-As dirediocsty thaPhys Store in a dry or place, at a temperaturet exceeding 30 SCHEDULEC ERESCRIPT DRUG-CADRO Not to be old bertail withol MITED ', {'entities': [[324, 340, 'COMMON NAME']]}], ['Image 213: MICRO R Ebastine Tablets IP 20 mg Ebast-20 SF-Ro 3x5 x15)Tablets ', {'entities': [[19, 35, 'COMMON NAME']]}], ['Image 217: 10 Blisters of 10Capsules Itopride Hydrochloride Sustained Release Capsules ITONORM 150 ', {'entities': [[37, 86, 'COMMON NAME']]}], ['Image 218: ItoprideHydrochlonde Tablets TOP50 fa TOP5040 MFG.JAN.22 B.No.TIT-802 PER 10TABS M.R.P.RS.100.00 EXP.DEC.23 ffa Each film coated tablet contains: f 50mg    Itopride Hydrochlcride Excipients q.s, anutactured by: ColourBliam Bue and ALIVE ThanranPioxden PRARMACEUTICAL PVLTO fg.Lic.No.790 DuyanaSimariya VDC,Sunsari,Nepal TOP50 ITOP50 ITOP50 440 Itopride Hydrechloride Tablets< ITOP ff ', {'entities': [[355, 385, 'COMMON NAME']]}], ['Image 219: 10BlistersX10 Tablets Itopride Hydrochloride Tablets TOP50 3152440 live ', {'entities': [[33, 63, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 220: ColourTartrazine Manufactured By PER 10TABS Magnus Pharma Pvt.Ltd M.R.P.RS.. EXP.DEC.2024 MFG,NAN.2023 B.No.AT23001 ragnus Rampur Tokani,Jeetpursimara-23 Bara,Nepal PIAGDOK10DT Domberidonexrablets BR Mfg.Lic.No.7634 .70.00 MAGDOR-TOOT   HHE \" Each uncoated dispersible tablet contains : omperidone Maleate BP eq.tamperidone 10 mg Colour ManufacwuredBy Magnus Pharma Pvt.Ltd. Rampur ipursimara-23 ', {'entities': [[188, 210, 'COMPOSITION NAME']]}], ['Image 221: Domperidone Tablets BP MAGDOM-10DT -0 20x 10Tablets ', {'entities': [[11, 33, 'COMPOSITION NAME'], [34, 45, 'COMMON NAME']]}], ['Image 222: SCYEDULEHFRESCRIPTION ORUG-CAUTION Itopride Tablets l.P. Not  be sold by retail without he oresciption oRegistered Medical Pracatone Ganaton 50mg Mfg.Lc.No.M/750/2016 Manutactured in India by:Swiss Garnier BF Each tilm coated tabiet contains: Genexiaa Sciences Pvt.Lto.Unit-1D 50mg Plot No.568-569&576-579.Tapin Sock topride Hydrochicride t.p Phenock RongliEast Sikkim-737133India Excipients q.s. Marketed byAbbott tndia Limited CoouTtanium Dioxidel.P Angal Spacs.Litstyle Bldg.No.D-4.Gala No.7 DosageAs orescribso by the Physician to10.17to 20.Ground Flo0r.107 to 110&117 Store protected trcm moistere, to12.Furst Aloor,Pimplas Village. DistThane at a temperature notexcsecing 30C Bhiwanu-421302,india MedicineKeep out ofreach of children Regd.Trademark of Abbott GMBH &CO.KG RX LENPRESCRIPTION ORUG SGABTION Ganaton ltopride Tubiets l.P d by relail wihout the prectn HGonatopsong ', {'entities': [[821, 828, 'COMMON NAME'], [829, 849, 'COMPOSITION NAME']]}], ['Image 223: Rx Itopride Tablets I.P. Abbott Ganaton ? 50 mg 10x10 Tablets ', {'entities': [[14, 35, 'COMPOSITION NAME'], [43, 50, 'COMMON NAME']]}], [\"Image 224: Marketed by: tanium Dioxide.Quinoline Yeliow Ws True Derma S.A. Bniant Blue FCF TRUE Under Technical Guidanca of Dietary Supplement SUPPLESRENT True S.A.LLC. 11025 Not for Medicinal Use 13374 Redspire Dr, Silver Spring Dosage:As suggested by health care MD,20906USA provider/Dietician. EXPPT 2251449 Recommended Usage: Not to exceed the Copermin stated recommended daily dose. Storage:Store in a dry place, at a temperature 2023 IBS RELIEF not exceeding 25C.Protect from direct sunlight Keep out of reach of children. Capsules Mfg.Lic.No.:1353 PEPPERMINT OIL Manufactured in Indla by: Composition: Softgel Healthcare Pvt. Ltd. Each enteric coated soft gelatin capsule contains: Survey No.20/1, Peppemint oil (Mentha Piperata) 0.2 ml Vandalur-Kelambakkam Road Exciplents: Pudupakkam Village, S220030 Kancheepuram District, di-alpha tocopheryl acetate, Soya bean oil. Colours: Tamilnadu-603 103 Titanium Dioxide,Quinoline Yellow WS Marketed by: Bnlliant BlueFCF True Derma S.A. ON' TRUE Dietary Supplement Under Technical Guidance of Not for Mediclnal Use. True S.A.LLC. B Dosage: As suggestad by neatth care 13374 Redspire Dr,Silver Spring ovider/Dietician. MD,20908USA \", {'entities': [[348, 356, 'COMMON NAME']]}], ['Image 225: 3 x 10 Enteric Coated Capsule Copermin IBS RELIEF Capsules PEPPERMINT OIL Effective, soothing relief from IBS Painful Spasms Bloating Trapped Wind Diarrhoea Constipation ', {'entities': [[41, 49, 'COMMON NAME']]}], ['Image 226: Domperidone Dispersible Tablets DOMETIC-DT slAfe-f. 10x 10 Tablets ', {'entities': [[11, 42, 'COMPOSITION NAME'], [43, 53, 'COMMON NAME']]}], ['Image 227: Emidoneo mdone-DT Wara-fsyEmianoT 437- Emidone-D amaceroc sidone-n ', {'entities': [[50, 59, 'COMMON NAME']]}], ['Image 228: Physician. Store in a dry place SCHEDULE H PRESCAIPTION DRUG-CAUTIONNotto be sold by retail withour the prescnption of a Registered Medical Practitionsr Tablet should be dispersed in water immediately betore use Manutactured by INTAS INTAS PHARMACEUTICALS LTD 7/3 GIDC Estate Vatva Ahmedabad382 445 INDIA Mfg.Lic.No.G/162 2061102686568 Rx DOMPERIDONE TABLETS10mg DOMELMT Each-uncoated dispersible rabet contains Qomperidone IP10mg xcipients:Q.S oseAs directed by the let shouldbe dispersed in Fimmediately Dooreus ', {'entities': [[350, 373, 'COMPOSITION NAME'], [374, 381, 'COMMON NAME']]}], [\"Image 229: 10 x 20's Tablets Domperidone Tablets IP DT Emidone Panas \", {'entities': [[29, 51, 'COMPOSITION NAME'], [55, 62, 'COMMON NAME']]}], ['Image 230: ROREN-OU PROBENFOO Each filmcoated tablet contains: f 50mg Itopride Hydrochlonide Mfg>LicNo.:13781 Color: Titanium dioxide N&,110.00 M.R.P/10 EXP.AUG.24 MFD.SEP.22 B.NO.ITTS Manufactured by Ohm Pharmaceuticals Lab.Pvt.Ltd. Tathali-9.Bhaktapur,Nepal PROBEN-50 PROBEN-50 ROBEN-50 PROBEN-50 Itopride Hydrochloride Tablets HAE TAOS PROBENSO t:fafntr at-far 97-40 PROBEN-50 ROBEN-50 PROBEN-50 PROBEN-50 Each film coated tablet contains: f 50mg Itopride Hydrochloride CC.No.13781 ColorTitanium dio Manufactured<by Ohm Pharmaceuticals Lab.Pvt.Ltd. ', {'entities': [[289, 298, 'COMMON NAME'], [299, 329, 'COMPOSITION NAME']]}], [\"Image 231: Itopride Hydrochloride Tablets PROBEN-50 9107-40 20x10's Tablets OPL \", {'entities': [[11, 41, 'COMPOSITION NAME'], [42, 51, 'COMMON NAME']]}], ['Image 232: magnus Rampur Tokani,Bara,Nepa Mfg.Lic.No:10738 GIP-50 5iq-40 GIP-50 GIP-50 Giq-y0 ItopridebydrochlorideJabiets PER10 TABS GIP-509-40 Each filmcoated tablet contains HE Itopride Hydrochloride 50mg a Colour:Xitanlm Dioxide Manufactured By Magnus Pharma PxtLtd. Rampur TokaniBaraNepal wg.Lic/No 10738 CIP-SU P-50 ', {'entities': [[80, 86, 'COMMON NAME'], [180, 207, 'COMPOSITION NAME']]}], ['Image 233: Itopride Hydrochloride Tablets GIP-50 519-40 20x 10Tablets ', {'entities': [[11, 41, 'COMPOSITION NAME'], [42, 48, 'COMMON NAME']]}], ['Image 234: Itopnide Hydrochloride Tablets feyT f Retune f   Composition: Each film coated tablet contains: 50mg Itopride Hydrochloride Mtg.LicNo.175011085246 Mig.L1750111085248 Colour:Titanium Dioxide IP Manutactured in Nep ManutacoredinNeparby Nova Genstica Pvt SnevaGaeticayt.Ltd Khant Khola-7.Naubise KanKhoa-Naubise.Dhading Retune Rerr Retune- Retune etune Retune MFD.MAR.2023EXP.FEB/Z025 3.NO.PPI erne R.P.RsARO.00FOR10TABS ', {'entities': [[11, 41, 'COMPOSITION NAME'], [49, 55, 'COMMON NAME']]}], ['Image 235: Retune Itopride Hydrochloride Tablets 5x5x10 Tablets LDS.E. Nova Genetica ', {'entities': [[11, 17, 'COMMON NAME'], [18, 48, 'COMPOSITION NAME']]}], [\"Image 236: OMPCRIDONE DISPERSIBLETABLETS mOTInORmDT-IO mG MOTInORmpT-IO mG SCHEDULEAPRESCXPTON Each dispersible tablet contains DRUG-CAUTON Domperidone L.P. 10mg Hot to be soid by ratalwyon tho prescription ot a Raptstereo Excipients q.s Dosage:As directed by the Physician Medical Pracutioner. ESOO52 Keep in a cooi dry place.protecied trom light Mfg.Lic No.:JK01/05-06/75 Direction for use:Disperse the tablet Manutactured by easpcontul (5 ml) c1 boiled MEDLE PHARMACEUTICALS LTD Cooied wzter innmediatehy medjer Lan Ho3.Pnase-1.SiDc industria Cadministraton.. Copx Bari Brahmana.Jagu-181 133 ep out of reach otsydren Rogo.OniceMedoy HouseD2 D ren Andhen East.Mumba 402 099NIA PON'E MECS DOMPERIDONE DISPERSIBLE TABLETS MoTIDO MOTInORmDT-IO mG HEDULE H PRESCAUPT Fesp dispersible tablet contains DRUG-CA Dornuendone L.P. 10 mg Nottobas no.orer \", {'entities': [[690, 721, 'COMPOSITION NAME'], [729, 742, 'COMMON NAME']]}], ['Image 237: Rx DOMPERIDONEDISPERSIBLE TABLETS moTInORm DT-IOMG Registered Trademark ', {'entities': [[14, 44, 'COMPOSITION NAME'], [45, 53, 'COMMON NAME']]}], ['Image 238: 5x4x 10 Tablets Rx DOMPERIDONE TABLETS 10 mg DOMELMT INTAS ', {'entities': [[27, 55, 'COMPOSITION NAME'], [56, 63, 'COMMON NAME']]}], ['Image 239: AMTECAOCPYTLTD   Katahan-4,MorangNepa (WHO-GMP Cerlified Company) EUPA Ontron 4 Ontron 4 Ontron 4 Ontron4 Ondansetron Hydrochloride Tablets IP Ontron4 E Each uncoated tablet contains Ondansetron Hydrochloride IP eqv.to Ondansetron 4 mg Mfg.Lic.No.12130 Manufactured in Neoal by AMTECHMEDPVT.LTD Katahari-4,Morang,Nepal WHO-GMP Cerlfled Company) Ontron 4 Ontron 4 Ontron 4 Ontron 4 Ontron4 ', {'entities': [[100, 108, 'COMMON NAME'], [194, 222, 'COMPOSITION NAME']]}], ['Image 240: Ondansetron Hydrochloride Tablets IP Ontron 4 3cl 8 20x10 Tablet ', {'entities': [[11, 47, 'COMPOSITION NAME'], [48, 56, 'COMMON NAME']]}], ['Image 241: Regis. Manufacturedinindia by. ARIsTo Phalttaceuflcals Pvt.Ltd. RISTO DAMAN (U.T) Granisetron.Mouth Dissolving Tablets grandem mp Composition: Each uncoatedmouth dissolving tableticontains: Granisetron Hysrochloride BP 1.mg eq.toGranisetron Excipients: q.s Colour:SunsetYellow.FCF Dosage: As directedby the Phvsician. Store in a cooldry place Protect from light. eep out of reacot children. LNo:DD/83 a egistered Medical loner Recistered Tradem ufactured vt.Ltd. Survey Village: N3010ama0-39621 Granisetron Mouth Jissolvingablets granden ap ', {'entities': [[42, 48, 'COMMON NAME'], [201, 229, 'COMPOSITION NAME']]}], ['Image 242: 10x10Tablets R Granisetron Mouth Dissolving Tabletgy grandemmp ARISTO ', {'entities': [[74, 80, 'COMMON NAME']]}], ['Image 243: Sustained Release Tablets 150 mg HHE PROBEN150SR MRP/10TABS Rs.250.00 MFD.SEP.22 EXP.AUG24 B.No.ITTT 03 9.3 Mfg.Lic.No:1770414090748 Each uncoated tablet contains: Itopride Hydrochioride 150 mg Manufactured by: Ohm Pharmaceuticals Lab.Pvt.Ltd OPL Tathali-9,Bhaktapur,Nepal PROBEN 150SR 9. PROBEN 150SR 9. ItoprideHydrochloride     Sustained Release Tablets 150 mg PR0BEN150SR 9. ', {'entities': [[284, 290, 'COMMON NAME'], [316, 374, 'COMPOSITION NAME']]}], ['Image 244: Itopride Hydrochloride Sustained Release Tablets PROBEN 150SR 9.3 10x10 Tablets OPL ', {'entities': [[11, 59, 'COMPOSITION NAME'], [60, 66, 'COMMON NAME']]}], ['Image 245: GamaE Methyl Paraben 218)Propyl Paraben (216 and Purified water Recommended Usage: As directed by the Dietician Not to exceed the stated recommended daily usage Each soft gelatin capsule per serving contains  400 mg Storage: Store in a cool,dry & dark place below 25C Stamin E Protecttrom direct sunlight, heat &moisture. Wheat Germ Oil 100mg 30mg Keep out of reach of children. Omega 3 Fatty Acids Ths product is not intended to diagnoseprevent treat or cure Excipients q.s. a human disease. Nutritional Information BIETARY SUPPLEMENT (Approx.value per serving/capsuie NOT FOR MEDICINAL USE Energy BEST BEFORE 24 MONTHS FROM MANUFACTURE 3.051 Kcal Carbohydrates 0.027g fssat Protein 0.268g LiC.No.10018021003170 Fat 0.099g 0.025g Net Content10N Saturated fatty acids Manufactured in India by: CAMA Polyunsaturated fatty acios 0.035g Monounsaturated fatty acigs 0.039 g Renown Imported&Marketed By Cholesterol 0 mg RENOWN PHARMACEUTICALS PVT.LTD. Gama Trade Concem Nepal Prt.Ld. Appropriate overages of vitamns are added to compensate for Survey No.143/A&BVillage-Ranu.Taluka-Pada Kathmandu,Nepal isadodara-391445Gujarat India. oss on storage yewwww.krpharma.org.in CONTAINS PERMITTED SYNTHECFOOD COLOURS EMzllkspharma017@gmail.com oftgel Capsuestn Omega 3FanyAcidsVitamin&Wheat Germ.O ngredienisGelatin (Food Grade/428)Glycenn 422Sorbitor 420 MethylParaben (218)PropylParaben (216) and Puritied water ', {'entities': [[11, 16, 'COMMON NAME']]}], ['Image 247: Pheniramine MaleateBP7.5mg ColoursIndigocarmine and Tartrazine DECONGESTANT TABLETS RHINEX RHINEX PHINEX RHINEX RHINEX Simea Made in Nepaby SIMCA LABORATORISSPVT LTD. MfgLic.No.:543 Byasi,Bhaktapur S RHINEX RHINEX RHINEX RHINEX RHINEX Each tablet contains: RHINES BP 500mg Paracetamol Phenylephrine HCI BP 10 mg Pheniramine Maleate BP 7.5 mg TSAC Colours : Indigocarmine and Tartrazine DECONGESTANCTABLETS RHNEX RHINEX RHINEX RHINEX RHINEX ', {'entities': [[74, 94, 'COMPOSITION NAME'], [95, 101, 'COMMON NAME']]}], [\"Image 248: RHINEX DECONGESTANT TABLETS simca Blisters of 30x10's \", {'entities': [[11, 17, 'COMMON NAME'], [18, 38, 'COMPOSITION NAME']]}], ['Image 249: ANTI COLD TABLETS MCOLD TABLETS NEW NEW FORMULA FORMULA DE-COLD DE-COLD    f-anes f-s Each uncoated tablet contains hoated tablel contains e.p 500Rig se0mng Paracetamol BP MugiNO255LP19 Cremyeohnea HC 7.5mg ChonherramneMaleatsr 4M .alceraxp Marwared LOMUS LOMUS Colour.amazne Oordazine Pharmaceuticals Pvt Pharmaceuticais Pvt.Ltd GothatarKathmanduNep Gothatar, Kathmandu,Nepal 3T45T LOMUS COLD DE-COLDDE-COLD DE-COLD 5XRXNO6MRPRAOOTARS ', {'entities': [[75, 82, 'COMMON NAME'], [168, 182, 'COMPOSITION NAME']]}], ['Image 250: GeO Each uncoated tablet contains Dexamethasone IP 0.5mg Excipients q.s. Keep out of reach of children ORUG~CAUTION a Registered Med Mig.Lic.No.G/25A4715-A Mkt.byZydus GeO 2076920 A div. of Zydus Healthcare Ltd. Mfg.by:Zydus Healthcare L.td Plot No.1&2.First floor. Near Erhardt+ Leimer,Sarkhej Bavla Highway No.8 A Sari Patiya.Matoda, Tal.:SanandAhmedabad-Rural-382220 Mig.atPlot No.407Ahmedabad Ind. EstateSarkhej-Bavla Road Moraiya Tal:SanandDistAhmedabad-382210. Registered Trademark Dexamethasone Tablets IP Dexona Zydus GeO Each uncoated tablet contains: Dexamethasone IP 0.5mg Excipients q.s. Store below 30C.Protect from light and moisture Dosage :As directed by the Physiclan Keep out of reach of children OAUTION t i be sold by ietal n9proscnptlor bl a Registered Ms Honer Mfg.Lic.No.:G/25A4715-A Mkt.byZydus GeO 2078820 (A div.of Zydus Healthcare Ltd. Mig.by:Zydus Healthcare Ltd. Plot No.1&2First floor Mfg.atPlot No.407.Ahmedabad ind. EstateSarkhej-Bavla RoadMoraiya Tal:SanandDist.Ahmedabad-382210. Registered Trademark Dexamethasone Tablets IP Dexona Zydus GeO Exciplents q.5. ', {'entities': [[499, 523, 'COMPOSITION NAME'], [524, 530, 'COMMON NAME']]}], ['Image 251: DOXOBID-400 safas-800 Each uncoated tablet contains : 400 mg Doxofylline IP H     AHE- Hf  faf-fa ', {'entities': [[11, 22, 'COMMON NAME'], [72, 86, 'COMPOSITION NAME']]}], ['Image 252: Sa-800  fa-fa Each uncoated tablet contains IP 400 mg Doxofylline magnus ADivision of Magnus Manufactured By Magnus Pharma Rvt.L1 Rampur Tokani,Jeetpursimara-23 Bara,Nepal DOXOBID-400STRT-800 DOXOBID-400 ras-800 Doxotvlline Tablets IP Mfg.Lic No.10214   DOXOBID-400 HHET slalfacx00 faf-fa Each uncoateotablet contains Doxofylline IP 400 mg STRAL magnus ADivision of Magnus Manufactured By Magnus Pharma PytLtd Rampur Tokani, Jeetpursimara-23, Bara,Nepal ', {'entities': [[203, 214, 'COMMON NAME'], [329, 343, 'COMPOSITION NAME']]}], ['Image 253: Hydroxychloroquine SulphateTabletsIP CORQUIN-200 SR-R00 . .. . . . COREL 10X 10 Tablets ', {'entities': [[11, 47, 'COMPOSITION NAME'], [48, 59, 'COMMON NAME']]}], ['Image 254: aydroxychloroquine Sulphate Tablets 1P COROORR3OORP M5 COROUIN-200 CORQUIX-2OO r-0 NN Nsi Each film coated tablet coqtains. Mfg.Lic.No.:1761009060820 Hydroxychloroquine Sulphate IP 200 mg PEAB Solour:Titanium dioxide AAARR Manufactured in NepaPby Corel Pharmaceuticalc Pr Lg Rohini-04 Rupanden -700 EXP COROUIN-Z00 hrrer CORQUIN-200 BOM-R00 CORQUIX-POO Y HydroxychloroquineSulphate Tabletsip COROUINOO - ferar fa-fanr LOUIN-200 ORO CORD ', {'entities': [[66, 77, 'COMMON NAME'], [161, 198, 'COMPOSITION NAME']]}], ['Image 255: Registered Trademack Storebelow 30C Etophylline and Theophylline M222T Prolonged Release Tablets IP Qeriphyllinretard300 Dosage As directed bythe Physician Keep out of reach of.childreo 300 M.LNoM/765/2016 Each film coated prolonged release tablet contains Mkt.by:German Remedies Etophylline 231 mg (A division of Zydus Healthcare Ltd.) Theophylline IP Anhydrous equivalent to Mfg.by:Zydus Healthcare Ltd.Unit-II Theophylline IP Hydrate 69mg 967 (P)968 P)970 P)Duga Circle 2023344 Excipients q.s. Kamarey Bhasmay, CotourTitanium.DioxideIp KumrekEast-Sikkim 737132 Store-below 30Cin dryplace Registered Trademark tophylline and Theophylline Prolonged ReleaseTablets IP Deriphyilin? retardsos As.drected.by the Physician ut of-reach of children 400 M.L. M/765/2016 Mkt. by:German Remedies ich film coated prolonged release tabletcontains 31mg division of Zydus Healthcare Ltd.) Etophylline heophylline IP Anhydrous equivalent Mfg Zydus HealthcareLtd.Unit-II .9-mg ophylline IPHyar 968 P.970 P)DugaCircle 2202334 annon ore below 30c in dry place Registered Trademark Etophylline and Theophyllige ProlongedrReleaseTabletsyR ', {'entities': [[679, 690, 'COMMON NAME'], [1075, 1130, 'COMPOSITION NAME']]}], ['Image 256: Etophylline and Theophylline Prolonged Release Tablets IP Deriphyllin retard 300 3300 Mfg.Lic.No.M/765/2016 Marketed by:German Remedies A division of Zydus Healthcare Ltd.) Manufactured by: To report adverse events Zydus Healthcare Ltd.Unit-Il call toll freeon 18004191141or 967P)968 (P)970P visit www.zyduscadila.com Duga Circle,Kamarey Bhasmay Registered Trademark 89076610080741 Kumrek,East-Sikkim737 132 ', {'entities': [[11, 68, 'COMPOSITION NAME'], [69, 91, 'COMMON NAME']]}], ['Image 257: venoxynethyloenicinin Tablets BP henocinsyK R cillin PotassiumBp nenoxymeth 250 mg q.to.Phenox etnylpenicillin PhenocinavK ChOnOGAyK Phenocin V henocin cillindablets BP ', {'entities': [[11, 43, 'COMPOSITION NAME'], [122, 133, 'COMMON NAME']]}], ['Image 258: Mfg.Lic.No/1751203101908 Each Lncoatedtablet contains 400mg Doxofyllineex MES Manufactured in Nepal by Colour:Tartrazine Lake HE Grace (A Division of Grace Grace Pharmaceuticals Pvt.Ltd Tilottama-11,Rupandehi DOXOVENT-400 DOXOVENT-400 DOXOVENT-400 soxorvlineTablets.IP DOXOVENT-400   S00 Mfg.Lic.No.1751203101908 Each unccered tablet contains 400 g Doxofylline<IP Manufactured in Nepal by: Colour:Tekrazine Lake Grace A Division of Grace Grace Pharmacodticals Pyt Lid ', {'entities': [[220, 232, 'COMMON NAME'], [360, 374, 'COMPOSITION NAME']]}], ['Image 259: Doxofylline Tablets IP DOXOVENT 400 S800 Grace 10x10Tablets ', {'entities': [[11, 33, 'COMPOSITION NAME'], [34, 46, 'COMMON NAME']]}], ['Image 260: Salbutamol Sulphate,Etofylline & Bromhexine HydrochlorideTablets S SCHEDULERORUG Albutamol-S Tablets arging To be sold by retail on the prescription Qfa Registered Medical Practitjoner only Each uncoated tablet con Mfg.Lic.No175 Centaur SalbutanolSulphate IP PFCCA0972AB equivalent to Salbutamol 210781 Etofylline IP PHARMACEUTICALSPVT.LTD. Bromhexine Hydrochloride IP PlanPlotNo.3,5B,2C,Tivimindustrial Eslate.Karaswada.Mapusa,Goa-03 526 Dosage:As directed by the Physician Regd.OffCentaur House.Santacruz(E) Store below 30na dry place unbai-400 055. Protect from light ORegistered Trademark Ro Nepal Sale only Salbutamol Sulphate,Etoryiine & ', {'entities': [[11, 75, 'COMPOSITION NAME'], [92, 103, 'COMMON NAME']]}], ['Image 261: Roflumilast Tablets Roflumil 82347 ROFLO0500 4ooMg.Lic.No.1780516082347 ROFLOO5 Composition: Composition: Each film coated tablet contains: Each film coated tablet co Roflumilast IP 500 mcg Roflumilast IP 500 ColourYellow Oxide of Iron Colour: Yellow Oxide of Ir Hraafnnt fa fa- aff faf Manufactured By: Magnus Pharma Pvt.Ltd.    Nepal agus Rampur Tokani,Jeetpursimara-23,Bara,Nepal 400 00 ROFLO0500 400 ROFLO0500 ROFLOO500 B.No.PV22001 MFG.AUG.2022 EXPJUL2024 M.R.PRs2Q0.00PER10TAB ', {'entities': [[11, 30, 'COMPOSITION NAME'], [46, 55, 'COMMON NAME']]}], ['Image 262: Sulphate IP 200 mg FGP 21106 &ipca HOOCSOOH Colour. Titanium Dioxide IP Ipca Laboratories Ltd. Dosage: As directed by the Physiciar C-6.Sara Ind.Estate,Chakrata Road Store in a dry place protect Rampur.Dehradun 248 197 from sunlight Regd.Off48Kandivli Ind.Estate Keep out of reach of children Mumbai 400067 Hydroxychloroquine Tablets P200mg HCQS-200 Warning:To be sold by retail on the prescription of a Registered MedicalPractitioner only -200 Regd.Trade Mark Each film-coated-tablet contains EGPULB Made in India by Hydroxychloroquine Sulphate IP 200 mg M10G SLipea dx Colour Titanium Dioxide IP Ipca Laboratories Ltd Dosage: As directed by the Physician C-6,Sara lnd.Estate,Chakrata Road m Store in a dry placeprotect RampurDehradun 248 197 from sunlight RegdOft48Kandivli Ind.Estate reep out of reachor chldren Mumbai400067 ', {'entities': [[318, 344, 'COMPOSITION NAME'], [352, 360, 'COMMON NAME']]}], ['Image 263: Lipca R Hydroxychloroquine Tablets P 200 mg HCQS-200 -200 ', {'entities': [[19, 45, 'COMPOSITION NAME'], [55, 63, 'COMMON NAME']]}], ['Image 264: Manufactured by. Abbott Healthcarc Pytaltd. onyfactired by Abbott Heahhcare PytLid age Bhaauli Khord.P.0 Baddia7c205a99 ge BhoauliKhurdP.0.Bodd173 205. Dist.SolanHimachal Pradesh.lndin Dist.Solan Himachal Pradeshba. 00107 Regd.Trade Mark of Abbot Healihcare Pvt.Lid. Reyd.Trnde Mark of Abbot Healthcare Pvt.Ltd Nicoumalone a Nicoumalone Tablersl.P. Acitrom Acitrom 3 mg Acitrom\" Anticoaguiant Anticoagulant Each uncoated tablet contains Eoch uncoated tablet contoin Nicoumalone l.P. mo Nicoumalone l.P. 3mg axcipients As prescribed by the Physrcio Store at a temperatore notexceeding Acfron Store at a temperature,not exceeding 30C.Protect from lign& moisture. 30C.Protect from lignt& moisture. Medicine:Keep out of reach of children hedicineKao. childr ', {'entities': [[336, 359, 'COMPOSITION NAME'], [368, 377, 'COMMON NAME']]}], ['Image 265: Nicoumalone Tablets I.P. Acitrom3 SCAN FOR MORE INFO CAUTION:Not to be sold by Each uncoated tablet contains: retail without the prescription 3 mg Nicoumalone l.P. of a Registered Medical Excipients q.s. Practitioner. Dosage: As prescribed by Mfg.Lic.No.:MNB/06/295 the Physician. Manufactured by: Store at a temperature not Abbott Healthcare Pvt.Ltd. Village Bhatauli Khurd exceeding 30C.Protect P.O.Baddi-173 205,Dist.Solan from light & moisture. Himachal Pradesh,India Medicine: Keep out of reach  Regd.Trade Mark of of children. Abbott Healthcare Pvt.Ltd. ', {'entities': [[11, 35, 'COMPOSITION NAME'], [36, 44, 'COMMON NAME']]}], ['Image 266: Phenoxymethylpenicillin Tablets BP ? Phenocin.VK LAPEN ', {'entities': [[11, 45, 'COMPOSITION NAME'], [48, 59, 'COMMON NAME']]}], ['Image 267: 0.00g Cholestero 1.0g Ahmedabad,Gujarat, India 3 Poty-Onsaturated Fa OilSoftgelCapsules EveningPrimrose Other Ingredients: Gelatin(INS 428), Eve Glycerol (422)Sorbitol (INS420).Glazing agent(INS 901),Preservatives (217,219) Approved colors used in empty capsule shellAppropriate overages are added to Nutritional informationKApprox.Valves compensate loss on storage. Each serving softgel capsule contains 1000 mg Usage As a Dietary Supplement or as Evening Primrose Oi directed by the dietician Excipients q.s, StorageStere in coel dry & tark place 9.38Keal Energy below25c.ProtecriromdireetSuhight 1.0g Fot Lic.No.10720026000746 BEST BEFORE2MOXTHS 0.02 g Marksted By Protein FROM DATE OF MANUPACTURE 0.075 g Carbohydrate ANC 0.00 g Cholesterol 1.0g Ahmedabad,Gujarat india Poly Unsaturated Fai Softgel ICapsules Evening Rrimrose OeIngredients: Gatin(INS 428) Gye(422)Sorbito 420)Glazing 19 ', {'entities': [[80, 98, 'COMPOSITION NAME']]}], ['Image 268: Evening Primrose Oil Softgel Capsules Evelife 10 x 10 Softgel Capsules ', {'entities': [[32, 48, 'COMPOSITION NAME'], [49, 56, 'COMMON NAME']]}], ['Image 270: Dietary Supplement Evening Primrose Oil BPRRRPE (10% GLA cold pressed)1000 mg and D-Alpha Tocopherol (Natural Vitamin E)400 mg Softgel Capsules BIOPRIM-E 1x10 Soft Gel Capsules ', {'entities': [[51, 154, 'COMPOSITION NAME'], [155, 164, 'COMMON NAME']]}], ['Image 271: 15mg 3RRT DEXIN DEXI Each uncoated tablet contains Each uncoated table Dexamethasone BP 0.5 mg Dexamethasone Br Mg.LN4982/LP-224 Mig.LiCNo.498 Manutaotured-by Manufactured by LOMUS LOMUS PharmaceuticalsPvt.Ltd, Pharmaceuticals Gothatar Kathmandu Gothatar Kathmandu.Nepal R LOMUS DEXIN DEXIN DEXIN DEXIN DEXIN DEX DEXIN DEXIN NIXIN NDX NIXEN DEXEN NIX3N NIXEN LONUS LONUS Pphnaee hejne LOWOT 221 DEXIN Lbee ', {'entities': [[82, 98, 'COMPOSITION NAME'], [290, 295, 'COMMON NAME']]}], ['Image 272: DexamethasoneTabletsBP DEXN Tablets 25 Blisters of 20 Tablets ', {'entities': [[11, 33, 'COMPOSITION NAME'], [34, 38, 'COMMON NAME']]}], ['Image 273: PREDNISO Mnig fuati-90 PRELON-10 PRELON. Each uncoated tablets contains Each uncoated table BP 10mg Pradnisolone Prednisoione BF Manwiacuredb Manufactured by LOMNS LOMUS Pharmaceuticals Pyt.Ltd. Pharmaceuticals Mfg.Lic.No4984/LP-226 LP-226 Gothatar Kathmandu.Nepal Gothatar Katmard R R LOMUS MUS PRELON-10 PRELON10 PRELON-10PRELON-10 PRELON-10 RELGN.10 LOMUS SONOT Pnhnnreeer   LONUS LOWUS  h 1006 PRELO 08-5 PREDN ', {'entities': [[317, 325, 'COMMON NAME']]}], ['Image 274: Prednisolone Tablets BP 10 mg PRELONE10 25Blisters of 20 Tablets f9a 90 ', {'entities': [[11, 34, 'COMPOSITION NAME'], [41, 50, 'COMMON NAME']]}], ['Image 275: 1 x10 Tablets Sildenafil Citrate Tablets IP Medigra-25 H3-R4 ', {'entities': [[25, 54, 'COMPOSITION NAME'], [55, 65, 'COMMON NAME']]}], ['Image 276: SildenafilCitrateTablets IP Medigra-25 BHE 9 S-34 Mfg.Lic.No.7189 Each filn-coated tablat contains Sitdenafil Citratelp equwalentto Sildenafil. 25.mg Coiours:Brilliant Blue Lake & Titanium Dioxide Manutactured inNepaby Quest Pharmxceaticas(RLtd Chhata Pipara Bara Birganj Sidenafil rate Tables IP Medigra.t5 ', {'entities': [[11, 38, 'COMPOSITION NAME'], [39, 49, 'COMMON NAME']]}], ['Image 277: 1x4 Capsules Itraconazole Capsules BP ONITRA-200 3T-R00 ', {'entities': [[15, 48, 'COMPOSITION NAME'], [49, 59, 'COMMON NAME']]}], ['Image 278: MfgLic.No:1750927043526 ONNTIONTI0 ONITRA-200 Manufactured by QMED Qmed Formulation Pvt.Ltd. ChhalingBhaktapur, Nepal ONITRA-200 ItraconazoleCapsules BP ONITRA-200 - Itraconazole Pellets 200mg eqv.to Itraconazole: BP 200 ', {'entities': [[140, 163, 'COMPOSITION NAME'], [164, 174, 'COMMON NAME']]}], ['Image 279: TadalafilTablets IP T-FIL10 f-fn90 10x4 Tablets ', {'entities': [[11, 30, 'COMPOSITION NAME'], [31, 38, 'COMMON NAME']]}], ['Image 280: Manufacuredby AT Pharma Pvt.d Bahuwari-5BaraN RI ELOZ100 ELOZ100 ELOZ100 ELOZ100 ELOZ100 ELOZ100 ELO00 ELOZ100 ELOZ100 OZ100 ELO7100 ELOZ10 COZ100 ELOZ100 Z100 ELOZ100 ELOZ100 LOZ100 ELOZ100 Itraconazoe Capsules BP 996: ELOZ100 Itraconazol 00:mg d.n.capsuleshells Mfg.Lic.No.109 Caution Patient under medication should not be 5900 administered with Terfen Astemizole or Cisapride Manufacturedbe m Maruti Pharma Pvt. Bahuwari-5BaraNepa ELOZ100 Edi AHTOO ELOZ100 ELOZ100 OZ100 ELOZ100 ELOZ100 ELOZ100 LOZ10 FL Z10 LOZ100 R07100 ELOZ100 ELOZ100 P1OZ100 ELO7100 ', {'entities': [[194, 201, 'COMMON NAME'], [202, 225, 'COMPOSITION NAME']]}], ['Image 281: Itraconazole Capsules BP ELOZ 100 $900 10 x 10 Capsules ', {'entities': [[11, 35, 'COMPOSITION NAME'], [36, 44, 'COMMON NAME']]}], ['Image 282: METHAPRED16 METHAPRED16 METHAPRED16 aredniso.onenablets THAPRED16 METHAPRED-16 uncoated tadlelcontains prednisolone IR ', {'entities': [[11, 22, 'COMMON NAME']]}], ['Image 283: METHAPRED16 METHYLPREDNISOLONE TABLETS IP 16 mg OMNICA ', {'entities': [[11, 22, 'COMMON NAME'], [23, 52, 'COMPOSITION NAME']]}], ['Image 284: Fourrts 10.Tablets Tadalafil/Tablets IP5 mo R MILDFIL ', {'entities': [[30, 47, 'COMPOSITION NAME'], [57, 64, 'COMMON NAME']]}], [\"Image 285: R00    SYNTRAN 200 300 f    HHE  ROO SMAN200 afa  Composition: Each capsule contains Mfg.Lic.No.:1750825045100 ItraconazolePellets RTAR00 SYNTAN280 Manufactured by: MMEC eq.to Itraconazole BP 200 mg ARYA HARMALAB Approved colours used in capsule shells. ChhatapiparaBara Nepal Itraconazole Capsules BP BAN' RR00 SYATRAN 20G   SYNTRAN 200 300    AHE RR afat  Composition, \", {'entities': [[288, 312, 'COMPOSITION NAME'], [337, 348, 'COMMON NAME']]}], ['Image 286: 10x1x 10 Capsul sotretinoin Capsules IP REZISORT 10 ', {'entities': [[27, 50, 'COMPOSITION NAME'], [51, 62, 'COMMON NAME']]}], [\"Image 287: sotretnoins&apsulesip REZISORKIO Waming to Femaia Patients: This mnedicine eto nay causa savsrs birth dofacts. You must not take this rnedlcina if you ar pregnant cr may Composition: nkely become pregnant during treatnant You should also avoid pregnency icr 6 rnonths Each soft gelaun capsulo mtains: after stopping ths trwstrnent. Isotrstnoin IP... Excipients ..... WamingThs drug should be sold by retai on the prescription ot Dsrmatologlats ony Suneet Yallow FCF. MOSC Poncesu 4R Supra & TKanlum Dlaxide IP Mig.Lic.No.:DD/302 Made in India by Dosage: As dirsctsd by b Demstologlats Indchemie Stor at or below 28'C. ovcina Io lignt in dry piscs. HealtnSpecisllties Pyt.&td. oui oy rson.cf cnlldren PlotNo.7.OlDCMahatna Gandhi Saution: Avold inhislln & skin contsct UdyogNegar.DabhOsman-30210 Mth contant of ospsuie H.O.:510.Shah & Na sl Estate, PI222 Please carsfully read ths padent Dr.E.Moses Rodwbai-400 018, nformation ieaflet providyt insie the pack Ragistared Trede Mark.T Treds Mark sotretnoin Cabsules&P Waming to Femsie Rs:Thls madlcine REZISORXXO wret may csuse evars bln csets.You must no tahe ts madicinaKegnsnt or my kely bscome pragoancdupngeeatmsnt You nd a \", {'entities': [[33, 43, 'COMMON NAME']]}], ['Image 288: ME.LC.N01731216080323 Manutactured in Nepal by T TIME Pharnaceuticais (P.)Lta Gancakct-10.Naw alparasi Dapoxetinedatiets PROLONG-30 -30 Eacn film coated tablet contains Dapoxetine Hydrochloride Ip 30 mg Ed to Dapoxetine Colour:Sunsetxenow R 11216080323 Ppalby IME icals PLtd ', {'entities': [[132, 142, 'COMMON NAME'], [180, 207, 'COMPOSITION NAME']]}], ['Image 289: Dapoxetine Tablets PROLONG-30 5-30 ', {'entities': [[11, 29, 'COMPOSITION NAME'], [30, 40, 'COMMON NAME']]}], [\"Image 290: egdratabletsp TADAGRA'S TADAGRA5 CISTT Eacn film coated tatlet contains adalafil mg RAS ColorYellow Qxber lron TSMEKTADAGRASCTSTAT Ifq.LicNo.70130093828 Banwfactured in NeoatBy Phaceuicast.id Sanga.Banepa-14Kavre ladalatilabletsIP ACAS TADACRAS ISTT Each film coa contains \", {'entities': [[35, 43, 'COMMON NAME']]}], ['Image 291: Tadalafil Tablets IP TADAGRA5 CTSTT 4 1 Strip of 4 Tablets ', {'entities': [[11, 31, 'COMPOSITION NAME'], [32, 40, 'COMMON NAME']]}], ['Image 292: ECONA capsule conta to ltraconazole 100 mg ECNNA caution Patient shoua omrtake Terfenadine or Aste ultaneousty NEPAEPHARMACEOTTCHRS SABORTORYARVTLTDE Neca ItraconazdleCapsuies FCO ECONAESSA ach capsule com eq. raconazole mg 134 ', {'entities': [[11, 16, 'COMMON NAME'], [166, 186, 'COMPOSITION NAME']]}], [\"Image 293: 1x4's Strip Itraconazole Capsules ECONA TM npl \", {'entities': [[23, 44, 'COMPOSITION NAME'], [45, 50, 'COMMON NAME']]}], ['Image 294: 100 iMfg. Manufactured in ndia by: el GlenmaRk Pharmaceuticals.td Registered Trade Mark PD38986 DOL ItRaconazole Capsules B.p.10omg R canditraL100 5900 Composition: Each Hard Gelatin Capsule Contains -00 Itraconazole B.P 100mg Excipients q.s armoisine & ', {'entities': [[111, 132, 'COMPOSITION NAME'], [145, 157, 'COMMON NAME']]}], ['Image 295: 6 ItRaconazole capsules B.p.ioo mg * ? canoitRal 100 900 10 x 10Capsules C GlenmaRk ', {'entities': [[13, 34, 'COMPOSITION NAME'], [50, 63, 'COMMON NAME']]}], ['Image 296: 1x4 Capsules Itraconazole Capsules Icon 3sdd ', {'entities': [[24, 45, 'COMPOSITION NAME'], [46, 50, 'COMMON NAME']]}], [\"Image 297: Se the t lreaspoontul s  c.No.54515 Tablets40_0222AL and coole water Immediately beton. 's'b stration orcarlake tablet with water Manuractured In India by Pozer Limited P.137.nase - Vemandustral Estare Veea.803403722 Registered Proprtor-yeth LLCUSA Licensed User-Pfizer LimitedIndia. Prednisolone Dispersible Tablets 5mg Wysolong015 Jazyl. Cach uncoated dispersible tablet contains Pregnisolone l.P. 5 mg Excipients q.s. Dosage:As directeo by the Physician Stane below aorCProtect krom Light. pout the p coreracutoner Mfg.LicNo.54515 Tablet een IRECTIONSFORUSE ano Immediateh sb Burg Pior 37.Phase l-A Vema adestriar Estate, Vema 403722 Propr yeth LLCUSA India \", {'entities': [[295, 331, 'COMPOSITION NAME'], [332, 343, 'COMMON NAME']]}], ['Image 298: SOR 20mg CAUDES CRTH DEPECTS   Each soft gelatin capsule contains Isotretinoin IP 20 mg DO NOT GET FREGNA Excipients g.s. Colours:ErythrosineBrilliant Blue FCF & AVOID PREGMANCY Titanium Dioxide IP. IMPORTANT:It is mandatory tar the patients to sign Dosage:As directed by the Dermatologist the Consent Form supplied with the pack betore Store at temperature not exceeding 30C undertaking the treatment of Isotretinoin. protected from light &moisture. SCHEDULE H PRESCRIPTIONDRUG-CAUTIO. Please carefully read the Patient Information Not to be sold by retail without tha prascription Leaflet provided inside the pack. of a Dermatologist. The drug should be sold by retail on the Mfg.Lic.No.:MNB/95/2 prescription ot Dermatologists only. Manufactured in India by: This medicine may cause severe birth defects; you sun pharmaceutical ind.Itd must not take this medicine if you are pregnant or Village Ganguwala,Paonta Sahib may likely become pregnant during treatment. Dist.Sirmour-173 025 (H.P. You should also avoid pregnancy for 6months after For queries.email mysotret@sunpharma.com stopping the treatment Registered Trade Mark ISOTRETINOIN CAPSULESIP SOTRET 20 mg   Each soft gelatin capsule contains Isotretinoin IP 20 mg DO NOT BETPREGNANT Excipients q.s. Colours:ErythrosineBrilliant Blue FCF & AVOID PREGNANCY Titanium Dioxide iP. MPORTANT:t is mandatory tor the patients to sign Dosage:As directed by the Dermatologist the Consent Form supplied with the pack betore ', {'entities': [[1140, 1163, 'COMPOSITION NAME'], [1164, 1170, 'COMMON NAME']]}], ['Image 299: ELUCONAZOLE CAPSULESIP Flucomed-200 PER CAR M.R.P.R5.30.00 EXP.0CT2024 MFG.NOV.2022 B.NO.CFC79010 Eacb nard gelatin capsule 446g conons onazole IP200 mg fr Oproved coiours used in psule shells tgLic.No1750818094345 Flucomed-200 Manutactred by me Pharaceuticals Pvt.Ltd Birgnnj-Parsa (Nepal KUCONAZOLE CAPSULESIR Sucomed-200 ', {'entities': [[11, 33, 'COMPOSITION NAME'], [34, 46, 'COMMON NAME']]}], ['Image 300: FLUCONAZOLE CAPSULESIF FLUCOMED-200 4ch143-200 1x1Capsule Irime ', {'entities': [[11, 33, 'COMPOSITION NAME'], [34, 46, 'COMMON NAME']]}], ['Image 301: T - T T  20 Mfg.Lic.No: 1740904103938 SONO0 Deurali-Janta Pharmaceuticals Pvt.Ltd Dhapasi Katnmandu,Nepal 01TITO Itraconazole:@apsules 200mg DIGICON230 DICCeON DIGICON200 1311200 Each capsule co uivalent DIGICON 200 Itraconazole pellese 200mg to Itraconazole olors ppro ', {'entities': [[124, 151, 'COMPOSITION NAME'], [171, 181, 'COMMON NAME']]}], ['Image 302: ? 200 DIGICON 200 Itraconazole Capsules 200mg 8 Capsules x 10 Strips ', {'entities': [[17, 28, 'COMMON NAME'], [29, 56, 'COMPOSITION NAME']]}], ['Image 303: OLAYROSOLADC SOLAYXHM SOLAY ISOLAY ISOLAY No206017 Manufactured n Nepal by S QuestPharmaceuticals (P.) Ltd Chhata Pipara.Bara.Birgan SOLAY BIGKSOLAX RISSOLAY SIS SOLAL 2MRP5TABS SOLIREMACIN SOOCINATETABLETS 496 SOLAY SOLA zach f Tartrazineritanlum Dlox SOLAY SOLAY SOLAY SOLAY fa Manufacturex epal by miralse ', {'entities': [[189, 217, 'COMPOSITION NAME'], [222, 227, 'COMMON NAME']]}], ['Image 304: 5x4x15Tablets SOLIFENACINSUCCINATETABLETS SOLAY ', {'entities': [[25, 52, 'COMPOSITION NAME'], [53, 58, 'COMMON NAME']]}], ['Image 305: ChlorpheniraminsMaleate Phenylephrine Hydrochtoride 4m Paracetamot 10mg 500mg OXA fa SINEX M0363463730729070700 Manuiactured in Nep. Chlorpheniramine henylephrine &Paracetamol Tablets FR Anti.eold Tablets d tablercontain sa heniramine Malea 10 mg Paracctamo fhrnant SINEX TIMD arast Chlorphenk Gano Pe ', {'entities': [[96, 101, 'COMMON NAME'], [144, 194, 'COMPOSITION NAME']]}], ['Image 306: SINEX HISAR T ', {'entities': [[11, 16, 'COMMON NAME']]}], ['Image 307: / HET: ARJOTI EXS0 Mfg.Lic.No.1750106013135 Manufactured in Nepal by TP TIME Pharmaceuticals (P.) Ltd. Gaindakot-10,Nawalparasi. Marketed by: COSMO (A Division ot Time Pharmaceuticals P.Ltd.) FUZON FUZON FUZON FUZON Alfuzosin Hydrochloride Extended Release Tablets FUZON Each uncoated extended release tablet contains: Alfuzosin Hydrochloride USP 10 mg LicNo.1750106013135 ', {'entities': [[203, 208, 'COMMON NAME'], [330, 363, 'COMPOSITION NAME']]}], ['Image 308: Rx R Tamsulosin Hydrochloride ModifiedRelease Tablets 0.4 mg Veltam0.4 SNTAS Each film coated modified release tablet contains Tamsulosin Hydrochloride 1P.0.4 mg Colour :Titanium Dioxide IP 8 ExcipientsQ.S 9233339 Dose:As directed by the Physician Keep out of reach of children SCHEDULEHPRESCRIPTION DRUG-CAUTION NINIA Not to be sold by retail.without the prescrption ot-a Urologist Rx Tamsulosin Hydrochloride ModifiedRelease Tablets 0.4 mg Veltam0.4 (TASS Each filmcoated modified release ', {'entities': [[72, 81, 'COMMON NAME'], [138, 172, 'COMPOSITION NAME']]}], ['Image 309: Tamsulosin Hydrochloride Capsules USP (Modified Release Capsules 0.4 mg) AlfaPro-0 3Tclby1-0.8 10Capsules x 10Blisters DJPL ', {'entities': [[11, 48, 'COMPOSITION NAME'], [84, 93, 'COMMON NAME']]}], ['Image 310: 5x2x15 tablets PX Metoprolol Succinate Prolonged Release Tablets IP SelokenXL 100 mg ', {'entities': [[29, 78, 'COMPOSITION NAME'], [79, 88, 'COMMON NAME']]}], ['Image 311: Pach-titrn.coatedsustained-release tablet contains Nitrofurantoin IP. .100mg Colour:Titanium Dioxide IP ExcipientsQ.S. Dose:As directed by the Physician. Store in a cool& dryplace, protected from-light, Keep all`medicines out of reach ot children Mibid Uribid Rx Nitrofurantoin.Sustained BeleaseTablets100.mg Each film coatedsustained release ablet contains: Nitrofurantoin IP .100 mg Colour:Titanium Dixide IP ExcipientsQ.S ', {'entities': [[62, 87, 'COMPOSITION NAME'], [264, 270, 'COMMON NAME']]}], ['Image 312: 5 x 3 x 10 Capsules Silodosin Capsules RAPIFLO8 445 ', {'entities': [[31, 49, 'COMPOSITION NAME'], [50, 58, 'COMMON NAME']]}], ['Image 313: 10x14 Tablets Aspirin Delayed-Release Tablets USP 75 mg DelisprinT75 OtsiraGenetica ARISTO A division of ARISTO Pharmaceuticals Pvt.Ltd ', {'entities': [[25, 66, 'COMPOSITION NAME'], [67, 79, 'COMMON NAME']]}], ['Image 314: TorsemideTabletsUSP TORIDE-20 10x10Tablets ', {'entities': [[11, 30, 'COMPOSITION NAME'], [31, 40, 'COMMON NAME']]}], ['Image 315: Bharatpwr-16ChitwaoNepal RAPIFLO8RAPIFLO8RAPIFLO8 RAPIFLO& RAPIFLO Silodosin Capsules RAPIF&O8 T5 ch Hard Gelatin Capsule Contains. RAF osin8mg eroved colours used in capsule shells Manufactured and Marketed by DIVINEHealthcare Pvt.Lid. NAPIFLO Bharatpur-t6, Chitwan,Nepat RA PIFLO8RAIFLO8RAPFLO8 RAPIFI.Q3RAPIFLO.8. PIFLOS Siodosm.Capsules PIF ', {'entities': [[70, 77, 'COMMON NAME'], [78, 96, 'COMPOSITION NAME']]}], [\"Image 316: Silodosin Capsules SILOCAP 4 Rianlau-8 Panas 5 x 1 x 10's Capsules \", {'entities': [[11, 29, 'COMPOSITION NAME'], [30, 39, 'COMMON NAME']]}], [\"Image 317: CoNaes MMEPRSS Dr.REDDY'S LABORAT Dr.Reddy.s FINAST DrREDCY'S LABORATORIESLTD. Finasteride Tablets 5 mg FINAST Dr.Reddy's Finasteride Tablets 5mg Dr.REDDYS EABORATORIES LTD. CO Dr.Redd FINAST MPERR REDDYSLABORATORIESLTD teride'Tablets 5 mg Reddy's eride Tablet LABORATORIESLTD Dr.REDD Or.Reddy' NAST SLABORATORI ablets 5 mg \", {'entities': [[115, 121, 'COMMON NAME'], [133, 156, 'COMPOSITION NAME']]}], ['Image 318: a-fr AMT23064MAR.2023FEB. RONO M.R.P.Rs Mfg.Lic.No4160 National Healthcare Manufactured by National Healthcare Pyt.Ltd. Chhatapipra BaraNepal. Frusemide & Amilonde HCI Tablets AMMTDE MPG 00PER1OTABS Each uncoated tabiecorlains Frusemide 40mg Amiloride HC! IP 5ng 3.. Mig.Lic.N S0 National Healthcare National Healtht ChnatappraBara ', {'entities': [[154, 186, 'COMPOSITION NAME'], [187, 193, 'COMMON NAME']]}], ['Image 319: Jins: DRUG-CAUTIONNot to be soid Azathioprine IP 25 mg by retall without the prescription oi Excipients q.s. a Registered Medical Practitioner Dosage:As prescribed by the Mfg.Lic.No.:G/599 physician. Manufactured in India by; Storage: Store protected from RPG LIFE SCIENCESLIMITED light. 3102/A,G.1.D.C.Estate Ankleshwar-393002 Registered Trade Mark Dist.Bharuch, Gujarat,India neoEMEK R KTablets Azathioprine Tablets IP25 mg Azoram25 Composition: SCHEDULE HPRESCRIPTIONS Each uncoated tablet contains DRUGCAUTIONNottobe sola Azathioprine1P 25.mg by retail without the prescription o Excipients q.s a.Registered MedicalPractitioner Dosage:As prescribedby the MfgLic.No.G599 physician Manufacturedinndia by 3102/A.G.1.D.C.Est ', {'entities': [[408, 436, 'COMPOSITION NAME'], [437, 445, 'COMMON NAME']]}], [\"Image 320: Khani Khola7,Naubise,Dhading TamsulosinHydrochloride Moaified Release Capsules R-0 Flopress-0. -0 Each capsule contains dX e -y TamsulosinHydrochlonge18400-mcg as moditiedrelease pellets f Flopress-0 MMD Mfg.Lic.No419 NovoGenetico kyt tod BN'O KhaKhola-7,NaiseDhad Tamsulosa Hydroctoride Moaified Release Cpsules 9-0 Floprass-0 q-0. Each capsule contains: CER \", {'entities': [[40, 89, 'COMPOSITION NAME'], [94, 105, 'COMMON NAME']]}], [\"Image 321: KhaniKhoia-7,Naubise,Dhading famsulosin Hydrochloride Modified Release Capsules -0 Flopress-0.4 9-0 ach capsule contains: amsulosinHydrochloride400 mcg es modifiedrelease pellets Flopress-0, MED   Mfg.Lic.No.8419 Manutactured in Napalby Nova Genctica Pvt.Lto Khani Khola-7,Naubise,Dhadi ON'O Tamsulosin Hydrochioride Modified \", {'entities': [[40, 90, 'COMPOSITION NAME'], [94, 106, 'COMMON NAME']]}], ['Image 322: DUTAAS-O.5 PAAS-0.5 DUTAAS-0.5 DUTAAS-O.5 5yCRH-0.4 DUTAAS-O.5 art fa  f a-fa ASI A 5yCR-O. Mfg.Lic.No.:1740515061329 Each filmcoated tablet contains Store below30C Dutasteride Ip 0.5mg ColourTitanium DioxideIP *Trade Mark Registered SOAN Manufactured in Nepat by: Asian Pharmaceuticals Pvt.Ltd. ASIAN Omsatiya-1,Rupandehi. SIAN B.N0.DTT.9011MFG.APR.2023 EXP.MAR.2025 ASIAN M.R.P.RS240.00 PER0TABS ', {'entities': [[11, 21, 'COMMON NAME'], [176, 196, 'COMPOSITION NAME']]}], ['Image 323: Lie Mfg. ARG -09b ood Bicalon 474. 10 474 Bicalon 220 No. Lic. JG Mfg. EU Bicalon Tablet Dod Bicalon Bicalon No Lic. INTE Bicalon O JSP yod Sicalon ide lon ', {'entities': [[53, 60, 'COMMON NAME']]}], ['Image 324: Bicalon Bicalutamide USP 50mg 28 MRPNRS2184.00/ Tablets Anmol Health Care ', {'entities': [[11, 18, 'COMMON NAME'], [19, 40, 'COMPOSITION NAME']]}], [\"Image 325: Dist.BharuchGujarat, India. TM-Trade Mark 1503200-1 10 Tablets erriht R Spironolactone& Frusemide Tablets SPIROMIDE Composition: Each film coated tablet contains: Spironolactone IP.50 mg Excipients... ....q.s. Colour: Titanium Dioxide IP &Red oxide of lron Dosage:As prescribed by the Physician. Storage:Store in a cool dry place,protecied from light and moisture. SCHEDULEHPRSCRIPN DRUC-CAUTCNNct to be soid by retaut the wrescription'so.enisw Medical Pracurusnes Mfg.Lic.No.:G/599 Manufactured in indla by: RPG LE SCENOS LITE 3102/A,G.I.D.C.Estate, Ankleshwar-393 002, Dist.BharuchGujarat.India. M0 TM-Trade Mark 1503200-1 10 Tablets R Spironolactone & Frusemide Tablets SPIROMIDE Composltion: Eachfilm coated tablet contains: Spironolactone IP..50 mg \", {'entities': [[83, 116, 'COMPOSITION NAME'], [117, 126, 'COMMON NAME']]}], ['Image 326: Regd.C Mumbarn.400.00. Aspirin Gasio-resistant Tableisipemgn Ecosprim75 sfe- ablet contains Each gastro-resill ', {'entities': [[34, 71, 'COMPOSITION NAME'], [72, 82, 'COMMON NAME']]}], ['Image 327: 25x14 Tablets Aspirin Gastro-resistant Tablets IP 75 mg Ecosprin-75 USV ', {'entities': [[25, 66, 'COMPOSITION NAME'], [67, 78, 'COMMON NAME']]}], [\"Image 328:  Registered Trade Mark 1503477-0 STAEESEETEAEEEEEES 15 Tablets Spironolactone Tablets 1P-50 mg Aidactone'so Composition Each uncoated tapiet contains: Spironolactonei 50 mg Excpients q.s. Dosage: TECRIPTION ORUG-CAD Aot to bs solo pson ct e \", {'entities': [[74, 105, 'COMPOSITION NAME'], [106, 118, 'COMMON NAME']]}], ['Image 329: 10x5 x15 Tablets R Spironolactone Tablets IP50 mg Aldactone50 340 RPG LIFE SCIENCE ', {'entities': [[30, 60, 'COMPOSITION NAME'], [61, 72, 'COMMON NAME']]}], ['Image 330: ALPINE-LH Each uncoated bilayered tablet contains Losartan Potassium BP 25 mg 922h Amlodipine Besylate BP eq to Amlodipine 5 mg Colour:Tartrazine R Araurft f-fa NIMBUS NIMBUS (A division of LOMUS) ALPINE-LH ALPINE-LH ALPINE-LH Losartan Potassium & Amlodipine Tablets IP ALPINE-LH ', {'entities': [[238, 280, 'COMPOSITION NAME'], [281, 290, 'COMMON NAME']]}], ['Image 331: ALPINE-LH Each uncoated bilayered tablet contains Losartan Potassium BP 25 mg 922h Amlodipine Besylate BP eq to Amlodipine 5 mg Colour:Tartrazine R Araurft f-fa NIMBUS NIMBUS (A division of LOMUS) ALPINE-LH ALPINE-LH ALPINE-LH Losartan Potassium & Amlodipine Tablets IP ALPINE-LH ', {'entities': [[238, 280, 'COMPOSITION NAME'], [281, 290, 'COMMON NAME']]}], ['Image 332: AMPROL AMPROL AMPROLOE AMPRO LAMPRO LAMPROL AMPROL RO AMPROL AMLODIPINE AND LOSARTAN POTASSIUM TABLETS IP AMLODIPINE AND LOSARTAN POTASSI AMPROL AMPRO tfa - ayt e Corgt Each film coated tablet contains: Each film coated tablet con Amlodipine.Besylate IP Amlodipine Besylate equ.to Amlodipine 5mg egu.to Amlodipine Losartan Potassium USP 50 mg Losartan.Potassium UsP5 Cotor: Iron Oxide Red and Color:Iron Oxide Red and Titanium Dioxide Manufactured in Nepal by: Titanium Dioxide Pharmonics Life Sciences Pvt.Ltd, H Duhabi-12,Sunsari,Nepal. B.No. MFG. EXP. M.R.P. 016.009 SEP.2023 AUG.2025 RS.130.00/10 TABS ', {'entities': [[65, 71, 'COMMON NAME'], [72, 116, 'COMPOSITION NAME']]}], ['Image 333: AMPROL AMPROL AMPROLOE AMPRO LAMPRO LAMPROL AMPROL RO AMPROL AMLODIPINE AND LOSARTAN POTASSIUM TABLETS IP AMLODIPINE AND LOSARTAN POTASSI AMPROL AMPRO tfa - ayt e Corgt Each film coated tablet contains: Each film coated tablet con Amlodipine.Besylate IP Amlodipine Besylate equ.to Amlodipine 5mg egu.to Amlodipine Losartan Potassium USP 50 mg Losartan.Potassium UsP5 Cotor: Iron Oxide Red and Color:Iron Oxide Red and Titanium Dioxide Manufactured in Nepal by: Titanium Dioxide Pharmonics Life Sciences Pvt.Ltd, H Duhabi-12,Sunsari,Nepal. B.No. MFG. EXP. M.R.P. 016.009 SEP.2023 AUG.2025 RS.130.00/10 TABS ', {'entities': [[65, 71, 'COMPOSITION NAME'], [72, 116, 'COMMON NAME']]}], [\"Image 334: viig.Dc,No.k1780320154627 Equivaisn to Anlodipine 5 mg Manufacturect inNopel by ColouBnilliant Blue& Titanum Dioxide Elixir Life Science (P) Ltd 22 MRTPRRRRS . Gunjanagar.Bharrtpur1 2 MYPRESS'S AYPRESSS MYPRESSS 00 Amlodipine Tablets IP MYPRESS 5 Composition: Each film coated tablel contains: f Anlodipine BesylatoP Mfg.Lic.No.:1780320154627 Equivalont to Amloouiresmg Manufactured in.Nepe/hy CoourBrilliant hsm Dioxide ElixirLifeSclencajR)Ltd \", {'entities': [[226, 247, 'COMPOSITION NAME'], [248, 257, 'COMMON NAME']]}], [\"Image 335: viig.Dc,No.k1780320154627 Equivaisn to Anlodipine 5 mg Manufacturect inNopel by ColouBnilliant Blue& Titanum Dioxide Elixir Life Science (P) Ltd 22 MRTPRRRRS . Gunjanagar.Bharrtpur1 2 MYPRESS'S AYPRESSS MYPRESSS 00 Amlodipine Tablets IP MYPRESS 5 Composition: Each film coated tablel contains: f Anlodipine BesylatoP Mfg.Lic.No.:1780320154627 Equivalont to Amloouiresmg Manufactured in.Nepe/hy CoourBrilliant hsm Dioxide ElixirLifeSclencajR)Ltd \", {'entities': [[226, 247, 'COMPOSITION NAME'], [248, 257, 'COMMON NAME']]}], ['Image 336: Changunarayan-8Sudal,Bhaktapur Nepal I M.R.P.Rs.210/-PER15TABS MFG.12/2022 EXP.11/2024 B.No.CM2212004 Losartan Potassium& LOSANGI-H Hydrochlorothiazide Tablets LOSANG-H Mrent-ua LOSANGI-H Each Film Coated tablet contains. Losartan Potassium IP 50mg Hydrochiorothiazide IP 12.5 mg Colour:Erythrosine & Black Iron oxide Storage :Store protected from light & moisture LOSANGI-H iqifafa fa-faaor LOSANGI-H f .c Mfg.Lic.No.:1760502041624 LOSANGI-H Manufactured in Nepal by arrow Pharmaceuticals Pyt.Ltd Changunarayan-8,Sudal,Bhaktapur,Nepal H-ISNSSO LOSANGI-H -ydrochlorothiazide lablei LOSANGI-H LOSANG EachFim Coatedtablei contains 50.mg ', {'entities': [[189, 198, 'COMMON NAME'], [233, 282, 'COMPOSITION NAME']]}], ['Image 337: Changunarayan-8Sudal,Bhaktapur Nepal I M.R.P.Rs.210/-PER15TABS MFG.12/2022 EXP.11/2024 B.No.CM2212004 Losartan Potassium& LOSANGI-H Hydrochlorothiazide Tablets LOSANG-H Mrent-ua LOSANGI-H Each Film Coated tablet contains. Losartan Potassium IP 50mg Hydrochiorothiazide IP 12.5 mg Colour:Erythrosine & Black Iron oxide Storage :Store protected from light & moisture LOSANGI-H iqifafa fa-faaor LOSANGI-H f .c Mfg.Lic.No.:1760502041624 LOSANGI-H Manufactured in Nepal by arrow Pharmaceuticals Pyt.Ltd Changunarayan-8,Sudal,Bhaktapur,Nepal H-ISNSSO LOSANGI-H -ydrochlorothiazide lablei LOSANGI-H LOSANG EachFim Coatedtablei contains 50.mg ', {'entities': [[171, 179, 'COMMON NAME'], [233, 282, 'COMPOSITION NAME']]}], [\"Image 338: Marketed By Hydrochlorothiazide IP 12.5 mg ASPIRE Colour:UniversalPink A Division of SHC) Aspire f Manufactured By: (A Division of Suprema Healtncare) Supreme Health Care Pvt.Ltd Lipanimal-8,BaraNepal. dXP HH-400 Aslos-50H Aslos-50 H Losartan Potassium & Hydrochlorothiazide Tablets:P MMEC Mfg.Lic.No.1740305053911 Aslos-50 H raerd forr fant-facr BN'O Each film coated tablet contains Losartan Potassium P50 mg Hydrochlorothiazide IP 12.5 mg Marketed By ASPIRE Colour:Universal Pink A Division of SHC) f1 Aspire Manufactured By A onision al Suprame Health SavoPudLld Soprame Haaitncarar \", {'entities': [[234, 244, 'COMMON NAME'], [245, 293, 'COMPOSITION NAME']]}], [\"Image 339: Marketed By Hydrochlorothiazide IP 12.5 mg ASPIRE Colour:UniversalPink A Division of SHC) Aspire f Manufactured By: (A Division of Suprema Healtncare) Supreme Health Care Pvt.Ltd Lipanimal-8,BaraNepal. dXP HH-400 Aslos-50H Aslos-50 H Losartan Potassium & Hydrochlorothiazide Tablets:P MMEC Mfg.Lic.No.1740305053911 Aslos-50 H raerd forr fant-facr BN'O Each film coated tablet contains Losartan Potassium P50 mg Hydrochlorothiazide IP 12.5 mg Marketed By ASPIRE Colour:Universal Pink A Division of SHC) f1 Aspire Manufactured By A onision al Suprame Health SavoPudLld Soprame Haaitncarar \", {'entities': [[224, 233, 'COMMON NAME'], [245, 293, 'COMPOSITION NAME']]}], ['Image 340: Metoprolol Succinate Extended Release TabletsUSP Metop-25 XR 30 Tablets X 5 Blisters ', {'entities': [[11, 59, 'COMPOSITION NAME'], [60, 71, 'COMMON NAME']]}], ['Image 341: Metoprolol Succinate Extended Release TabletsUSP Metop-25 XR 30 Tablets X 5 Blisters ', {'entities': [[11, 59, 'COMPOSITION NAME'], [60, 71, 'COMMON NAME']]}], ['Image 342: rega.Pharmaccuticals.Pyt.Lid HIET 03F M.R.P/10TABSRs.20.00 B.No.040033 Digoxin Tablets MYOXIN-0.125 fa- HR-0.939 Each-uncoa DigoxinUSP125 mcg Mfg.Lic.No.12832070/071/VEGA-40 ColorPonceau 4R Manufactgred in Nepal by Vega Pharmaceuticals Pyt.Lfd H 03FM126/ Digoxin Tablets MYOXINLO 125 ', {'entities': [[82, 97, 'COMPOSITION NAME'], [98, 110, 'COMMON NAME']]}], ['Image 343: rega.Pharmaccuticals.Pyt.Lid HIET 03F M.R.P/10TABSRs.20.00 B.No.040033 Digoxin Tablets MYOXIN-0.125 fa- HR-0.939 Each-uncoa DigoxinUSP125 mcg Mfg.Lic.No.12832070/071/VEGA-40 ColorPonceau 4R Manufactgred in Nepal by Vega Pharmaceuticals Pyt.Lfd H 03FM126/ Digoxin Tablets MYOXINLO 125 ', {'entities': [[82, 97, 'COMPOSITION NAME'], [98, 110, 'COMMON NAME']]}], [\"Image 344: Each uncoated tablet contains Mfg.Lic.No.0413 1039 Nebivolol Hydrochloride IP Made in India by ML05F-0371 equivalent to Nebivoloi2.5 mg MICRO LABS LIMITED UNIT-HI 00' Store in a dry &dark place, R.SNo.63/3&4,Thiruvandar Koi Dosage:As directed C at a temperature Puducherry-605 102. by the Physician not excesoing 30C. MICRO.LABS Regd. Trade Mark Nebilong-2.5 Nebilor Nebivolo Tablets P ESCRIF DRUC ON Not tooby retail withoul Nebilong-2.5 the pre n of a Registerec Medk iC.NO. 0413-1039 Each-uncoated: de In lndla by MLO3F-037 Nebivolol Hydroch WICROLADS LIMITEO UNITN equivalentto-Nebivolo R.SWa.633&4Thirvandako Storenadr Dosage:As directe at a temperatur Puaucheny-605 102. not exceeding 30C by the Physician. MICRO LABS Regd Trade Mark WET Nebilong-2.5 aaiT-R.9 Nebilong-2.5 afamir-39 Nebivolol Tablers. \", {'entities': [[62, 88, 'COMPOSITION NAME'], [357, 369, 'COMMON NAME']]}], [\"Image 345: Each uncoated tablet contains Mfg.Lic.No.0413 1039 Nebivolol Hydrochloride IP Made in India by ML05F-0371 equivalent to Nebivoloi2.5 mg MICRO LABS LIMITED UNIT-HI 00' Store in a dry &dark place, R.SNo.63/3&4,Thiruvandar Koi Dosage:As directed C at a temperature Puducherry-605 102. by the Physician not excesoing 30C. MICRO.LABS Regd. Trade Mark Nebilong-2.5 Nebilor Nebivolo Tablets P ESCRIF DRUC ON Not tooby retail withoul Nebilong-2.5 the pre n of a Registerec Medk iC.NO. 0413-1039 Each-uncoated: de In lndla by MLO3F-037 Nebivolol Hydroch WICROLADS LIMITEO UNITN equivalentto-Nebivolo R.SWa.633&4Thirvandako Storenadr Dosage:As directe at a temperatur Puaucheny-605 102. not exceeding 30C by the Physician. MICRO LABS Regd Trade Mark WET Nebilong-2.5 aaiT-R.9 Nebilong-2.5 afamir-39 Nebivolol Tablers. \", {'entities': [[62, 88, 'COMPOSITION NAME'], [755, 767, 'COMMON NAME']]}], ['Image 346: R Nebivolol Hydrochloride Tablets I.P B1CARD-2.5 2.5 mg 10COMPOSITE PACKS OF5 x 15 TABLETS EACH ', {'entities': [[13, 48, 'COMPOSITION NAME']]}], ['Image 347: R Nebivolol Hydrochloride Tablets I.P B1CARD-2.5 2.5 mg 10COMPOSITE PACKS OF5 x 15 TABLETS EACH ', {'entities': [[13, 48, 'COMPOSITION NAME']]}], ['Image 348: Rx SCHEDOLEHPRESCRIPTION Propranolol DRUG-CAUTION Abbott Not tobe sold by retail witncut the Tablets I.P. pressiption ot a Regisiered Medical Practinonerd Inderol*20 or sale only in India and Nepo! coch-uncoated tablet contains Mtq.Lic.No:MNB/06/295 Propranolol Hydrochloride 1.P. 20 mg Manutactured by. Abbott Healhcnre Pvt. Ltd. Excipients q.s. Village Bhatauli Khurd.P.0.Baddi173 205 Dosage: As prescribed by the Physician. Dist.Solan. HimachalPradesh, Incig Store at a temperature not exceeding Inderal is a Trode Mark of the 30C Protect trom light &moisture AstraZececa grouc or compcnies Medicine Keep out of reach of children icensed User Abboit Healthcare Pvt.Ltd Rx SCHEDULE HPRESCRIPTION Propranolol DRUG-CAUTION Abbert B sold by retai wihiou. the lablets..P ekegistaredwedico ', {'entities': [[166, 176, 'COMMON NAME'], [261, 297, 'COMPOSITION NAME']]}], ['Image 349: Rx SCHEDOLEHPRESCRIPTION Propranolol DRUG-CAUTION Abbott Not tobe sold by retail witncut the Tablets I.P. pressiption ot a Regisiered Medical Practinonerd Inderol*20 or sale only in India and Nepo! coch-uncoated tablet contains Mtq.Lic.No:MNB/06/295 Propranolol Hydrochloride 1.P. 20 mg Manutactured by. Abbott Healhcnre Pvt. Ltd. Excipients q.s. Village Bhatauli Khurd.P.0.Baddi173 205 Dosage: As prescribed by the Physician. Dist.Solan. HimachalPradesh, Incig Store at a temperature not exceeding Inderal is a Trode Mark of the 30C Protect trom light &moisture AstraZececa grouc or compcnies Medicine Keep out of reach of children icensed User Abboit Healthcare Pvt.Ltd Rx SCHEDULE HPRESCRIPTION Propranolol DRUG-CAUTION Abbert B sold by retai wihiou. the lablets..P ekegistaredwedico ', {'entities': [[166, 176, 'COMMON NAME'], [261, 297, 'COMPOSITION NAME']]}], ['Image 350: Rx Propranolol Tablets I.P. Inderal*20 GTIN:18904145935595 Imported&Distributed by in Nepal EXP250531 Gunjeshwari B.NO:INZ23014 Pharma Adarsh Nagar-13 S.NO:21102721711443 Birganj,Parsa Email:gpadmn@gmail.com Exim Code:3005153140148NP 20 mg 20 x2 x 15 Tablets ', {'entities': [[14, 38, 'COMPOSITION NAME'], [39, 49, 'COMMON NAME']]}]]}\n"]}],"source":["print(TRAIN_DATA)"]},{"cell_type":"markdown","metadata":{"id":"8mRn7y7mRNaG"},"source":["__CONVERT THE TRAINING DATA INTO SPACY FORMAT.__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":1184,"status":"ok","timestamp":1705231230115,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"AjetVFx07krc","outputId":"bbda73bc-6161-4987-c57e-e21024fd61b5"},"outputs":[{"name":"stderr","output_type":"stream","text":["100%|████████████████████████████████████████| 336/336 [00:01<00:00, 207.73it/s]\n"]}],"source":["for text, annot in tqdm(TRAIN_DATA['annotations']):\n","    doc = nlp.make_doc(text)\n","    ents = []\n","    for start, end, label in annot[\"entities\"]:\n","        span = doc.char_span(start, end, label=label, alignment_mode=\"contract\")\n","        if span is None:\n","            print(\"Skipping entity\")\n","        else:\n","            ents.append(span)\n","    doc.ents = ents\n","    db.add(doc)\n","\n","db.to_disk(\"./test-train-data/training_data.spacy\") # save the docbin object"]},{"cell_type":"markdown","metadata":{"id":"6yt9rD4eRNaH"},"source":["__CREATE A CONFIGURATION FILE.__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":11962,"status":"ok","timestamp":1705231245923,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"mGbRe7FrJnR1","outputId":"4466e4e5-de4d-4da7-9cce-d0da8d382fe2"},"outputs":[{"name":"stdout","output_type":"stream","text":["\u001b[38;5;3m⚠ To generate a more effective transformer-based config (GPU-only),\n","install the spacy-transformers package and re-run this command. The config\n","generated now does not use transformers.\u001b[0m\n","\u001b[38;5;4mℹ Generated config template specific for your use case\u001b[0m\n","- Language: en\n","- Pipeline: ner\n","- Optimize for: efficiency\n","- Hardware: CPU\n","- Transformer: None\n","\u001b[38;5;2m✔ Auto-filled config with all values\u001b[0m\n","\u001b[38;5;2m✔ Saved config\u001b[0m\n","config.cfg\n","You can now add your data and train your pipeline:\n","python -m spacy train config.cfg --paths.train ./train.spacy --paths.dev ./dev.spacy\n"]}],"source":["! python3 -m spacy init config config.cfg --lang en --pipeline ner --optimize efficiency"]},{"cell_type":"markdown","metadata":{"id":"HhrB2iPORNaL"},"source":["__TRAIN THE MODEL.__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":1488048,"status":"ok","timestamp":1705238558207,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"9n4QmUStKBf0","outputId":"03e22c62-453b-410f-de71-ebfc4f3ead2d"},"outputs":[{"name":"stdout","output_type":"stream","text":["\u001b[38;5;4mℹ Saving to output directory: .\u001b[0m\n","\u001b[38;5;4mℹ Using CPU\u001b[0m\n","\u001b[1m\n","=========================== Initializing pipeline ===========================\u001b[0m\n","\u001b[38;5;2m✔ Initialized pipeline\u001b[0m\n","\u001b[1m\n","============================= Training pipeline =============================\u001b[0m\n","\u001b[38;5;4mℹ Pipeline: ['tok2vec', 'ner']\u001b[0m\n","\u001b[38;5;4mℹ Initial learn rate: 0.001\u001b[0m\n","E    #       LOSS TOK2VEC  LOSS NER  ENTS_F  ENTS_P  ENTS_R  SCORE \n","---  ------  ------------  --------  ------  ------  ------  ------\n","  0       0          0.00     40.50    0.00    0.00    0.00    0.00\n","  1     200        285.89   1864.53   11.54   13.07   10.34    0.12\n","  2     400       1633.44   1724.78   34.53   34.67   34.39    0.35\n","  3     600        319.27    928.61   68.64   70.59   66.80    0.69\n","  5     800        168.34    702.79   82.04   79.37   84.89    0.82\n","  7    1000        271.72    525.27   85.89   89.80   82.31    0.86\n","  9    1200        343.87    441.28   94.99   95.76   94.23    0.95\n"," 12    1400        368.01    354.31   94.37   95.52   93.24    0.94\n"," 16    1600        263.29    303.07   97.21   97.60   96.82    0.97\n"," 21    1800        463.39    316.94   98.00   98.40   97.61    0.98\n"," 27    2000        308.80    233.65   98.10   98.59   97.61    0.98\n"," 35    2200        459.04    277.24   98.21   98.21   98.21    0.98\n"," 44    2400        533.36    289.46   97.63   97.05   98.21    0.98\n"," 54    2600       2178.43    352.73   98.51   98.22   98.81    0.99\n"," 63    2800        750.32    284.15   98.41   98.60   98.21    0.98\n"," 73    3000        289.03    245.35   98.50   99.39   97.61    0.98\n"," 83    3200       2369.42    291.76   98.43   97.47   99.40    0.98\n"," 92    3400        765.19    266.32   98.61   98.61   98.61    0.99\n","102    3600       2195.49    295.95   98.52   98.03   99.01    0.99\n","111    3800       1068.34    285.96   98.61   98.42   98.81    0.99\n","121    4000        866.23    258.79   98.61   98.22   99.01    0.99\n","131    4200        345.38    216.79   98.61   98.42   98.81    0.99\n","140    4400       1916.15    260.93   98.61   98.61   98.61    0.99\n","150    4600        330.03    204.01   98.61   98.22   99.01    0.99\n","159    4800        657.37    216.00   98.70   99.00   98.41    0.99\n","169    5000       1899.29    277.75   98.90   99.40   98.41    0.99\n","179    5200       1600.72    305.56   98.50   99.39   97.61    0.98\n","188    5400        982.99    243.93   98.71   98.42   99.01    0.99\n","198    5600       1121.63    276.71   98.71   98.80   98.61    0.99\n","208    5800        674.01    204.76   98.80   99.00   98.61    0.99\n","217    6000        364.02    197.44   98.91   98.62   99.20    0.99\n","227    6200        222.48    176.44   98.91   99.00   98.81    0.99\n","236    6400        762.56    212.26   98.91   98.24   99.60    0.99\n","246    6600        417.28    178.64   98.91   98.81   99.01    0.99\n","256    6800       3105.08    238.09   98.81   98.81   98.81    0.99\n","265    7000       1575.33    277.01   98.90   99.60   98.21    0.99\n","275    7200        468.78    221.06   98.80   99.00   98.61    0.99\n","284    7400      12459.85    297.09   98.90   99.40   98.41    0.99\n","294    7600       1844.99    250.19   98.71   98.61   98.81    0.99\n","303    7800        440.63    212.61   98.91   99.00   98.81    0.99\n","313    8000        476.66    173.53   98.90   99.20   98.61    0.99\n","\u001b[38;5;2m✔ Saved pipeline to output directory\u001b[0m\n","model-last\n"]}],"source":["! python3 -m spacy train config.cfg --output ./ --paths.train ./test-train-data/training_data.spacy --paths.dev ./test-train-data/training_data.spacy"]},{"cell_type":"markdown","metadata":{"id":"Rec5BDiCRNaN"},"source":["__LOAD THE TRAINED MODEL.__\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"7fjTCALDKL86"},"outputs":[],"source":["nlp_ner = spacy.load(\"models/model-best\")"]},{"cell_type":"markdown","metadata":{"id":"yFYh1LJZRNaN"},"source":["__LOAD TRAINING EXAMPLE FROM OCR.__"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"Vhk3O7owNB0Z"},"outputs":[],"source":["doc = nlp_ner(''' Rosuvastatin Tablets IP 10 mg CAUmON:Nat to be soldo 2023 TAXES Turbovas-10 retailwithout the prescriptior  Regisiered Medical Prad Each film-coated toblet contains: Mfg.Lic.No.:M/600/2012 Dosage:As directed by Rosuvastatin Caicium ip the Physician Made in India by: equivalent to MICROLABS LAMITED Rosuvastatin 10 mg Store in a dry & dark place Mamoog.Namthang Road Colours:Red Oxide of Iron & at a temperature SouthSikkm-737132 not exceeding 30c RegdTrace Mark Titanium Dioxide IP Turbovas-10 Turbovas. Cararpet Rosuvastatin Tablets P 10 mg NNot to be s Turbovas-10 out the pre Each film-coate osage Rosuvastatin Calcium Physician equivalent to Store ina &dark place CRO LABS LIMTEC Rosuvastatin 10 mg Mamring.Namthang Colours: Red Oxide f ron & at a teoaaroture South Sikkim-737 1 not excesdg 30C. Titanium Dioxide Regd.Trade M Turbovas-10 Turbovas- Tefar ''')"]},{"cell_type":"markdown","metadata":{"id":"vDdN7wbxRNaO"},"source":["__DISPLAY THE OUTPUT.__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":157},"executionInfo":{"elapsed":425,"status":"ok","timestamp":1705238594709,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"elmvSEp6NPst","outputId":"127f13a2-27bf-430d-d07d-7363f17a1115"},"outputs":[{"data":{"text/html":["<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\"> \n","<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n","    Rosuvastatin Tablets\n","    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">COMMON NAME</span>\n","</mark>\n"," IP 10 mg CAUmON:Nat to be soldo 2023 TAXES Turbovas-10 retailwithout the prescriptior  Regisiered Medical Prad Each film-coated toblet contains: Mfg.Lic.No.:M/600/2012 Dosage:As directed by Rosuvastatin Caicium ip the Physician Made in India by: equivalent to MICROLABS LAMITED \n","<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n","    Rosuvastatin 10 mg\n","    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">COMPOSITION NAME</span>\n","</mark>\n"," Store in a dry &amp; dark place Mamoog.Namthang Road Colours:Red Oxide of Iron &amp; at a temperature SouthSikkm-737132 not exceeding 30c RegdTrace Mark Titanium Dioxide IP Turbovas-10 Turbovas. Cararpet Rosuvastatin Tablets P 10 mg NNot to be s Turbovas-10 out the pre Each film-coate osage Rosuvastatin Calcium Physician equivalent to Store ina &amp;dark place CRO LABS LIMTEC \n","<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n","    Rosuvastatin 10 mg\n","    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">COMPOSITION NAME</span>\n","</mark>\n"," Mamring.Namthang Colours: Red Oxide f ron &amp; at a teoaaroture South Sikkim-737 1 not excesdg 30C. Titanium Dioxide Regd.Trade M Turbovas-10 Turbovas- Tefar </div></span>"],"text/plain":["<IPython.core.display.HTML object>"]},"metadata":{},"output_type":"display_data"}],"source":["spacy.displacy.render(doc, style=\"ent\", jupyter=True)"]},{"cell_type":"markdown","metadata":{"id":"pRQY3iP4RNaP"},"source":["__LOAD THE TEST DATA.__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":486,"status":"ok","timestamp":1705238600315,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"QXbGLy52za3W","outputId":"d952cd4b-25fc-4264-e2a7-6846ffdc6b09"},"outputs":[{"name":"stdout","output_type":"stream","text":["{'classes': ['COMPOSITION NAME', 'COMMON NAME'], 'annotations': [['Image 351: Rx Propranolol Tablets I.P. Inderal*20 GTIN:18904145935595 Imported&Distributed by in Nepal EXP250531 Gunjeshwari B.NO:INZ23014 Pharma Adarsh Nagar-13 S.NO:21102721711443 Birganj,Parsa Email:gpadmn@gmail.com Exim Code:3005153140148NP 20 mg 20 x2 x 15 Tablets ', {'entities': [[14, 33, 'COMMON NAME']]}], ['Image 352: Rx 120 mg 100 Tablets ControlledRelease Tablets of DiltiazemHydrochloride DILCONTIN XL120 CONTINUS controlled release system f0 UNDIPHARMA ', {'entities': [[33, 84, 'COMMON NAME']]}], ['Image 353: Rx 120 mg 100 Tablets ControlledRelease Tablets of DiltiazemHydrochloride DILCONTIN XL120 CONTINUS controlled release system f0 UNDIPHARMA ', {'entities': [[33, 84, 'COMMON NAME']]}], ['Image 354: Amlodipine& Mig.Lic.No916541 .osartan Potassium Tablets IP M.R.P15TABS.Rs.187.50 MFD.JUL.23EXP.JUN.25 B.No.165286 Mylod-L omsons-uCr Ench ljlm-coated iabletcontains Amiodipine Besylate IP equivalent to Amlodipine Sing Manutactured.by: Quest Pharmaceuticals (P.)Ltd osartan Potasslum IP 50mg Chhata PiparaBaraNepal Colours:Titanium Dioxide &Sunset Yellow Lake MylodL Mylod-L Mylod-L Mylod-L Mylod-L Mylod-L H4 Mfg.Lic.No.10541 Amlodipine & osartan Potassium Tablets IP Mylod-L ', {'entities': [[176, 195, 'COMPOSITION NAME']]}], ['Image 355: Amlodipine& Mig.Lic.No916541 .osartan Potassium Tablets IP M.R.P15TABS.Rs.187.50 MFD.JUL.23EXP.JUN.25 B.No.165286 Mylod-L omsons-uCr Ench ljlm-coated iabletcontains Amiodipine Besylate IP equivalent to Amlodipine Sing Manutactured.by: Quest Pharmaceuticals (P.)Ltd osartan Potasslum IP 50mg Chhata PiparaBaraNepal Colours:Titanium Dioxide &Sunset Yellow Lake MylodL Mylod-L Mylod-L Mylod-L Mylod-L Mylod-L H4 Mfg.Lic.No.10541 Amlodipine & osartan Potassium Tablets IP Mylod-L ', {'entities': [[176, 195, 'COMPOSITION NAME']]}], ['Image 356: 20x 2x 15 Tablets R ENALAPRIL MALEATE TABLETS IP 5mg ENVAS ENUAS Enalapril Maleate 5mg CADILA PHARMACEUTICALS LIMITED ', {'entities': [[31, 56, 'COMMON NAME']]}], ['Image 357: 20x 2x 15 Tablets R ENALAPRIL MALEATE TABLETS IP 5mg ENVAS ENUAS Enalapril Maleate 5mg CADILA PHARMACEUTICALS LIMITED ', {'entities': [[31, 56, 'COMMON NAME']]}], ['Image 358: 10x 15 Tablets Rosuvastatin Tablets I.P R Novastat20 LUPIN ', {'entities': [[26, 46, 'COMMON NAME']]}], ['Image 359: 10x 15 Tablets Rosuvastatin Tablets I.P R Novastat20 LUPIN ', {'entities': [[26, 46, 'COMMON NAME']]}], ['Image 360: Rosuvastatin Tablets IP 10 mg CAUmON:Nat to be soldo 2023 TAXES Turbovas-10 retailwithout the prescriptior  Regisiered Medical Prad Each film-coated toblet contains: Mfg.Lic.No.:M/600/2012 Dosage:As directed by Rosuvastatin Caicium ip the Physician Made in India by: equivalent to MICROLABS LAMITED Rosuvastatin 10 mg Store in a dry & dark place Mamoog.Namthang Road Colours:Red Oxide of Iron & at a temperature SouthSikkm-737132 not exceeding 30c RegdTrace Mark Titanium Dioxide IP Turbovas-10 Turbovas. Cararpet Rosuvastatin Tablets P 10 mg NNot to be s Turbovas-10 out the pre Each film-coate osage Rosuvastatin Calcium Physician equivalent to Store ina &dark place CRO LABS LIMTEC Rosuvastatin 10 mg Mamring.Namthang Colours: Red Oxide f ron & at a teoaaroture South Sikkim-737 1 not excesdg 30C. Titanium Dioxide Regd.Trade M Turbovas-10 Turbovas- Tefar ', {'entities': [[11, 31, 'COMMON NAME'], [310, 328, 'COMPOSITION NAME']]}], ['Image 361: Rosuvastatin Tablets IP 10 mg CAUmON:Nat to be soldo 2023 TAXES Turbovas-10 retailwithout the prescriptior  Regisiered Medical Prad Each film-coated toblet contains: Mfg.Lic.No.:M/600/2012 Dosage:As directed by Rosuvastatin Caicium ip the Physician Made in India by: equivalent to MICROLABS LAMITED Rosuvastatin 10 mg Store in a dry & dark place Mamoog.Namthang Road Colours:Red Oxide of Iron & at a temperature SouthSikkm-737132 not exceeding 30c RegdTrace Mark Titanium Dioxide IP Turbovas-10 Turbovas. Cararpet Rosuvastatin Tablets P 10 mg NNot to be s Turbovas-10 out the pre Each film-coate osage Rosuvastatin Calcium Physician equivalent to Store ina &dark place CRO LABS LIMTEC Rosuvastatin 10 mg Mamring.Namthang Colours: Red Oxide f ron & at a teoaaroture South Sikkim-737 1 not excesdg 30C. Titanium Dioxide Regd.Trade M Turbovas-10 Turbovas- Tefar ', {'entities': [[11, 31, 'COMMON NAME'], [696, 714, 'COMPOSITION NAME']]}], ['Image 362: T ach film coated tablet contains Mfg.Lic.N 0488 M.R.P/10 TARS. MFG.DEC.22 B.No.005032 Atorvastatin calcium USP Manufacturercin Nepal by: Equivalent to Atorvastatin 10 mg Vega Pharrnaseuticals Pvt Ltd vega Lalitpur-22 Color:Sunset Yellow & Titanium dioxid. Oungmati,Nepal Registere Toade Mark 03FV10/19 ATOPNASOPOROBLEDS HXP.N(V.24 -fa VASTATIN-18 10/.50 HTRETCT-9 Each film coatedtaolet contains: Atorvastatin calciom USP Mfg.Lic. 488 Manufa Nepal by: Equivaleni ', {'entities': [[163, 181, 'COMPOSITION NAME']]}], ['Image 363: T ach film coated tablet contains Mfg.Lic.N 0488 M.R.P/10 TARS. MFG.DEC.22 B.No.005032 Atorvastatin calcium USP Manufacturercin Nepal by: Equivalent to Atorvastatin 10 mg Vega Pharrnaseuticals Pvt Ltd vega Lalitpur-22 Color:Sunset Yellow & Titanium dioxid. Oungmati,Nepal Registere Toade Mark 03FV10/19 ATOPNASOPOROBLEDS HXP.N(V.24 -fa VASTATIN-18 10/.50 HTRETCT-9 Each film coatedtaolet contains: Atorvastatin calciom USP Mfg.Lic. 488 Manufa Nepal by: Equivaleni ', {'entities': [[163, 181, 'COMPOSITION NAME']]}], ['Image 364: vega Atorvastatin Tablets IP 10m6 VASTATIN-10 H-90 10Tabs.x15 Strips ', {'entities': [[16, 36, 'COMMON NAME']]}], ['Image 365: vega Atorvastatin Tablets IP 10m6 VASTATIN-10 H-90 10Tabs.x15 Strips ', {'entities': [[16, 36, 'COMMON NAME']]}], [\"Image 366: ta temgeraturs.not.excesding.oo.e MACRA Turbovas2 Carar Turbovas-20 Rosuvastatin Tablets IP 20 mg CDATE 00 AN Turbovas-20 cacd Rosuvastatin ail without the equivalent to AA Registered Medic actitioner Rosuvastatin 20 Colours: Red Oxige of Iron Mfg.Lic.No.:04 13 1Q39 MLO5F-0364 Made in Ingaby &Titanium Dioxida MICRO LABS LIMITED UNIT-II Dosage:As direcied by the Physician R.S.No. Thiruvandar Koil Store in a dry &darkpia Puduch atatamoe notexce F0ORS Turbovas Turbovas-20 BBN' Rosuvastatin Tablets IP20 mg Turbovas-20 \", {'entities': [[79, 99, 'COMMON NAME'], [212, 224, 'COMPOSITION NAME']]}], [\"Image 367: ta temgeraturs.not.excesding.oo.e MACRA Turbovas2 Carar Turbovas-20 Rosuvastatin Tablets IP 20 mg CDATE 00 AN Turbovas-20 cacd Rosuvastatin ail without the equivalent to AA Registered Medic actitioner Rosuvastatin 20 Colours: Red Oxige of Iron Mfg.Lic.No.:04 13 1Q39 MLO5F-0364 Made in Ingaby &Titanium Dioxida MICRO LABS LIMITED UNIT-II Dosage:As direcied by the Physician R.S.No. Thiruvandar Koil Store in a dry &darkpia Puduch atatamoe notexce F0ORS Turbovas Turbovas-20 BBN' Rosuvastatin Tablets IP20 mg Turbovas-20 \", {'entities': [[79, 99, 'COMMON NAME'], [212, 224, 'COMPOSITION NAME']]}], ['Image 368: MICRO Rosuvastatin Tablets IP 20 mg Turbovas-20 C-Ro 10x 15 Tablets MICRO LABS ', {'entities': [[17, 37, 'COMMON NAME']]}], ['Image 369: MICRO Rosuvastatin Tablets IP 20 mg Turbovas-20 C-Ro 10x 15 Tablets MICRO LABS ', {'entities': [[17, 37, 'COMMON NAME']]}], ['Image 370: eguivalent toClopidogrel 75 mg Coiours Iron Oxide Red & Titaniurn Dioxide Clopid Manufacturei-by M.R.P./15TABS.Rs165.00 B.No.069108 MFD. Quest Pharmaceuticals (P.) Ltd Chhata PiparaBaraNepal Clopid Clopid .OCT Clopid Clopid Clopid Clopid Clopidogrel Bisulphate Tablets IP a r.22EXPSEP.24 Clopid MfgLicNo.:4480 Clopid, Each film-coatedtablet contains. f Clopidogrel Bisulphate!P equivalent to-Clopidsgrei-75.mg Colours:Iron-Cxide Red & TitaniumDisxide Clopid Manufacturedby QuestPharinaceuticals (P.) Ltd ChhataPipara Bara, Nepal Clopid Clopid clopid Clopid Clopid ', {'entities': [[249, 279, 'COMMON NAME']]}], ['Image 371: eguivalent toClopidogrel 75 mg Coiours Iron Oxide Red & Titaniurn Dioxide Clopid Manufacturei-by M.R.P./15TABS.Rs165.00 B.No.069108 MFD. Quest Pharmaceuticals (P.) Ltd Chhata PiparaBaraNepal Clopid Clopid .OCT Clopid Clopid Clopid Clopid Clopidogrel Bisulphate Tablets IP a r.22EXPSEP.24 Clopid MfgLicNo.:4480 Clopid, Each film-coatedtablet contains. f Clopidogrel Bisulphate!P equivalent to-Clopidsgrei-75.mg Colours:Iron-Cxide Red & TitaniumDisxide Clopid Manufacturedby QuestPharinaceuticals (P.) Ltd ChhataPipara Bara, Nepal Clopid Clopid clopid Clopid Clopid ', {'entities': [[249, 279, 'COMMON NAME']]}], ['Image 372: 10x 15 Tablets Clopidogrel Bisulphate Tablets P Clopid ', {'entities': [[26, 56, 'COMMON NAME']]}], ['Image 373: 10x 15 Tablets Clopidogrel Bisulphate Tablets P Clopid ', {'entities': [[26, 56, 'COMMON NAME']]}], ['Image 374: 10x 15 Tablets Amlodipine & Losartan Potassium Tablets IP Mylod-L HISCs-UC ', {'entities': [[26, 65, 'COMMON NAME']]}], ['Image 375: 10x 15 Tablets Amlodipine & Losartan Potassium Tablets IP Mylod-L HISCs-UC ', {'entities': [[26, 65, 'COMMON NAME']]}], ['Image 376: FORNEPALEXPORTONL Mfg Lic.No.JK/01/08-09/155 Manufactured by Emcure 2250 PHARMACEUTICALS LTD Lane No.3.Phse-l,SDCO Ban-BrahmanJanmu-181133India Registered Srade Mark Owners S-Amlodipine Tablets P Asomex5 Composition Each uncoaJd tablet contains: S (-) Amlodipne Besylate IP equivalent to S(-)Amlodipine 5mg Excipients qs Colour Yellow Oxide of Iron Dosage:As directed by the Physician. Store in a cobl,dry & dark placo Keep out of reach ot children. SCHEOULE H PRESCRIPTION DRUO-CAUTION Not tobesoidby retall withou the prescriotion of a Registered MedicalPracutioner FOR NEPAL EXPORT ONLY Mtg LIc.No.JK/01/08-09/155 LOONSEASETTIS Manulactured by Emcure PHARNACEUTICALS LTD ane No.3.Pnase-l.SiDCO Bari-Brahmana.Jammu-181133.  Ragislered Trade Mark Owners S-Amlodipine Tablets IP Asomex5sht Goraposiuon ', {'entities': [[184, 204, 'COMMON NAME'], [299, 317, 'COMPOSITION NAME']]}], ['Image 377: FORNEPALEXPORTONL Mfg Lic.No.JK/01/08-09/155 Manufactured by Emcure 2250 PHARMACEUTICALS LTD Lane No.3.Phse-l,SDCO Ban-BrahmanJanmu-181133India Registered Srade Mark Owners S-Amlodipine Tablets P Asomex5 Composition Each uncoaJd tablet contains: S (-) Amlodipne Besylate IP equivalent to S(-)Amlodipine 5mg Excipients qs Colour Yellow Oxide of Iron Dosage:As directed by the Physician. Store in a cobl,dry & dark placo Keep out of reach ot children. SCHEOULE H PRESCRIPTION DRUO-CAUTION Not tobesoidby retall withou the prescriotion of a Registered MedicalPracutioner FOR NEPAL EXPORT ONLY Mtg LIc.No.JK/01/08-09/155 LOONSEASETTIS Manulactured by Emcure PHARNACEUTICALS LTD ane No.3.Pnase-l.SiDCO Bari-Brahmana.Jammu-181133.  Ragislered Trade Mark Owners S-Amlodipine Tablets IP Asomex5sht Goraposiuon ', {'entities': [[184, 204, 'COMMON NAME'], [299, 317, 'COMPOSITION NAME']]}], ['Image 378: 10x2x15 Tablets P S () Amlodipine Tablets IP Asomex-5 3TACR-4 Emcure ', {'entities': [[34, 52, 'COMMON NAME']]}], ['Image 379: 10x2x15 Tablets P S () Amlodipine Tablets IP Asomex-5 3TACR-4 Emcure ', {'entities': [[34, 52, 'COMMON NAME']]}], [\"Image 380: t  Amlodipine Tablets IP fn- Amlodipin AMREST5 VNIRY AMRES 001771112091701 Mfg.Lic.No.:1771112091701 Each uncoated tablet contains EVEREST Each uncoateoriab pharmoceuticals Amlodipine Besylateip Amlodipine&esylo equivalent to Amlodipine 5 mg Manuraotund n Napalby equralont toAmk oatocaero Everest PharniaceuonlaPvt Lid rnent agoure argalg Narcha.Dbakwpun .STS AHIESTS AMREST'S RRT AMRESTS B.NO.AM2-04MFD.DEC.22EXP.NOV.24 M.R.PRs.50.00PER10 TABS \", {'entities': [[14, 32, 'COMMON NAME'], [237, 252, 'COMPOSITION NAME']]}], [\"Image 381: t  Amlodipine Tablets IP fn- Amlodipin AMREST5 VNIRY AMRES 001771112091701 Mfg.Lic.No.:1771112091701 Each uncoated tablet contains EVEREST Each uncoateoriab pharmoceuticals Amlodipine Besylateip Amlodipine&esylo equivalent to Amlodipine 5 mg Manuraotund n Napalby equralont toAmk oatocaero Everest PharniaceuonlaPvt Lid rnent agoure argalg Narcha.Dbakwpun .STS AHIESTS AMREST'S RRT AMRESTS B.NO.AM2-04MFD.DEC.22EXP.NOV.24 M.R.PRs.50.00PER10 TABS \", {'entities': [[14, 32, 'COMMON NAME'], [237, 252, 'COMPOSITION NAME']]}], ['', {'entities': []}], [\"Image 382: rfff Mig.Lic.NO.1846 Maautacturedby NEPAL PMARMACEUTICALS LABORATORY-PRIVATE LIMITED LAPEN JeetpurBlrganlNopal ORegistereltrudeinark AMLOD'2.5 AMLOD 22 AmlodioineBesiatelabietsil AM 88804 LOD2.5 AMLOI Eacnpm.coarerabietbonan 0'Amlodipine 2.5 mg cojour:Titanium  e Mig.Lic.No. LAPEN sion ofNPL) Manu \", {'entities': [[238, 255, 'COMPOSITION NAME']]}], [\"Image 383: rfff Mig.Lic.NO.1846 Maautacturedby NEPAL PMARMACEUTICALS LABORATORY-PRIVATE LIMITED LAPEN JeetpurBlrganlNopal ORegistereltrudeinark AMLOD'2.5 AMLOD 22 AmlodioineBesiatelabietsil AM 88804 LOD2.5 AMLOI Eacnpm.coarerabietbonan 0'Amlodipine 2.5 mg cojour:Titanium  e Mig.Lic.No. LAPEN sion ofNPL) Manu \", {'entities': [[238, 255, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 384: Amlodipine Besilate Tablts P 2.5 R AMLOD R.y TM LAPEN NP ', {'entities': [[11, 37, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 385: Amlodipine Besilate Tablts P 2.5 R AMLOD R.y TM LAPEN NP ', {'entities': [[11, 38, 'COMMON NAME']]}], ['', {'entities': []}], [\"Image 386: Amlodpine Bestate IP 401827603 r-Amlovas-5 equvaient to Amlodpine 5 mg Dosage. As directed by the Physician. STOREIN COOL AND DRY PLACE. MACLEODS (TM Manufactured in India by MACLEODSPHAEMACEUTICALS LTD KrasraNo.21.22.66,6768 Aho-Yangtam.Namchepung PORanipool.Sim-737135 LNos2015 Atanta ArcadeMarol Church Road Andheri E.Mumbai-400059  MACLEODS HARMACETCALS LTD Amlodipine Besilate Tablets P Amlovas5 Each uncoated tablet contains: PM01027603   A ps Amlodpine Bes'ate P equivalent to Amiodpine 5mg rd  y Dosage: As directed by the Pnysician. STORE IN COOL AND DRY PLACE. MACLEODS Manufactured in India by MACLEODS PHARHACEUTICALS LTD Knasra No.2122.66.67 &68 yerrara-4 Amlova Aho-YangtamNamchepung N582015 PORanipool.Sm-737135. ABanta ArcadeMarol Church Road AndneriE)Mumbai-400059 T MACLEODSPHARMACEUTICALS LTD. Amlodipine Besilate Tablets IP \", {'entities': [[373, 400, 'COMMON NAME']]}], ['', {'entities': []}], [\"Image 387: Amlodpine Bestate IP 401827603 r-Amlovas-5 equvaient to Amlodpine 5 mg Dosage. As directed by the Physician. STOREIN COOL AND DRY PLACE. MACLEODS (TM Manufactured in India by MACLEODSPHAEMACEUTICALS LTD KrasraNo.21.22.66,6768 Aho-Yangtam.Namchepung PORanipool.Sim-737135 LNos2015 Atanta ArcadeMarol Church Road Andheri E.Mumbai-400059  MACLEODS HARMACETCALS LTD Amlodipine Besilate Tablets P Amlovas5 Each uncoated tablet contains: PM01027603   A ps Amlodpine Bes'ate P equivalent to Amiodpine 5mg rd  y Dosage: As directed by the Pnysician. STORE IN COOL AND DRY PLACE. MACLEODS Manufactured in India by MACLEODS PHARHACEUTICALS LTD Knasra No.2122.66.67 &68 yerrara-4 Amlova Aho-YangtamNamchepung N582015 PORanipool.Sm-737135. ABanta ArcadeMarol Church Road AndneriE)Mumbai-400059 T MACLEODSPHARMACEUTICALS LTD. Amlodipine Besilate Tablets IP \", {'entities': [[373, 400, 'COMMON NAME'], [495, 508, 'COMPOSITION NAME']]}], ['Image 388: Rabeprazole Sodium Tablets IP RAB-20 R-R0 ASTRAL 20x 15Tablets A Division of Magnu ', {'entities': [[11, 37, 'COMMON NAME']]}], ['Image 389: EROFOZIN Each film coated tablet contains: Ferrous-Ascorbate equivalent to elemental Iron 100 mg Folic Acid BP 1.5mg FEROFOZIN Zinc Sulfate Monohydrate USP equivalent to elemental Zinc 22.5mg Colour:Ponceau 4R and Titanium Dioxide 9- FEROFOZIN 3 MfgLc.No:11283 /10 TABS.Rs.150 Manufactured by: en FEROFOZIN Deurali-Janta Pharmaceuticals Pvt.Ltd DnapasiKathmanduNepal Registered Trade Mark EXP 021FFT22 Ferrous Ascorbate.Folic Acid & FEROFOZIN Zinc Sulfate Tablets JAN25 Haematinic with Zinc FEROFOZIN R FEROFOZIN Each.tilm coated tablet contains Ferrous-Ascorbate equivalent to elemental Iron 100 mg FolicAcid BP 1.5 mg FEROFOZIN Zinc Sulfate Monohydrate USP equivalent to elemental Zinc 22.5 mg Colour Ponceau 4R and Titanium Dioxide FEROFOZ ', {'entities': [[54, 118, 'COMPOSITION NAME']]}], ['Image 390: For Nationa Heaitthcare SBZ SSZ tiamin B-Complex Fortified with Zinc Capsules SBZ Mfg.Lc.No4135 ng mo Nationa Healthcare Manufacturedby National Healthcare Pvt. E Chhatapipra,Bara Neoal Sez SRT Vitamin B-Complex Fortified with Zinc Capsules Mononitrase 10mg 10mg mg 1mg National 15 Healthcare aame Manufactured by: Nationat Heaithcare Pvt.Ltd sheys Chhatapipra,Bara, Nepal ', {'entities': [[205, 252, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 391: 25x20Capsules Vitamin B-Complex Fortified with Zinc Capsules National Healthcare ', {'entities': [[25, 71, 'COMMON NAME']]}], ['Image 392: Netrcnal hfomatids Apcrox Vaes UsAGE Asa Dietary Supplement oras directad by the dletician Eeoh serving abe conins F Composition Dese Unlt %otROA STORAGE.Store in cooj.dry anddark placebelow25\\'C.Protectfromdirect Sunlight Ferrous Ascorbate 100 mg 72.37 Folic Acid Dietary supplement.NOT FORMEDICiNAL USE. mcg 100,00 Zinc Sulphate mg 17.88 Excipients q.s. LIc.No.10720026000746 BEST BEFORE24MONTHS Energy 0.40 Kcal Marketed By: FROM DATE OF MANUFACTURE Carbohydrates 0.410 Protein 0.00 Manutactured By: a Fat XANON 0.00 0 ZEON BIOTECH PVT.LTD % of RDA calculated basec on tCMR guldaes.for men dolngmoeat Wo Healthcare PLDTNO1307/1308.PHASE-.G.LD.C RDA s not established Ahmedabad Gujarat India VATVAAhmedabad,Gujarat-382445.india Ferrous Ascorbate,Folic Acid &Zinc Sulphate Tablets Ferocare-XT OTER INGREDIENTS:StarchINS1405)Talc INS 553 (.Di Calcium Phosphate NS 341 i.Magneslum Stea(ate INS470MicrocrystallineCellulose INS460 Appropriate overages are addedto compensate loss on storage. Nutritional information Agprox Values) DSAGE:As a Dietary Supplement or as.directed by the dietician. Each serving tablet contains Composition RAGE:Store in cool.diy and darkplace balow25C.Protectfrom directSurlight Dasa\" Unit 1-60 Ferous Ascorbato 100 -FoeAcld tatary.SupplemenLNOTEORMEDICINAL-OSE 176 Zinc Sulphate ', {'entities': [[740, 791, 'COMMON NAME']]}], ['Image 393: Ferrous Ascorbate Folic Acio Zinc Sulphate Tablets Ferocare-XT blets Dietary Supplement not for medi ', {'entities': [[11, 61, 'COMMON NAME']]}], ['Image 394: Ferrous Ascorbate,Folic Acid & Zinc Sulphate Monohydrate Tablets S.Pe Bnterpristy FEELMIN 5X2X15 Tablets Dietary Supplement Not For Medicinal Use ', {'entities': [[11, 75, 'COMMON NAME']]}], ['', {'entities': []}], [\"Image 395: sMgLIc.No.6991 9 Manufactured by fHETGTE. Tfa ARYA     PHARMALAB PVT.LTD l   Chhatapipara,Bara,Nepal Vitamin B-Complex with Zinc Vitazine EEX- Capsules Each capsule contains Thiamine Mononitrate 10 mg Riboflavine 10r0g MMPG Byndoxioe Hydrachlarlde P 3mg Vitazinc Follc Acid IP 1mg Cyanocobalamig IP 15 mcg Niacinamide IP 50mg Calcium Pantothenafe IP 12.5 mg fHCIGE Zinc Sulphate Monohydrate IP PON'E eq.to Elemental Zinc 22.5 mg Approved colours usedin capsule shells 946 Mfg.Lic.No6991 9 Manufactured.by HETS ARYA \", {'entities': [[112, 140, 'COMMON NAME']]}], ['Image 396: 20 Ascorbic Acid Tablets IP CVIT ', {'entities': [[14, 35, 'COMMON NAME']]}], ['Image 397: 446n f Mfg.Lic.No.1770425092559 Manutactured in Nepalby AMTECHMEDPVT.LTD Katahari-4.Morang.Nepal Ascorbic Acid Fablets IP  Each chewable tablet contains Ascorbic Acid 100mg Sodium Ascorbate eqv.to Ascorbic Acid 400 mg Colour:SunsetYellow 21s ', {'entities': [[164, 184, 'COMPOSITION NAME'], [208, 228, 'COMPOSITION NAME']]}], ['Image 399: RabeprazoleSodium Tablets IP RabeprazoleS0 RAB-20 RAB-20 Each enteric coated tablet contains HHE Each enteric coated tablet contains Rabeprazole Sodium IP20 mg f Rabeprazole SodiumIP20 mg Colours: Titanium Dioxide & Brilliant Blue  fasar Colours:Titanium Dioxide & Brilliant B Mfg.Lic.No.:9012 ASTRAL   magnus ADivision of Magnus Manufactured By Magnus Pharma Pvt.Ltd. Rampur Tokani Bara,Nepal B.No.CB23002MFG.MAR.2023EXP.AUG.2024 MR.P.Rs.180.00PER15TA8S ', {'entities': [[11, 37, 'COMMON NAME'], [144, 170, 'COMPOSITION NAME']]}], ['Image 400: 3 OMINIVIT MULTIVITAMIN CAPSULES Made in Nepal by OMNICA LABORATORIES PVT.I Bhaktapur,Kathmandu ', {'entities': [[22, 43, 'COMPOSITION NAME']]}], ['Image 405: 10x 15Capsules Haematinic Capsules R Softeron-Z ARISTO ', {'entities': [[26, 45, 'COMMON NAME']]}], [\"Image 407: Ferrous Ascorbate,Folic Acid  Zinc Sulphate Tablets XT R.B.TONE Each film coated tablet contains Ferrous Ascorbate I.P. equivalent to Elemental Iron 100mg Folic Acid I.P. 1500mcg Zinc Sulphate Monohydrate l.P 61.8mg equivalent to Elemental Zinc 22.5mg Colours:Ponceau 4R Lake and Titanium Dioxide I.P. Dosage :Adults 1 tablet daily or as directed by the Physician Storage:Store protected from moisture,at temperature not exceeding 30'C Rogistored Trademark \", {'entities': [[11, 62, 'COMMON NAME']]}], ['Image 408: Sompraz20 SCHEDULS GCRIPTIONDRO enteric-coatednsblet contains CAUTION:No be sold by retall neprazoie MagnegLrn Trihydrate IP without the presctption of a Reglstere valent to Esomeprazole 20mg MedicalPracrnoee pients q.s urs:Ferric OxideRed USP-NF  Registered Trade Merk ThaniumiDioxidep gs As direcled by tne Physician M..M645/2014 ets shouid be swsllowed whole Manufacturodin India by not to be chewed or crushed sun pharma abdratories Itd e at temperature not exceeding 30C Plot No.107-108.Namli Block ectedtrom light and moisture P.O.Ranipool.at-Sikkim-737 135 Sompraz20 Sompraz20 mpraz20 EsomeprazoleTablets IP Sompraz20 SCHEDULE RPOESCRIPTION DRUC h enteric-coateo-tediet contains CAUTiON.Noerbe sold by retaill meprazole Magnosum Trihydrate IP without the pressptlon of a Register ivalent to Esomopr-zole 20 mg Medical Prac pients OR ', {'entities': [[185, 202, 'COMPOSITION NAME']]}], ['Image 409: ViiaminB USP 4.5mg 22 Vitamin B BP 5 mg Vitamin B. BP 2 mg Nicotinamide BP 45mg Cyanocobalamin (Vitamin B BP 6mcg Calcium Pantothenate BP 11 mg Follc Acid BP 1mg Mfg.Lic.No.:2235 Manufactured by - Deurali-Janta Pharmaceuticals Pyt.Ltd Dhapasi- Kathmandu.Nepal ORegistered Trade Mark FORTIPLEX- FORTIPLEX-X FORTIPLEX-X Multivitamin Capsules ', {'entities': [[329, 351, 'COMMON NAME']]}], ['Image 410: R FORTIPLEX -m RWRT-TH Multivitamin Capsules 30Capsules x ', {'entities': [[34, 55, 'COMMON NAME']]}], ['Image 411: Feeronnr CONTAINS PERMITTED NATURAL SYNTHETIC Ferony-FZ FOOD COLOUR(S) Appropriate overages added to compensate Soft Gel Copsules tor toss on storage. Dosage:As directed by the dietician Each soft gelatin capsule contains approx. Storage:Store below 25 C in a dry place %RDA Protect trom direct sunlight Ferrous Bisglycinate 100mg. 131 Usage:1 Capsule daily with breakfast Folic Acid 1mg AR Zinc Bisglycinate 2.0mg Keep out ot reach of children. 50.69 Excipients q.S Manufactured by Broad Injectables An ISO &GMP Certified Un) kerrrnrer Notitonal information: Piot No 51-52,ind.Area,Tahwal Approx.values per serving/capsule Dist. Una-174301(H.P) Total Energy 5.64Kcal Imported &MarKered by Carbohydrates 286gm Protein 278gm Fat 375.gm Saturated Fatty Acid 246gm NIEON LIFE Poly Unsaturated Fatty AcidC135om Mono Unsaturated Fatty Ac372 gm Trans Fatty Acid Araces Cholesterol 0om XIEONUSFEINTERNATIONAL ROARCNR Sinanangat Kachaande NRDA establshed Nepal e Ferrous Bisglycire Folic Acid & Znc Bisglycinate Sontgel Capsules CONTAINS PESMTTED NATURAL SYNTHETIS Ferony-FZ FOOO COLOUSER Appropnatxcs added to compens forlossoo 1310 heolas ', {'entities': [[966, 1031, 'COMMON NAME']]}], ['Image 413: ARNAV Arorate overages of vitamins aded  compensate loss on storage SNTESPRISES Dosage Imported & Marketed By As directed by the Dietician ARNAV ENTERPRISES, StorageStore in a cool dry & dark place. Dietary Food Supplement Not For Miedicinal Use KATHMANDU,NEPAL IMMUNE-UP IMMUNE-UP IMMUNE-UP IMMUNE-UP Vitamin C&Zinc Chewable Tablets IMMUNE-UP BEST BEFORE 18 MONTHS FROM THE DATE OF MANUFACTURING Taalets fssai Lic No.:10817016000051 nonal informationApproximale vaves per.serving PecTabiel Mfg by:PURISTO PHARMA G Composition: Per Serving Tablet VPO-Bhadour.Near Bus Stand Each Chewable tablet containsapprox. RDA Yaue% Tehsil Madlauda,Panipat Haryana-132103 Vitamin C 1000mg 1112 Zinc 15mg 100 Excipients q.s. AE Colour:Sunset Yellow Recommended Daily allowances (RDA excess not established RDA of Nutrients as per guidelines of Indn counci of medical Research Appropriate overages of vitamins added to compensate loss on storage ARNAV ENTERPRISES Dosage: Imported & Marketed By As.directed by the Dietician StorageStore in a cool.drr & dark place ARNAV ENTERPRISES Dietary FoodSupplemenr Not For Medicina KATHMANDU,NEPAL IMMUNE-LP IMNLNEAIP IMUNE-UP IMUNE-UP ', {'entities': [[313, 344, 'COMMON NAME']]}], ['Image 414: Ferrous Ascorbate,Folic Acid & Zinc Sulfate Tablets FEROFOZIN Haematinic with Zinc 10 Tablets x 10Blisters ', {'entities': [[11, 63, 'COMMON NAME']]}], ['Image 415: Each film coated tablet contains Manutactured.by MycophenolateMofetinP500 mg IRTAS Colours:Ferric Qxide Red USP-NF INTAS Iron OxideBlack, Indigo Carmine PHARMACEUTICALS LTD. Aluminum Lake and Titanium Dioxide JP Samardung Road Excipients:Q.S Kabrey Block Dose :As directed by the Physician. Namthang Elaka, Store protected from light and moisture, at a temperature not exceeding 30C Sikkim-737132INDIA 92 125829406351 Keep out of reach of children. Rx Mycophenolate Mofeti DRUEACACNOR Tablets IP500 mg Notto bosoldse. Yetailwin the prescriptio ra Specialis Mycofit 500 Mfg.Lic.No.M/717/2016 Each film coated tablet contains: Manufacturedby: Mycophenolate Mofetil IP 500 mg INTAS Colours:Ferric Oxide Red USP-NF INTAS Iron Oxide Black, Indigo Carmine PHARMACEUTICALS LTD. Aluminum Lake and Titanium Dioxide IP Samardung Road, 500 Excipients:Q.S Kabrey Block, Dose :As directed by the Physician Namthang Elaka Store protected from light and moisture, Sikkim-7371321NDIA ', {'entities': [[652, 683, 'COMPOSITION NAME']]}], ['Image 416: 5x2x10Tablets METFORMIN HYDROCHLORIDE TABLETS IP 850MG R GLYCOMET-850 E-C40 USV ', {'entities': [[25, 57, 'COMMON NAME']]}], ['Image 417: Lintor M 1000 LintorN7000 Lintor M 1000 Lintor M1000 Manufactured by Quest Pharmaceuticals (P.) Ltd. Chhata Pipara,Bara,Nepa Lintor M1000 Lintor M 1000 Lintor M 1000 Lintor M1000 Linagliptin & Metformin Hydrochlori Lintor M1000 foc ach fitm coated tablet contains MfgLic.No.17 nagliptin2.5mg Metformin Hydrochloride IP 1000 mg Colours:Erythrosine Lake& HHE Titanium Dioxide Hfa Lintor M 1000 Lintor M1000 Lintor M 1000 Lintor M 1000 Manufactured by Quest Pharmaceuticals (P.) Ltd. Chhata Pipara, Bara Nepa Lintor M100 M1000 Linte31000 Lintor M 1000 ', {'entities': [[303, 337, 'COMPOSITION NAME']]}], ['Image 418: blets Linagliptin & Metformin Hydrochloride Tablets Lintor M 1000 fd  9OOO ', {'entities': [[17, 62, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 419: Metformin Hydrochloride Extended Release Tablets IP GLYFALL-1G ER T54-9.5.3R 15 Tabs.x10 Strips ', {'entities': [[11, 59, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 420: 10x10 Tablet Metformin Hydrochloride Sustained Release Tablets IP Metfor SR 1000 HEUT 3T 9000 ', {'entities': [[24, 73, 'COMMON NAME']]}], ['', {'entities': []}], [\"Image 421: Metformin Hydrochloride Sustained Release & Linagliptin Tablets Lipta-M 500 -00 P ILAP 0 x 10's Blister Strips \", {'entities': [[11, 74, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 422: Lipta-M 500 f esw an R- y00 fa Each uncoated bilayered-tablet contains: Linagliptin 2.5mg Metformin Hydrochlonde 500 mg Mfg.Lic.No.1740630045301 IP (nSustained ReleaseForm) Colour:Red Oxide of ron Lipta-M500 Rer-y Lipta-M 5o0 -y00 Lipta-M500 -yO0 SO6-N7ON LAPENADiyison of NPL) Manutaciaredby. NEPALPHARMACEUTICAI,S LABORATORYPVT.LTD. Jeelpur.BirganjNepal. a-M500 e- Lipta-M500 yo0 Lipta-M500 Aetformin Hydrochloride Sustained Release & Linagliptin Tablets Lipta-M 500 fff -09400 f uncoated bilayetegyablet contains lagliptn 2.5 fg.Lic.No034530 normn Hydre OR 500 ', {'entities': [[101, 130, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 423: Empagliflozin Tablets GLIFAZ-25 f0-R4 ', {'entities': [[11, 32, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 424: Empagliflozin Tablets 822112006 Mfg.Lic GLIFAZ-10 TER 5 f34-80 Composition: Eacn film coated tablet contains Empagliflozin 10 mg Colour Yellow Oxide of Iron Manutactu Ltd. Magnus-P mara-23 RampurTok magnus Bara,Nepal fMNT-0 fT-90 GLIFAZ-10 f-90 GLIFAZ10 ', {'entities': [[11, 32, 'COMMON NAME'], [120, 140, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 425: MPPLNATTO-OO Empagliflozin Tablets 750629075938 Mfg.Lic.No.17 GLIFAZ-25 f4-74 HHE Composition: Each film coated tablet contains: Hant:fafan Empagliflozin 25 mg fa-faaur ColourPearly white f Manufactured By: y a Pvt.Ltd Magnus PharmaP Bara,Nepal maqnus Rampur Tokani,Ba -25 -4GLFAZ-25-4GLFAZ-25 -4GLIFAZ-2 B.No.KZ23001 MFG.FEB.2023 EXP.JAN.2025 M.R.PRs.55000PER10TABS ', {'entities': [[23, 45, 'COMMON NAME'], [151, 170, 'COMPOSITION NAME']]}], ['', {'entities': []}], ['Image 427: 10x30 T Rx Amlodipine Tablets IP 5 mg Amtas-5 JHCRA-4 INTAS ', {'entities': [[22, 40, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 428: SAWNoNeNero vesoh bvretaf withol INTAS Baubea 708398 the presrrtlon ofa Hediaered Modics Practions Rx Amlodione Tablets P 5 mg TNTAS Amass Each uncoated tablet contains: AmlodipineBesylate IP equivalent to Amlodipine 5 mg Colour cindigocarmine Exciplenns QS DoseAs orectedbwthe Physician 85533333332 Store inadark & dry place. SCHEDUN HPRESCRRTION DRUG CAUTION Not to be solday retail withou the pre on of a Recistered Medica Rx Amlodisne TabletsP5 mg INTAS L Amtas-5 Eachuncoated tablet contains: Amlodipine Besylate P eqwvalent to Amlodipine 5 mg 1ISDI93 Colour:indigocarmine Excipients Q.S. Aq par Dose:As directed by thePhysician. Store in a dark & dry place 88 ', {'entities': [[113, 130, 'COMMON NAME'], [217, 232, 'COMPOSITION NAME'], [440, 457, 'COMPOSITION NAME']]}], ['Image 429: 5x10Tablets Telmisartan Tablets IP TIGATEL 20 ', {'entities': [[23, 42, 'COMMON NAME']]}], ['Image 431: 10x10 Tablets Sodium Valproate Gastro-resistant Tablets IP Encorate300 ', {'entities': [[25, 66, 'COMMON NAME']]}], ['Image 432: Store at room temperature Plot No.107-108.Nam Block ierrp protected from light and moisture P.0.Ranipool.East-Sikkim-737135 Levipil 250 Levipil 250 Levipil 250 Levetiracetam TabletsIP 90b9 Levipil250 CHEDULEHPRESCRIP DRUG-CAUTIONNOtO.be Each film coated tablet contains 250 mg soldbyretail without the Levetracetam IP PEE22PPP3D escoptonota.Neuplogis Excipents Q.S. ColocrsFenic Oxide Reg USP-NF M.LM/645/2014 Bgant Bue FCF Tajum Dioxide P MaacledncaDy DosageAs drecied by suRerarma lavaratqresio Neuroiogist. 107108N e at room temsaaue lected from lig Cmoisture anipoo.Easi-Sy135. vipil 250 Levipil Levipieo50 acetamrablasyP OVA 490 81250 ', {'entities': [[171, 192, 'COMMON NAME']]}], ['Image 433: R 1010 Tablets Levetiracetam TabletsIP Levipil 250 ', {'entities': [[26, 47, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 434: 10x 15 Tablets Ursodeoxycholic Acid Tablets IP Ursocol R 300 ', {'entities': [[26, 54, 'COMMON NAME']]}], ['', {'entities': []}], ['Image 435: erbonate 00mg Registered Trade Mark OosaeAs directed by the Physician a.s M.L.374/DR/Mfg/2013 PEEEEEE22 e arom lemperature Manufactured in india by otected from light and moisture sun pharma laboratories itd sbiet should be swallowed whole Vill Kokjhar. Mirza Palashbari Road and not to be chewed or crushed P.OPalashbariDistKamrupAssam-781128 LITHOSUNSR LITHOSUNSR LITHOSUNSR LITHOSUNSR Each uncoated prolonged release etail withoutthe presaripuon ot tablet contains dicalPractitioner. thium Carbonate IP 400.mg Sxclpients Registered Trade Mark q.s. DosageAs directed by tie Pnysician M.L374/OR/Mfg/2013 PEEPPPP12 Store atrcom temperature Manufactured in India by rotected.from light and moisture sun pharma laboratoriesltd t shoulg bo swallowed whole Vill Kokhar,Mirza PalashbarkRoad d not to be chewed or crushed. P.O.PalashbariDistKamrupAssam781128 LITHOSUNSR LITHOSUNSR LITHOSUNSR Lithium Carbonate Prolonged Release Tablets IP LITHOSUNSR TONDP CAUTION cach uncoated prolongedrelease Not to ber Od by retail without the echption ot tabietcontains: Regist MedicalPractitionee Jhiuruarbonate IP 400mg Registered Trade Mark Excirionte 9.8 M.L374/DR/Mfg/2013 PESPPP12 Josage s directed by the Physician Stere at room temperature Manutactursdnindia by: cted from light and msre sun pharma laboratories Itd et should be swallowra-whole Vill Kokjha Mirza Palashbari Roag not to be chewsd or zorshed P.O.Palabari.DistKamrupAssam781128 THOSUNSR LITHOSUNSSR LITHOSUNSR thium Caroonate Prolonged Release Tablets IP RTEOSUNPSK ', {'entities': [[897, 940, 'COMMON NAME']]}], ['Image 436: NIMS\" NIMS- NIMS NIMESULIDE TABLETS NIMS Fxcn untsated tabe contains Wresuideep s00mg TrtyMaryaecsered eepalt Asian Prarmaceuticals Pvt.Ltd Omsatrysp/.Rupandehi NIMS NIMS NIMS ', {'entities': [[28, 46, 'COMMON NAME']]}], ['', {'entities': []}], ['', {'entities': []}]]}\n"]}],"source":["\n","f = open('test-train-data/test.json')\n","TRAIN_DATA = json.load(f)\n","print(TRAIN_DATA)"]},{"cell_type":"markdown","metadata":{"id":"AEJRTAvBRNaQ"},"source":["CONVERT TEST DATA INTO SPACY FORMAT."]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":428,"status":"ok","timestamp":1705232803998,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"U9jjUe0azssy","outputId":"7beff83b-2f4d-417a-b7be-1c36ba5f4abd"},"outputs":[{"name":"stderr","output_type":"stream","text":["100%|██████████████████████████████████████████| 97/97 [00:00<00:00, 293.62it/s]\n"]}],"source":["for text, annot in tqdm(TRAIN_DATA['annotations']):\n","    doc = nlp.make_doc(text)\n","    ents = []\n","    for start, end, label in annot[\"entities\"]:\n","        span = doc.char_span(start, end, label=label, alignment_mode=\"contract\")\n","        if span is None:\n","            print(\"Skipping entity\")\n","        else:\n","            ents.append(span)\n","    doc.ents = ents\n","    db.add(doc)\n","\n","db.to_disk(\"./test_data.spacy\")"]},{"cell_type":"markdown","metadata":{"id":"U50lSRnnRNaQ"},"source":["__EVALUATE THE TEST SET.__"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":15691,"status":"ok","timestamp":1705238618993,"user":{"displayName":"ashish pokharel","userId":"07017119239751588930"},"user_tz":-345},"id":"4NqdkvtxG5fb","outputId":"5791b90a-8490-4dc4-b2e2-232b908094f9"},"outputs":[{"name":"stdout","output_type":"stream","text":["\u001b[38;5;4mℹ Using CPU\u001b[0m\n","\u001b[1m\n","================================== Results ==================================\u001b[0m\n","\n","TOK     100.00\n","NER P   95.64 \n","NER R   84.87 \n","NER F   89.94 \n","SPEED   12525 \n","\n","\u001b[1m\n","=============================== NER (per type) ===============================\u001b[0m\n","\n","                       P       R       F\n","COMMON NAME        96.26   81.32   88.16\n","COMPOSITION NAME   94.87   89.88   92.31\n","\n"]}],"source":["!python3 -m spacy evaluate models/model-last ./test_data.spacy"]},{"cell_type":"code","execution_count":1,"metadata":{"id":"yb_06StmRNaR","executionInfo":{"status":"ok","timestamp":1705844792082,"user_tz":-345,"elapsed":1224,"user":{"displayName":"xaxm mhrz","userId":"09532132245603657312"}},"outputId":"36bf0390-cef5-474b-a25d-a869f1560df2","colab":{"base_uri":"https://localhost:8080/","height":564}},"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x600 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}],"source":["import matplotlib.pyplot as plt\n","\n","def plot_metrics(epochs, f1_values, precision_values, recall_values):\n","    plt.figure(figsize=(10, 6))\n","\n","    # Plot F1\n","    plt.plot(epochs, f1_values, label='F1', marker='o')\n","\n","    # Plot Precision\n","    plt.plot(epochs, precision_values, label='Precision', marker='o')\n","\n","    # Plot Recall\n","    plt.plot(epochs, recall_values, label='Recall', marker='o')\n","\n","    plt.xlabel('Epochs')\n","    plt.ylabel('Score')\n","    plt.title('Training Accuracy')\n","    plt.legend()\n","    plt.grid(True)\n","    plt.show()\n","\n","# Example values (replace these with your actual data)\n","epochs = [0, 1, 2, 3, 5, 7, 9, 12, 16, 21, 27, 35, 44, 54, 63, 73, 83, 92, 102, 111, 121, 131, 140, 150, 159, 169, 179, 188, 198, 208, 217, 227, 236, 246, 256, 265, 275, 284, 294, 303, 313]\n","f1_values = [0.00, 11.54, 34.53, 68.64, 82.04, 85.89, 94.99, 94.37, 97.21, 98.00, 98.10, 98.21, 97.63, 98.51, 98.41, 98.50, 98.43, 98.61, 98.52, 98.61, 98.61, 98.61, 98.61, 98.61, 98.70, 98.90, 98.50, 98.71, 98.71, 98.90, 98.91, 98.91, 98.91, 98.91, 98.81, 98.90, 98.80, 98.90, 98.71, 98.91, 98.90]\n","recall_values = [0.00, 10.34, 34.39, 66.80, 84.89, 82.31, 94.23, 93.24, 96.82, 97.61, 97.61, 98.21, 98.21, 97.61, 99.40, 98.61, 99.01, 98.81, 99.01, 98.81, 99.01, 98.81, 98.61, 99.01, 98.41, 98.41, 97.61, 99.01, 98.61, 98.61, 99.20, 98.81, 99.60, 99.01, 98.81, 98.21, 98.61, 98.41, 98.81, 98.81, 98.61]\n","precision_values = [0.00, 13.07, 24.21 , 34.67, 70.59, 79.37, 89.80, 95.76, 95.52, 97.60, 98.40, 98.59, 98.21, 97.05, 98.22, 98.60, 99.39, 97.47, 98.61, 98.03, 98.42, 98.22, 98.61, 98.22, 99.00, 99.40, 99.39, 98.42, 98.80, 99.00, 98.62, 99.00, 98.24, 98.81, 98.81, 99.60, 99.00, 99.40, 98.61, 99.00, 99.20]\n","\n","# Call the function to plot the metrics\n","plot_metrics(epochs, f1_values, precision_values, recall_values)\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"IM2_oplwRNaS","outputId":"b1c9e2f4-8b45-40df-910d-764a49b253da"},"outputs":[{"name":"stdout","output_type":"stream","text":["Length of y_true: 359\n","Length of y_pred: 359\n","Length of tp_list: 283\n","Length of fn_list: 65\n","Length of fp_list: 11\n","NER Precision: 96.26%\n","NER Recall: 81.32%\n","NER F1 Score: 88.16%\n"]},{"data":{"image/png":"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","text/plain":["<Figure size 800x600 with 2 Axes>"]},"metadata":{},"output_type":"display_data"}],"source":["import spacy\n","from spacy.tokens import DocBin\n","from spacy.training.example import Example\n","from sklearn.metrics import precision_recall_fscore_support\n","import seaborn as sns\n","import matplotlib.pyplot as plt\n","\n","# Load your trained spaCy NER model\n","nlp = spacy.load(\"models/model-last\")\n","\n","# Load test data from a .spacy file\n","test_data_path = \"test_data.spacy\"  # Replace with the actual path to your test data\n","doc_bin = DocBin().from_disk(test_data_path)\n","test_data = list(doc_bin.get_docs(nlp.vocab))\n","\n","# Initialize lists for true positives, false positives, and false negatives\n","tp_list, fp_list, fn_list = [], [], []\n","\n","# Initialize lists for y_true and y_pred\n","y_true_list, y_pred_list = [], []\n","\n","# Specify the entity label you want to evaluate (e.g., \"COMMON NAME\")\n","eval_entity_label = \"COMMON NAME\"\n","\n","# Iterate through the test data\n","for doc in test_data:\n","    gold_dict = {\"text\": doc.text, \"entities\": [(ent.start_char, ent.end_char, ent.label_) for ent in doc.ents]}\n","    gold = Example.from_dict(nlp.make_doc(doc.text), gold_dict).reference  # Access gold annotations via .reference\n","\n","    # Get predicted entities from the model\n","    doc_pred = nlp(doc.text)\n","    pred_entities = [(ent.start_char, ent.end_char, ent.label_) for ent in doc_pred.ents]\n","\n","    # Initialize y_true and y_pred for the current document\n","    y_true, y_pred = [], []\n","\n","    # Update true positives, false positives, and false negatives\n","    for span in gold.ents:\n","        if span.label_ == eval_entity_label:\n","            if (span.start_char, span.end_char, span.label_) in pred_entities:\n","                tp_list.append(1)\n","                y_true.append(1)\n","                y_pred.append(1)\n","            else:\n","                fn_list.append(1)\n","                y_true.append(1)\n","                y_pred.append(0)\n","\n","    for ent in pred_entities:\n","        if ent[2] == eval_entity_label:\n","            if ent not in [(span.start_char, span.end_char, span.label_) for span in gold.ents]:\n","                fp_list.append(1)\n","                y_true.append(0)\n","                y_pred.append(1)\n","\n","    # Append y_true and y_pred to the lists\n","    y_true_list.extend(y_true)\n","    y_pred_list.extend(y_pred)\n","\n","# Ensure that y_true and y_pred have the same length\n","y_true = y_true_list\n","y_pred = y_pred_list\n","\n","# Print the lengths of y_true and y_pred\n","print(\"Length of y_true:\", len(y_true))\n","print(\"Length of y_pred:\", len(y_pred))\n","\n","# Print the lengths of tp_list, fn_list, fp_list\n","print(\"Length of tp_list:\", len(tp_list))\n","print(\"Length of fn_list:\", len(fn_list))\n","print(\"Length of fp_list:\", len(fp_list))\n","\n","# Calculate Precision, Recall, and F1 Score\n","precision, recall, f1, _ = precision_recall_fscore_support(y_true, y_pred, average='binary')\n","\n","# Print Precision, Recall, and F1 Score\n","print(f\"NER Precision: {precision * 100:.2f}%\")\n","print(f\"NER Recall: {recall * 100:.2f}%\")\n","print(f\"NER F1 Score: {f1 * 100:.2f}%\")# Create confusion matrix\n","conf_matrix = confusion_matrix(y_true, y_pred)\n","\n","# Plot confusion matrix\n","plt.figure(figsize=(8, 6))\n","sns.heatmap(conf_matrix, annot=True, fmt=\"d\", cmap=\"Blues\", xticklabels=['No Entity', 'Entity'],\n","            yticklabels=['No Entity', 'Entity'])\n","plt.xlabel('Predicted')\n","plt.ylabel('Actual')\n","plt.title('Confusion Matrix(COMMON NAME)')\n","plt.show()\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"GzoA9n9GRNaS","outputId":"2e06afd2-f2a6-468e-c562-d780ab5a1140"},"outputs":[{"name":"stdout","output_type":"stream","text":["Length of y_true: 259\n","Length of y_pred: 259\n","Length of tp_list: 222\n","Length of fn_list: 25\n","Length of fp_list: 12\n","NER Precision: 94.87%\n","NER Recall: 89.88%\n","NER F1 Score: 92.31%\n"]},{"data":{"image/png":"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","text/plain":["<Figure size 800x600 with 2 Axes>"]},"metadata":{},"output_type":"display_data"}],"source":["import spacy\n","from spacy.tokens import DocBin\n","from spacy.training.example import Example\n","from sklearn.metrics import precision_recall_fscore_support\n","import seaborn as sns\n","import matplotlib.pyplot as plt\n","\n","# Load your trained spaCy NER model\n","nlp = spacy.load(\"models/model-last\")\n","\n","# Load test data from a .spacy file\n","test_data_path = \"test_data.spacy\"  # Replace with the actual path to your test data\n","doc_bin = DocBin().from_disk(test_data_path)\n","test_data = list(doc_bin.get_docs(nlp.vocab))\n","\n","# Initialize lists for true positives, false positives, and false negatives\n","tp_list, fp_list, fn_list = [], [], []\n","\n","# Initialize lists for y_true and y_pred\n","y_true_list, y_pred_list = [], []\n","\n","# Specify the entity label you want to evaluate (e.g., \"COMMON NAME\")\n","eval_entity_label = \"COMPOSITION NAME\"\n","\n","# Iterate through the test data\n","for doc in test_data:\n","    gold_dict = {\"text\": doc.text, \"entities\": [(ent.start_char, ent.end_char, ent.label_) for ent in doc.ents]}\n","    gold = Example.from_dict(nlp.make_doc(doc.text), gold_dict).reference  # Access gold annotations via .reference\n","\n","    # Get predicted entities from the model\n","    doc_pred = nlp(doc.text)\n","    pred_entities = [(ent.start_char, ent.end_char, ent.label_) for ent in doc_pred.ents]\n","\n","    # Initialize y_true and y_pred for the current document\n","    y_true, y_pred = [], []\n","\n","    # Update true positives, false positives, and false negatives\n","    for span in gold.ents:\n","        if span.label_ == eval_entity_label:\n","            if (span.start_char, span.end_char, span.label_) in pred_entities:\n","                tp_list.append(1)\n","                y_true.append(1)\n","                y_pred.append(1)\n","            else:\n","                fn_list.append(1)\n","                y_true.append(1)\n","                y_pred.append(0)\n","\n","    for ent in pred_entities:\n","        if ent[2] == eval_entity_label:\n","            if ent not in [(span.start_char, span.end_char, span.label_) for span in gold.ents]:\n","                fp_list.append(1)\n","                y_true.append(0)\n","                y_pred.append(1)\n","\n","    # Append y_true and y_pred to the lists\n","    y_true_list.extend(y_true)\n","    y_pred_list.extend(y_pred)\n","\n","# Ensure that y_true and y_pred have the same length\n","y_true = y_true_list\n","y_pred = y_pred_list\n","\n","# Print the lengths of y_true and y_pred\n","print(\"Length of y_true:\", len(y_true))\n","print(\"Length of y_pred:\", len(y_pred))\n","\n","# Print the lengths of tp_list, fn_list, fp_list\n","print(\"Length of tp_list:\", len(tp_list))\n","print(\"Length of fn_list:\", len(fn_list))\n","print(\"Length of fp_list:\", len(fp_list))\n","\n","# Calculate Precision, Recall, and F1 Score\n","precision, recall, f1, _ = precision_recall_fscore_support(y_true, y_pred, average='binary')\n","\n","# Print Precision, Recall, and F1 Score\n","print(f\"NER Precision: {precision * 100:.2f}%\")\n","print(f\"NER Recall: {recall * 100:.2f}%\")\n","print(f\"NER F1 Score: {f1 * 100:.2f}%\")\n","# Create confusion matrix\n","conf_matrix = confusion_matrix(y_true, y_pred)\n","\n","# Plot confusion matrix\n","plt.figure(figsize=(8, 6))\n","sns.heatmap(conf_matrix, annot=True, fmt=\"d\", cmap=\"Blues\", xticklabels=['No Entity', 'Entity'],\n","            yticklabels=['No Entity', 'Entity'])\n","plt.xlabel('Predicted')\n","plt.ylabel('Actual')\n","plt.title('Confusion Matrix(COMPOSITION NAME)')\n","plt.show()\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"iMdiqdcvRNaU"},"outputs":[],"source":[]}],"metadata":{"colab":{"provenance":[{"file_id":"1JsFjiFEXdRAJNkE_dohP291rn7sJwIoA","timestamp":1705231125323}]},"kernelspec":{"display_name":"Python 3 (ipykernel)","language":"python","name":"python3"},"language_info":{"codemirror_mode":{"name":"ipython","version":3},"file_extension":".py","mimetype":"text/x-python","name":"python","nbconvert_exporter":"python","pygments_lexer":"ipython3","version":"3.10.12"}},"nbformat":4,"nbformat_minor":0}